Volume 20, issue 5 by Canadian Medical Association
Western University
Scholarship@Western
Canadian Journal of Surgery
9-1-1977
Volume 20, issue 5
Canadian Medical Association
Follow this and additional works at: https://ir.lib.uwo.ca/cjs
Part of the Surgery Commons
This Book is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Canadian Journal of Surgery by an
authorized administrator of Scholarship@Western. For more information, please contact tadam@uwo.ca, wlswadmin@uwo.ca.
Recommended Citation
Canadian Medical Association, "Volume 20, issue 5" (1977). Canadian Journal of Surgery. 112.
https://ir.lib.uwo.ca/cjs/112
September 1977 THE CANADIAN JOURNAL OF SURGERY 399
Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
TO DAVE SHEPHARD —  MANY THANKS
David A. E. Shephard joined the Canadian 
Medical Association in November 1974 and 
left in July 1977. Following training in anes­
thesia in Rochester (England), Boston and 
Montreal, and several years as an anesthetist 
in Halifax (during which he was editor of the 
Nova Scotia Medical Bulletin), he moved 
to become consultant and editor in the 
section of publications, Mayo Clinic, Ro­
chester, Minnesota. For 2 years he com­
bined interest and skill in writing before 
returning to Canada as associate scientific 
editor of the Canadian Medical Association 
Journal and associate editor of the Canadian 
Journal of Surgery. His vision, foresight and 
industry have helped our Journal. He insti­
tuted the section “Glimpses of Surgical His­
TREATMENT OF PRIMARY
The report by Norvell and colleagues in 
this edition (page 429) raises again the 
issue of elective lymphadenectomy for the 
treatment of primary malignant melanoma. 
To plagiarize Hiles, the question of dis­
carding lymphadenectomy for malignant 
melanoma is analogous to the old question 
of whether one has stopped beating one’s 
wife; “if the answer is ‘yes’ very good 
reasons are expected to justify the actions 
of the past but it is assumed that better 
tactics have prevailed. If the answer is ‘no’, 
even more forceful arguments in favour of 
the present procedures are necessary”.1
The problem is whether elective lympha­
denectomy should be discarded in favour 
of therapeutic lymphadenectomy. Norvell 
and associates propose the advantages of 
elective over therapeutic lymphadenectomy. 
Neither their report nor reports from the
tory” and has contributed to “Quill on 
Scalpel” as well as to the book review 
section. His behind-the-scenes efforts have 
been tireless, fruitful, imaginative and 
always productive. He leaves to accept a 
position in the new McGill Centre for Ad­
vanced Studies in Primary Care at the 
Montreal General Hospital, and in the 
department of family medicine, McGill 
University. He takes with him not only our 
thanks for the past, but our hopes for a 
successful and satisfying future. He has been 
a loyal supporter and a colleague of great 
talent.
L. D. MacLean , md, f r c s[c]
C. B. M ueller , md, f r c s[c]
MALIGNANT MELANOMA
literature provide sufficient evidence for the 
maintenance of elective lymphadenectomy. 
They report on a relatively small 
retrospective series that is open to all 
the criticisms of such series. They attempted 
to avoid selection of data, but this is difficult 
except in prospective randomized studies. 
The survival rate of only 33% for patients 
who did not undergo lymphadenectomy is 
lower than that anticipated for patients 
with stage I melanoma, levels 3 to 5 by 
depth of invasion.2 In addition, this is a 
regional study that is at variance with more 
cosmopolitan reports (see also page 474).
My bias is in favour of therapeutic 
lymphadenectomy. At the Toronto General 
Hospital lymphangiography is a routine 
procedure for all patients with melanoma 
of an extremity that is classified as level 
3 to 5 by the depth of invasion. A biopsy
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is taken of all clinically and radiologically 
suspicious lymph nodes and, if the biopsy 
is positive, a formal, thorough lymph-node 
dissection is performed. However, the rou­
tine use of elective lymphadenectomy, in 
which the frequency of short- and long-term 
complications (lymphedema, necrosis of 
skin flaps) is appreciable, is not justified 
on the basis of a thorough assessment of 
the literature. If the report by Norvell and 
colleagues can be confirmed by additional 
retrospective studies in other centres the 
use of elective lymphadenectomy should be 
re-examined by a national, prospective 
randomized study. Until evidence from
such a study is available, the elective use 
of lymphadenectomy for malignant mela­
noma is not justified.
R. E. Falk, md, frcs[c]
Department of surgery,
Toronto General Hospital,
Toronto, Ont.
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CARCINOMA OF THE ESOPHAGUS: ADVANTAGES OF THE
PROSPECTIVE TREATMENT PROTOCOL
Squamous cell carcinoma of the esophagus 
is associated with the lowest overall cure 
rate of any solid tumour. The esophagus is 
a distensible organ and obstructive symp­
toms occur late in the disease; also a rich 
submucosal lymphatic plexus and the lack 
of a serous covering favour early direct ex­
tension of malignant disease to adjacent vital 
organs as well as early distant lymphatic 
metastases, thus limiting the role of surgical 
excision or radiotherapy. These factors have 
resulted in a defeatist attitude by many1 in 
the management of patients with carcinoma 
of the esophagus.
Stoller and his colleagues in this issue 
(page 454) have presented further evidence 
to support this attitude. They rightly point 
out the shortcomings of a retrospective study 
in evaluating any form of treatment and 
have proposed a weighted grading system 
to quantitate palliation in an objective man­
ner.
In the McGill University teaching hos­
pitals in Montreal, we have taken the op­
posite philosophical approach to squamous 
col is based on radical surgery (to- 
followed a protocol for the past 5 years in 
which the ultimate goal is cure. The proto­
cell carcinoma of the esophagus and have 
tal esophagectomy) in a highly selected 
group of patients, similar to that proposed 
by Murray, Wilcox and Starek.2 Each pa­
tient is carefully studied by the usual clinical 
and radiologic investigations. Tissue diag­
nosis and geographic localization of the 
tumour are established by esophagoscopy and 
bronchoscopy. Any patient with extraeso- 
phageal spread, fistula formation, or distant 
metastases in liver or cervical nodes is 
immediately placed in the “palliative” treat­
ment group. All others receive hyperali­
mentation and preoperative radiotherapy ac­
cording to the technique described by Aka- 
kura and colleagues3 (500 rad/d for 5 days, 
followed by surgery).
Further patient selection is made in the 
operating room where each patient has a 
laparotomy and biopsy of a celiac lymph 
node. If the biopsy is negative and the le­
sion is located in the middle or upper thirds 
of the esophagus, cervicomediastinal ex­
ploration is performed through a vertical 
neck incision. This allows exploration of 
mediastinal nodes, assessment of the tracheo­
esophageal wall as well as biopsy of sub- 
carcinal nodes with the mediastinoscope. 
Involvement by tumour of celiac or me­
diastinal nodes precludes further surgery, 
and the patient receives a palliative course 
of radiotherapy. This course of action is based 
on the observation of Guernsey, Knudsen 
and Mark4 and others5 that patients with 
involvement of celiac or supraclavicular 
nodes were dead within 12 months regard-
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less of the form of therapy used. If both 
celiac-node biopsy and cervicomediastinal 
exploration are negative, a total esophagec­
tomy is carried out through a right thoraco­
tomy. Gastrointestinal continuity is re-estab­
lished with a total gastric pedicle in patients 
with lesions of the lower or middle thirds 
of the esophagus6 and with a reversed gas­
tric tube (Heimlich) in those with lesions of 
the upper third. In the latter esophagogas­
tric anastomosis is performed in the neck.
Twenty-eight of 78 patients with carci­
noma of the esophagus have completed the 
“curative” phase of this protocol in the past 
5 years. It is still too early to assess the 
value of this protocol but certain observa­
tions appear valid. With the aid of laparo­
tomy and cervicomediastinal exploration to 
select the most favourable candidates, radi­
cal surgery was associated with an operative 
mortality of 9%. Of the 28 patients there 
are presently 8 survivors (6 apparently free 
of disease). Excellent palliation as judged 
by restoration of swallowing and control of 
pain was achieved, and surviving patients 
would all score above 75 by Stoller’s grad­
ing system. From a rapid application of this 
grading system to our own results, it be­
came obvious that the numerical score is 
time-related and could change quickly with 
the recurrence of disease.
It is clear that the prospective protocol is 
essential for evaluating the impact of any 
therapeutic modality on squamous cell car­
cinoma of the esophagus. This is particu­
larly true when chemotherapy and immuno­
therapy are being evaluated as adjuvant 
therapy.
D. S. Mulder, md, frcs[c]
Department of surgery, 
Montreal General Hospital, 
Montreal, PQ.
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S E L F - A S S E S S M E N T
SESAP II QUESTION
520. The preferred method of differentiating a breast cyst from carcinoma of the breast is
(A) excisional biopsy
(B) incisional biopsy
(C) mammography
(D) needle aspiration
(E) thermography
For this incomplete statement select the one completion that is BEST from those noted 
above.
For the critique of Item 520 see page 426 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus: 
Surgical Education and Self-assessment Program No. 2.)
Hibitane*— r
2-PHASE PREOPERATIVE PREP
A skin disinfection technique to provide maximum reduction (kill) of bacterial flora at operation sites.
PHASE I
Hibitane 
Skin Cleanser 
on the ward
PHASE 2
Hibitane 
Gluconate 
20% Solution 
(suitably diluted) 
in the
operating room
Wet site of operation. 
Using a sterile gauze 
pad impregnated with 
HIBITANE Skin 
Cleanser, swab the 
site and surrounding' 
area for two minutes. 
Rinse and dry. Three 
applications are 
recommended the day 
before the operation!"
The 2-phase skin 
preparation is com­
pleted by application 
in the usual way, of 
0.5% w/v HIBITANE, 
gluconate in 70% 
alcohol solution.
HIBITANE is an ideal antiseptic for preoperative patient preparation. HIBITANE is active against qram-positive 
and gram-negative organisms. Long experience in hospitals has confirmed its outstanding antibacterial 
effectiveness, low toxicity, and rapid persistent effect.
Hibitane Skin Cleanser/Hibitane Gluconate 20% Solution
(4% w/v chlorhexidine gluconate)
Complete product information available on request.
(chlorhexidine gluconate solution B.P.)
Ayerst Q uality has no substitute AYERST LABORATORIESDivision of Ayerst, McKenna & Harrison Limited, Montreal, Canada
Made in Canada by arrangement with IMPERIAL CHEMICAL INDUSTRIES LIMITED
| PMAC J
•Reg'd 5673/2/77/E
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REV IEW  A R T IC L E
ALKALINE GASTRITIS AND ALKALINE ESOPHAGITIS: A REVIEW*
HARRY S. HIMAL, MD, FRCS[C]
Alkaline gastritis and alkaline esophagitis are 
now precisely defined syndromes. They occur 
most often after gastric surgery in which func­
tion of the pyloric and lower esophageal 
sphincter is compromised. Reflux of bile in these 
patients can then lead to severe inflammation 
of the gastric and lower esophageal mucosa. 
Epigastric pain, nausea and bilious vomiting are 
characteristic symptoms. Gastroscopy with biop­
sy is, therefore, the definitive diagnostic test; 
during endoscopy bile is seen in the lower 
esophagus or stomach, and the mucosa is red, 
friable and contains acute erosions. Conservative 
therapy including the administration of choles­
tyramine has not been helpful. Surgery con­
sisting of diversion of the duodenal contents 
away from the stomach and lower esophagus is 
the treatment of choice. The Roux-en-Y pro­
cedure has been used most often and has 
resulted in the amelioration of the symptoms 
and signs in most patients.
La gastrite alcaline et I’oesophagite alcaline 
constituent des syndromes maintenant bien 
definis. Celles-ci surviennent le plus souvent 
apres une chirurgie gastrique ou le fonctionne- 
ment du sphincter pylorique et de celui de 
I’oesophage inferieur a ete affecte. Un reflux de 
bile chez ces patients peut alors entrainer une 
grave inflammation de la muqueuse gastrique et 
oesophagienne inferieure. Les symptomes carac- 
teristiques comprennent des douleurs epigas- 
triques, des nausees et des vomissements de 
bile. La gastroscopie avec biopsie est done le 
test diagnostique definitif; durant I'endoscopie, 
on observe de la bile dans I’oesophage inferieur 
ou I'estomac, la muqueuse est rouge, friable et 
presente des erosions aigues. Un traitement 
conservateur comprenant (’administration de 
cholestyramine n'a ete d'aucune utilite. Le traite­
ment de choix est chirurgical et il consiste a 
detourne le contenu duodenal de I’estomac et
*From the department of experimental surgery, 
McGill University, and department of surgery, 
Royal Victoria Hospital, Montreal, PQ.
Presented in part at the sectional meeting, Royal 
College of Physicians and Surgeons of Canada, 
Montreal, PQ, October 1974.
Supported by the Medical Research Council of 
Canada.
Reprint requests to: Dr. Harry S. Himal, Depart­
ment of surgery, Royal Victoria Hospital, 687 Pine 
Ave. W, Montreal, PQ H3A 1A1.
de I’oesophage inferieur. Le procede de Roux- 
en-Y a ete utilise le plus frequemment et a 
procure une amelioration des symptomes chez 
la plupart des patients.
Within the last 25 years alkaline gastritis 
and esophagitis have become precisely 
defined syndromes; they have been separated 
from the complex of disease entities labelled 
postgastrectomy syndromes. Reflux of duo­
denal contents into the stomach and eso­
phagus is considered to be the important 
mechanism involved in the development of 
these syndromes. William Beaumont1 was 
the first to point out the relation between 
bile in the stomach and disease; he reached 
his conclusions on the basis of experiments 
he conducted on gastric juice collected from 
a young French-Canadian, Alexis St. Mar­
tin, who had sustained a shotgun injury to 
the abdomen. Beaumont reported that “bile 
is seldom found in the stomach, except under 
peculiar circumstances. It is never found 
in the gastric cavity in a state of health, and 
it is only in certain morbid conditions that 
it is found there.”
This review deals with the pathophysi­
ology, clinical findings and treatment of the 
alkaline reflux syndromes. Current concepts 
on subjects such as the effect of bile on 
ionic movements, lysosomal membrane in­
tegrity and gastric mucosal damage receive 
special attention.
A lkaline Gastritis
Pathophysiology
Historical aspects.— Until recently the 
term postgastrectomy syndrome included af­
ferent loop syndrome, early and late dump­
ing and postvagotomy diarrhea. In 1965, 
Toye and Williams2 proved conclusively that 
the afferent loop syndrome was not due to 
mechanical obstruction but was a gastritis 
caused by bile refluxing into the stomach. 
Beaumont first pointed out that bile played 
a role in gastric disease. Up to that time, 
investigators such as Magendie stated that 
in the healthy state bile was found in the
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stomach,1 but Beaumont, in his classic ex­
periments on Alexis St. Martin, discovered 
that only under certain conditions such as 
stress was this the case.
In 1914, Smith3 conducted experiments 
on cats and dogs illustrating that bile alone 
in contact with gastric mucosa did not cause 
gastritis; however, in the presence of acid, 
surface mucus precipitated and necrotic 
areas appeared in the gastric epithelium. 
Smith postulated that mucus protects the 
gastric mucosa and that bile alters the 
structure of mucus. In 1951, Grant and col­
leagues4 demonstrated that bile in contact 
with gastric mucosa caused severe cytolysis 
of the surface cells. The intracellular nuclei 
became shrunken and distorted, or dis­
appeared; under these circumstances there 
was evidence of severe and permanent cel­
lular damage. They also showed that it was 
bile salts (sodium dehydrocholate) that 
caused the cellular destruction.
Current developments.—By means of 
light and electron microscopy, Eastwood5 
has shown that instilling solutions contain­
ing sodium taurocholate into the stomach of 
the mouse caused the nuclear chromatin to 
clump. In addition cytoplasmic density with­
in the surface mucus cells was lost, and the 
surface cells ruptured. Other substances in 
the duodenal effluent may cause gastric 
mucosal damage. Lysolecithin is a normal 
constituent of duodenal juice; when put in 
contact with pancreatic phospholipase A, it 
hydrolyzes the biliary lecithin, and, when 
instilled into the stomach of shocked 
piglets, causes acute mucosal erosions.0
Normal gastric mucosa contains a barrier 
to the diffusion of hydrogen (H +) and sodi­
um (Na+) ions.7’ 8 Disruption of this barrier 
by various substances can lead to increased 
H + insorption and gastric mucosal damage.9 
Davenport10 considered increased H + and 
Na+ flux a measure of barrier damage; he 
irrigated vagally denervated fundic pouches 
in dogs with bile salts and demonstrated that 
disruption of the gastric mucosal barrier 
results. Similar studies in humans were per­
formed by Ivey, DenBesten and Clifton.11 
They compared ionic fluxes across human 
gastric mucosa after serial instillation of 
200 mL of 5.0 to 5.5 mM bile salts in 
hydrochloric acid (HC1) (160 mmol/L). 
The bile salt concentrations were similar to
those seen in the stomachs of patients with 
gastric ulcer. Bile salts produced a signi­
ficant loss of H + from the lumen and a 
significant gain in intraluminal Na+. Hamza 
and DenBesten12 demonstrated in normo- 
tensive dogs that acute gastric ulcers did not 
develop when bile salt solutions were 
instilled into the stomach. They13 also 
found that in dogs with an occluded pylorus, 
instillation of HC1 alone into the stomach 
led to a mean net flux of H + and Na+ that 
was similar in normotensive and in shocked 
animals. In addition, gastric mucosal lesions 
did not develop. However, when bile salts 
were added to the HC1 instillates, gastric 
erosions developed in all animals. Duodenal 
reflux as well as bile salts has been shown 
to cause acute gastric erosions during shock 
induced in laboratory animals.14
Although acute gastric erosions occur 
secondary to bile or duodenal reflux in 
animals, these erosions do not occur in nor­
motensive animals. Thus decreased blood 
flow in the gastric mucosa appears to be an 
important underlying factor in the pathogen­
esis of gastric erosions. Skillman and associ­
ates15 concluded from their studies that low 
mucosal blood flow was important in the 
pathogenesis of linear superficial fundic 
erosions and that submucosal arteriovenous 
shunting contributed to the low mucosal 
blood flow. Using the aminopyrine clearance 
technique to study gastric mucosal blood 
flow in dogs, O’Brien and Silen16 in­
vestigated the effects of high and low acid 
concentrations in vagally denervated fundic 
pouches during and after perfusion with bile 
salts. They determined that bile salts instilled 
into the pouches caused a notable reduction 
in gastric mucosal blood flow.
Experimental studies of bathing gastric 
mucosa with bile over a prolonged period 
have not shown a clear-cut relation between 
bile and gastritis. In dogs17 and in rats18’ 19 
it has been demonstrated that bile refluxing 
or flowing into the stomach does not lead to 
gastritis. However, reflux of duodenal con­
tents into the stomach of dogs can cause 
gastritis.20 Recently Dragstedt and associ­
ates,21 working with dogs, showed that 
although bile regurgitation caused micro­
scopic gastritis, frank gastric ulcers did not 
develop.
Clinically, there is evidence that reflux of
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duodenal contents is important in the patho­
genesis of gastritis and gastric ulcers.22 In 
the early 1960s Du Plessis,23’ 24 on evidence 
from gastrectomy specimens, incriminated 
bile as the cause of gastritis and chronic 
gastric ulcers. James and Pickering25 and 
Watkinson26 found that nocturnal samples 
of gastric juice from patients with gastric 
ulcer were more frequently bile stained than 
those from normal patients. Rhodes and 
associates27 have confirmed that bile re­
fluxing from the duodenum into the stomach 
is important in the development of. gastric 
ulcers. With carbon 1-4-labelled chenodeoxy- 
cholic acid they measured the radioactivity 
of gastric aspirates; in this way they demon­
strated reflux of bile salts from the duo­
denum into the stomach. The concentration 
of bile acids in the stomach was higher 
among patients with gastric ulcer in both 
fasting and postprandial states.
The association between gastric ulcer and 
gastritis is valid. It has been shown that in 
patients with gastric ulcers, there is consi­
derable antral gastritis.28’ 29
The role of acid is central to the devel­
opment of acute erosions and gastritis, as 
Smith3 demonstrated in the early part of 
this century. We conducted a series of ex­
periments in dogs30 with in-vivo explants of 
antrum placed in lucite chambers; the blood 
supply was left intact. We demonstrated that 
instillation of bile or HC1 alone did not 
cause acute gastric erosions; following the 
instillation of bile plus acid acute erosions 
occurred. These increased in size and num­
ber throughout the experimental period.
Bile regurgitating into the stomach can 
cause increased acid secretion. Because of 
persistent mucosal insorption of H +, mucosal 
damage is further aggravated.31 It is likely 
that bile stimulates antral gastrin release,32 
but is a stimulant only when it regurgitates 
into the stomach;33 in the duodenum it does 
not stimulate gastric secretion.
Duodenogastric reflux of bile into the 
stomach underlines the importance of the 
pyloric sphincter. The pylorus is related to 
antral motility. By endoscopy it can be seen 
that the pylorus is open most of the time. 
During antral motility, when a peristaltic 
wave reaches the pylorus, it closes. Thus, “the 
purpose of the pylorus is to prevent reflux 
into the stomach during cap systole”.34 By
means of pressure and motility studies, 
Fisher and Cohen35> 36 have shown that 
the pylorus acts as a true sphincter. It has 
also been shown that in the presence of 
gastritis and gastric ulceration the pylorus is 
incompetent and allows reflux of duodenal 
contents into the stomach.35- 37 Cigarette 
smoking increases reflux from the duodenum 
into the stomach in patients with gastritis 
and gastric ulcer.38 Nicotine is probably 
the etiologic factor since it increases gastro­
intestinal motility and causes relaxation of 
sphincters.39 Capper, Airth and Kilby40 
devised a test of pyloric competence; they 
instilled barium into the duodenum and 
found that in normal patients there was no 
leakage of barium from the duodenum into 
the antrum. On the other hand, the 
majority of patients with gastric ulcers 
demonstrated reflux.
Role of lysosomes.— The role of subcel- 
lular organelles such as lysosomes in the 
development of acute gastric erosions is 
being investigated. Lysosomes contain 
numerous acid hydrolases that when released 
can cause cellular damage and destruction. 
We have shown41 that HCl-saline solutions 
instilled into a canine antrum will result in 
increased acid hydrolase activity, indicative 
of lysosomal membrane disruption, and 
acute gastric erosions.
We also demonstrated42 that bile salts 
and HC1 instilled into the stomach disrupt 
lysosomal membrane-enzyme binding and 
initiate cell breakdown and ulceration.
Signs and Symptoms
Persistent epigastric pain is a character­
istic presenting symptom of alkaline gastritis 
and is often relieved by vomiting. Vomiting 
of bile is a common, distressing complaint. 
Afferent loop obstruction was postulated as 
the causative mechanism of this complica­
tion;43' 44 however, this was disproved by 
Toye and Williams,2 who demonstrated 
that when bile flowed from the afferent loop 
into the gastric stoma, the clinical syndrome 
of bilious vomiting appeared. In a detailed 
study of the symptomatology, Scudamore 
and associates45 pointed out that pain, 
nausea and vomiting, eructation, loss of 
weight and anorexia were commonly as­
sociated with bile reflux gastritis. Most pa-
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tients with alkaline gastritis have previously 
undergone operations for peptic ulcer; how­
ever, their symptoms usually do not appear 
for months to years after operation. Upper 
abdominal pain can be aggravated by the in­
gestion of meals, alkalis or milk products and 
this, in some instances, will cause patients 
to avoid eating; under such circumstances 
weight loss results.
Investigative Procedures
Gastroscopy with biopsy is the single 
most important diagnostic procedure present­
ly available. During endoscopy, ample reflux 
of bile into the antrum or gastric remnant 
can be seen. The gastric mucosa is friable, 
edematous and beefy red in colour, and acute 
erosions are often present. Gastric biopsy 
will reveal foci of mucosal atrophy, super­
ficial mucosal inflammation, erosions, sub­
mucosal inflammation and edema. Upper 
gastrointestinal radiographs do not help in 
the diagnosis, though they may eliminate 
such conditions as stomal ulceration. Gastric 
secretory studies usually demonstrate an 
alkaline basal pH with normal, hypo- or 
achlorhydria. In postvagotomy patients 
tests for insulin-induced hypoglycemia are 
usually negative.
Treatment
Clinical.— In attempts to reduce gastric 
acid secretion, a bland diet, antacids and 
anticholinergic medication have been tried 
initially, but have not been successful. 
Cholestyramine,46 a basic anionic exchange 
resin that binds bile salts, has also been used. 
Studies with animals have, however, been 
inconclusive: HC1 and taurocholic acid
instilled into the stomach of eight hypo­
tensive dogs produced severe mucosal 
ulceration in all animals; but HC1, tauro­
cholic acid and cholestyramine similarly 
instilled into another group of hypotensive 
dogs produced no acute erosions.47 Choles­
tyramine has prevented bile-induced acute 
gastric erosions in the rat also.48 However, 
in Eastwood’s49 study cholestyramine failed 
to prevent bile salt injury to mouse gastric 
mucosa.
In clinical studies, cholestyramine has 
been only moderately successful. Black and 
associates50 had minimal success in a con­
trolled trial to study the efficacy of choles­
tyramine in healing gastric ulcers in patients 
with bile reflux gastritis. Scudamore and 
Eckstam51 and others45' 50 used frequent 
clinical assessment and endoscopy in the in­
vestigation of patients with alkaline gastritis 
and demonstrated that cholestyramine was 
helpful in those with mild gastritis.
Preliminary work has been done on the 
effect of two triperpenoid compounds on 
the gastric mucosal barrier. In Heidenhain 
pouches of dogs irrigated with 10 mM bile 
acid solution at pH 2, H + and Na+ flux 
markedly increased, indicating damage to 
the gastric mucosa.52 Prior irrigation of the 
pouches with lauroyl glycyrrhetinic acid or 
carbenoxolone solution caused no increase 
in H + and Na+ flux when bile was instilled 
into the pouches.
Surgical.—Results of surgery have been 
more successful than other methods in treat­
ing alkaline gastritis. The basis of operative 
therapy is to divert duodenal contents away 
from the whole stomach or gastric remnant. 
Several reports attested to the value of duo­
denal diversion for the relief of postgas­
trectomy symptoms: Wells and Johnston53 
treated 21 patients who had bile reflux, 
dumping and bilious vomiting after opera­
tions for peptic ulcer, by conversion to a 
Roux-en-Y anastomosis. They made the 
point of performing a vagotomy, if not al­
ready done, and anastomosing the afferent 
loop to the efferent loop about 25 cm from 
the stomach. Fourteen patients obtained 
complete relief of symptoms and seven 
others had moderate relief. Conyers and col­
leagues54 studied 54 patients who had had a 
Roux-en-Y anastomosis for relief of postgas­
trectomy symptoms. The indications for 
revision were postprandial bilious regurgita­
tion, intermittent and copious vomiting of 
bile, and severe nausea or heartburn. Of the 
54 patients 30 were markedly improved. 
One patient had a stomal ulcer. Toye 
and Williams2 performed a conversion gas­
trectomy with interposition of a jejunal loop 
in nine patients. All were cured of their 
symptoms.
In 1967, Capper, Butler and Kilby55 
described a patient with flatulent dyspepsia, 
epigastric burning, dysphagia and regurgita­
tion of bile who had not had previous sur­
gery. Acid studies revealed hypochlorhydria
September 1977 THE CANADIAN JOURNAL OF SURGERY 407
and the pyloric regurgitation test de­
monstrated persistent reflux. Because the 
symptoms were increasing in severity, a 
Roux-en-Y procedure was carried out; the 
distal 5 cm of the pyloric antrum was ex­
cised and the anastomosis made about 25 
cm from the duodenojejunal junction. Three 
months later, the patient was completely 
asymptomatic.
Bartlett and Burrington56 reported five 
patients with bilious vomiting after gastrec­
tomy who were all symptom-free following 
construction of Tanner’s modified Roux- 
en-Y jejunojejunostomy.
In 1969 van Heerden and associates J 7 
described in detail the syndrome of post­
operative alkaline reflux gastritis. They 
discussed the clinical and gastroscopic find­
ings in five patients with gastritis following 
peptic ulcer surgery; in all, the establishment 
of a Roux-en-Y diversion prevented reflux 
and improved the clinical picture. Since 
then, many publications38’ 58-65 have suc­
cinctly outlined the clinical syndrome and 
surgical approach to postoperative reflux 
alkaline gastritis.
The three common surgical procedures to 
correct alkaline gastritis are: Tanner 19 (Fig. 
1), Roux-en-Y diversion (Fig. 2) and the
Fig. 1.—Tanner 19 procedure. Proximal half of 
afferent loop implanted into jejunum at least 30 
cm from gastroenterostomy stoma. Distal half of 
afferent loop implanted proximally.
Henley loop (Fig. 3). A vagotomy, if not 
previously done, should be added to these 
procedures. To date, about 282 cases of alka­
line gastritis treated surgically have been 
accurately documented in the English litera­
ture. I have analyzed the postoperative 
course according to the following rating sys­
tem (Table I): I—complete disappearance 
of preoperative symptoms, II— prior symp­
toms relieved, but mild new symptoms 
present, III— prior symptoms improved but 
still present and IV—no relief. Gastroscopy 
in the 10 patients with poor results (grades 
III and IV) after Henley loop reconstruc­
tion revealed persistent bile gastritis in all 
10.
Some of the poor results after remedial 
surgery can be attributed to poor gastric 
emptying. Davidson and Hersh66 studied 
22 patients with bile gastritis, who then 
underwent duodenal diversion; 7 had gastric 
atony and delay in gastric emptying, and the 
delay persisted after surgery. Even though
408 THE CANADIAN JOURNAL OF SURGERY Vol. 20
gastroscopy revealed resolution of late gas­
tritis, all patients had persistent abdominal 
pain, nausea and vomiting. Davidson and 
Hersh recommended that metoclopramide 
be prescribed for such patients; this drug 
promotes contraction of the fundus and 
proximal small bowel.67
In constructing the Roux-en-Y diversion, 
it is important to have the Roux-en-Y limb 
at least 40 to 50 cm from the gastroenteric 
stoma. A shorter limb fails to prevent reflux 
in the gastric remnant.21- 24- 56
The remedial surgery discussed above for 
alkaline gastritis is ulcerogenic, and unless 
acid secretion is greatly reduced, stomal 
ulceration will occur.68 Furthermore, diver­
sion of duodenal contents from the gastric
stoma can lead to increased acid secretion.50 
Thus, if not previously performed, antrec­
tomy or vagotomy, or both, must be done.
Because alkaline gastritis is common fol­
lowing operations for peptic ulcer, some 
a u t h o r s 69 have proposed diversion pro­
cedures as the primary approach to such 
operations. Du Plessis23 and Schofield and 
Anderson69 have proposed the Roux-en-Y 
procedure as the method of reconstruction 
in primary operations for peptic ulcers. 
However, Conyers and colleagues54 used 
this approach in 35 patients with duodenal 
ulcer, and stomal ulceration occurred in 3 
within 18 months of surgery.
Thus, the results of both experimental and 
clinical studies have demonstrated that alka­
line gastritis is a definite entity. Reflux of 
bile salts from the duodenum into the 
stomach is probably the major cause of gas­
tritis. Medical therapy is of minimal value, 
and only in mild cases. Surgical diversion of 
duodenal contents from the stomach that 
resulted in complete resolution of symptoms 
has caused anatomic alterations in the gastric 
mucosa. Roux-en-Y reconstruction is the 
most frequently used surgical procedure. 
Acid reduction by means of antrectomy or 
vagotomy, or both, in association with di­
version is necessary to prevent formation of 
stomal ulcers.
A lkaline E sophagitis
Pathophysiology
Esophagitis is almost always the result of 
regurgitation of acid peptic secretion from 
the stomach. However, the very operations 
that lower or abolish acid peptic secretion 
are sometimes followed by severe alkaline 
esophagitis.70- 71 There is evidence that bile 
is important in the pathogenesis of eso­
phagitis; Cross and Wangensteen,72 in ex-
-< 
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TABLE I.—P ostoperative Assessment in Patients with Alkaline Gastritis after D iversion of
Duodenal Contents
Procedure
Grade
T a n n er  19
(n  =  29)
R o u x -e n -Y  diversion  
(» = 214)
H enley  loop 
(n  = 39)
I ...........
II ............. 24
I l l ............. D O 5
IV............ !5
2
8
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periments with cats and dogs, showed that 
irrigation of the esophagus with bile or crea­
tion of an end-to-end esophagoduodenos- 
tomy caused severe esophagitis. Redo, 
Barnes and de la Sierra73 could not confirm 
these findings in short-term experiments with 
dogs, but others have done so.74"76
Gillison and colleagues77 obtained a high 
correlation between reflux of duodenal 
contents into the stomach and heartburn; 
they postulated that bile was an important 
etiologic factor. In experimental studies 
in primates, Gillison and others78 de­
monstrated that gastroesophageal com­
petence was more likely to lead to severe 
esophagitis if the gastric juice contained bile 
than if the reflux was bile-free. A close cor­
relation has been demonstrated between 
duodenogastroesophageal reflux and eso­
phagitis.79 Safaie-Shirazi and associates80 
found a barrier to the movement of H + in 
the lower esophagus similar to that in the 
stomach. Perfusion with bile and acid dis­
rupted the barrier and led to severe eso­
phagitis.
An incompetent gastroesophageal sphinc­
ter must be present before reflux can occur. 
There are many reports in the literature 
denoting that the intrinsic lower esophageal 
sphincter is the most important mechanism 
preventing reflux.81- 82 Abdominal compres­
sion is an important part of sphincter func­
tion, and vagotomy83 and atropinization84 
both block the response of the sphincter to 
abdominal compression. The hormone, gas­
trin, also has an effect on the lower eso­
phageal sphincter. Giles and associates85 
demonstrated an increase in sphincter pres­
sure when gastrin was infused even at rates 
(0.005 units/Kg) that gave submaximal acid 
secretion. Cohen and Lipshutz86 also dem­
onstrated the effect of gastrin in increasing 
lower esophageal pressure, and others87 
noted that gastrin released after a protein 
meal caused an increase in sphincter pres­
sure; the higher the serum gastrin concen­
tration was, the higher was the sphincter 
pressure.
There is an increased incidence of alka­
line esophagitis after peptic ulcer surgery. 
Vagotomy compromises lower esophageal 
sphincter pressure and gastrectomy removes 
the antrum, which is the main source of 
circulating gastrin. Several investigators88- 89
have demonstrated a weakened gastroeso­
phageal sphincter following peptic ulcer sur­
gery. Excision of the lower esophageal 
sphincter in patients who have had an eso- 
phagogastrectomy can lead to an increased 
incidence of alkaline reflux esophagitis, 
especially if these patients have previously 
had peptic ulcer surgery.
Signs and Symptoms
Clinically alkaline esophagitis causes 
heartburn, dysphagia and severe epigastric 
pain following peptic ulcer surgery. Eso- 
phagoscopy reveals severe esophagitis and, 
in some cases, stricture.
Treatment
Medical.—Medical therapy consisting of 
elevation of the head of the bed, antacids 
and cholestyramine has not been successful.
Surgical.— Diversion operations have been 
successful in most instances. The aim of sur­
gery is to prevent bile from refluxing into 
the lower esophagus. This has been achieved 
by duodenojejunostomy, Roux-en-Y chole- 
dochojejunostomy, gastrojejunostomy and 
Roux-en-Y gastrojejunostomy.
We90 have reported on five patients in 
whom alkaline esophagitis developed, with 
stricture formation in some. Four patients 
had undergone subtotal gastrectomy many 
years previously for duodenal ulcer diathesis, 
and one had had an esophagogastrec- 
tomy for carcinoma of the cardia. In all 
five patients, esophagoscopy revealed severe 
esophagitis, bile-stained esophageal mucosa 
and free reflux of bile into the lower eso­
phagus. All patients had diversion pro­
cedures—duodenojejunostomy, Roux-en-Y 
choledochojejunostomy and Roux-en-Y gas­
trojejunostomy. At follow-up, esophagoscopy 
revealed complete resolution of the esoph­
agitis in every patient. Others have had 
similar results. Cenni, Cox and Hands91 
reported on three patients with bile esoph­
agitis cured by Roux-en-Y diversion. Mack- 
man, Lemmer and Morrissey58 reported one 
patient who had had a thoracoabdominal 
repair of a hiatus hernia, vagotomy and 
pyloroplasty for reflux esophagitis and hiatus 
hernia. The symptoms recurred and a trans­
abdominal repair was attempted. (He also
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had a transthoracic vagotomy.) Roux-en-Y 
gastrojejunostomy was performed because of 
persistent symptoms and endoscopic evi­
dence of bile esophagitis. Postoperatively, 
the patient was free of symptoms and 
gained 8.6 kg. Coppinger and colleagues59 
reported eight patients with bile esophagitis 
and gastritis treated by a Roux-en-Y pro­
cedure. Seven of the eight patients had good 
results. In 10 patients with severe reflux 
alkaline esophagitis studied by Weaver, 
Large and Walt,92 the results of Roux-en-Y 
diversion of the duodenal contents were 
good.
Thus, as with alkaline gastritis, alkaline 
esophagitis is a definite entity that is being 
diagnosed more often. It is due to bile re­
fluxing into the lower esophagus. For this 
syndrome to occur, there must be abnormal­
ities or absence of both the lower esophageal 
and pyloric sphincters. Prevention of the 
reflux of bile into the lower esophagus by 
diverting the duodenal contents (Roux-en-Y 
procedure) will alleviate the symptoms and 
the associated esophagitis.
Conclusions
Present trends indicate that duodenal 
ulcer surgery is evolving towards a search 
for better methods of reducing acid secre­
tion without gastric resection. Results of 
controlled trials of superselective vagotomy 
and selective vagotomy with pyloromyotomy 
to treat duodenal ulcers may prove that these 
are the procedures of choice. If the pylorus 
is left relatively intact the incidence of alka­
line gastritis will decrease. Drugs, such as 
metoclopramide, that increase lower esoph­
ageal and pyloric sphincter pressures, may, 
in controlled trials, prove to be important in 
the treatment of alkaline gastritis and esoph­
agitis.
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the only translucent sterile strip providing a “window” 
for the surgeon to see how well the wound edges have been 
coapted. and to check progress of healing.
Adhesive consistency just right. Not too adhesive to cause 
irritation. Adhesive enough for wound security, patient comfort.
Wet strength. Exclusive polypropylene construction not 
affected by moisture.
Proven hyporeactive.
How Surgeons Are Using CLEARON Skin Closures
Following early removal of sutures.
Closing outer layer, plus subcuticular pull-out sutures. 
Alternating strips with sutures.
Convenient Dispensing
CLEARON Skin Closures are available in a wide variety 
of sizes adaptable to our convenient dispensing systems: the 
fifty-unit dispenser that fits on a shelf, and the one-dozen box 
that fits right into your ETHICON* suture dispenser rack.
ETH ICON
•Trademark E T H IC O N  S U T U R E S  LTD.
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SYMPOSIUM DU COLLEGE ROYAL
QUELQUES AFFECTIONS ANO-RECTALES 
1. INTRODUCTION*
GHISLAIN DEVROEDE, MD, FRCS[C]+
A normally functioning anus is a precious gift 
of God.
Proctologiste anonyme
D epu is  la nuit des temps, les hommes ont 
souffert de maladies ano-rectales. C’est ainsi 
qu’il est ecrit au cinquieme chapitre du pre­
mier livre de Samuel que “La main du Sei­
gneur est tombee sur chaque cite avec une 
force extremement grande. Les hommes qui 
n’etaient pas morts furent affliges d’hemor- 
roi'des dans leurs parties intimes et des cris 
monterent de chaque cite jusqu’au ciel ’. 
Pourtant si Ton revoit brievement l’histoire 
de la proctologie on se rend compte que 
peu de progres ont ete faits depuis 2000 
ans. Peu de facultes de medecine ont ins- 
crit ce chapitre a leur curriculum et la ma- 
jorite des programmes de formation en chi- 
rurgie generate confient aux residents se­
niors la responsabilite de l’enseignement aux 
residents juniors. II n’est pas surprenant, des 
lors, de constater que le controle de la qua- 
lite des soins est tres pauvre dans ce do- 
maine. Les methodes sont empiriques, la 
pathogenie inconnue, l’utilite des medica­
ments non etablie, les indications chirurgi- 
cales arbitraires et les resultats evalues de 
faqon subjective.
Au temps des egyptiens, il ne se prati- 
quait pas de chirurgie anale. Divers reme- 
des etaient appliques sous forme d’onguents 
composes d’elements heteroclites et farfelus. 
Des lavements etaient aussi administres et 
contenaient des preparations tres diverses. 
Une prescription populaire il y a 20 ans 
contenant du marron d’inde, substance 
presumee utile dans le traitement des 
hemorro'ides. Meme aujourd’hui, la televi-
* Presente au congres annuel du College royal des 
medecins et chirurgiens du Canada, Quebec, PQ, 
le 23 janvier, 1976
tProfesseur titulaire, Departements de chirurgie 
et de physiologie-pharmacologie, Centre Hospita- 
lier Universitaire, Sherbrooke, PQ.
Les demandes de tires-a-part doivent etre actres­
se s  au: Dr G. Devroede, Departement de chirur­
gie, Centre Hospitalier Universitaire, Universite 
de Sherbrooke, Sherbrooke, PQ J1H 5N4.
sion et les journaux vantent les merites de la 
“preparation H”, medicament qui selon le 
fabricant, provoque une retraction des he­
morro'ides et permet d’eviter la chirurgie. 
Le papyrus Chester Beatty decrivait 10 
traitements medicaux differents pour le 
prurit anal. Plus de 2000 ans plus tard, le 
compendium des specialites pharmaceutiques 
canadiennes de 1974 en mentionne 23. Quel 
progres! La chirurgie des hemorro'ides se 
pratiquait deja 370 ans avant le Christ, a 
l’epoque d’Hippocrate. Ce dernier recom- 
mandait la technique suivante:
Ecartez l’anus aussi fort que possible avec les 
doigts, faites rougir les fers au feu et brulez les 
hemorroides jusqu’a ce qu’elles soient dessechees. 
Vous les reconnaitrez sans difficulte car elles font 
saillie de l’interieur de l’intestin comme des rai­
sins de couleur foncee et, lorsque l’anus est ecar- 
te, elles font joillir du sang. Lorsque le cautere 
est applique, il faut tenir la tete et les mams du 
patient de sorte qu’il ne bouge pas, mais il fau- 
drait qu’il crie tres fort pour que le rectum pro- 
labe plus.
Au 7e siecle, Paul d’Egine, representant 
de la chirurgie arabe, est deja un petit peu 
plus raffine. Pour rendre plus manifeste la 
presence des hemorro'ides, il prescrit plu- 
sieurs lavements, ce qui a pour effet d’assu- 
rer un prolapsus hemorroidaire. Sa techni­
que est la suivante: le malade etant bien 
couche, le chirurgien passe une ligature a 
la base des hemorro'ides. Apres avoir appli­
que un bandage trempe dans l’huile, il dit 
au malade de rester tranquille. Parfois le 
chirurgien coupe l’excedent des tissue; d au­
tre fois il applique un medicament a base 
de caustique pour bruler ce tissu exceden- 
taire.
Au 14e siecle, Theodorich recomman- 
de le traitement chirurgical des hemorro'ides 
et fait pour la premiere fois une distinction 
entre les hemorro'ides internes et externes. 
Au milieu du 18e siecle, Lorenz Eister 
fait le pont entre la chirurgie arabe 
et la chirurgie europeenne. Lorsque les 
hemorro'ides saignent, il recommande que 
le patient soit place sur un lit et que 
les jambes soient maintenues elevees par 
deux assistants tres forts. Les hemorro'ides
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qui saignent sont ligaturees avec une aiguil­
le et un fil et les parties distales a la ligature 
sont excisees. Le traitement est semblable 
pour les hemorroi'des internes qui sont ex­
cisees apres l’insertion d’un speculum. L’en- 
treprise est hemorragique; parfois les sutures 
lachent et c’est ainsi que mourut Don Juan. 
Aujourd’hui, nous vivons une ere technolo- 
gique. Les techniques se sont done multi- 
pliees; on peut done exciser les hemorroi'des 
par la methode ouverte ou fermee, les bru- 
ler, les geler, les scleroser, les etrangler, ou 
les electrocoaguler. Non seulement les tech­
niques sont mal standardises et n’ont pas 
ete comparees de fagon aleatoire, mais les 
indications sont assez floues. Meme la de­
finition des hemorroi'des est imprecise et 
comme le disait recemment un collegue an­
glais paraphrasant un auteur celebre “Hem­
orrhoids, like beauty, are in the eyes of the 
beholder”!
Hippocrate connaissait 1’existence des 
fistules anales et des abces ischiorectaux. 
Son traitement des fistules, encore pratique 
il y a une dizaine d’annee, consistait a intro- 
duire a travers la fistule anale un fil de lin 
tres mince en esperant que, a mesure que 
la ligature etait resserree, le fil sectionne- 
rait les tissus amenant ainsi une guerison 
par seconde intention. John d’Ardern en 
Angleterre, toujours au moyen age, a recon- 
nu le rapport entre abces ischiorectal et fis­
tule anale. Ecoutons-le:
An abscess breeding near the anus should not 
be left to burst by itself, but the barber-surgeon 
should feel with his fingers at the place of the 
abscess and where so he’s found any softness, 
there the patient not knowing, carefully being 
boldly opened with a very sharp lance so that 
the pus and corrupt blood may go out. Or else 
the abscess will burst within the anus. If it only 
bursts within, it is hard to cure; if it bursts with­
out and within then it can never be cured except 
by a surgeon truly expert in his craft for then, 
may it from the first day, be called a fistula.
Voila done une description exacte de 
1’abces ischiorectal, de la fistule interne, de 
l’orifice primaire interne et secondaire a la 
marge anale de la fistule complete. Le 
traitement de la fistule anale a toujours 
ete et reste souvent une chose difficile. 
Ardern demandait a ses riches contempo- 
rains des honoraires qui etaient parmi les 
plus eleves de son temps et declare qu’il n’a 
jamais accepte moins de 100 shillings pour 
la guerison de cette maladie. En 1686, le
chirurgien frangais Felix opere avec succes 
le roi Louis IV et le guerit d’une fistule 
anale chronique. Le succes fut tel que 
Felix regut une somme d’argent fabuleuse, 
une ferme et un titre de noblesse. Aujour­
d’hui encore, certaines fistules anales pre- 
sentent des defis assez considerables, mais 
les titres de noblesse ne sont pas prevus au 
remboursement de l’Assurance-Maladie du 
Quebec. John d’Ardern a decrit le bistouri 
a fistule qui etait introduit a travers toute 
la fistule et guide par un doigt place dans 
le rectum. La lame etait alors dirigee de 
fagon a diviser les tissus ano-rectaux entre 
elle et le doigt. II n’y a la vraiment rien de 
different de ce qui se pratique aujourd’hui. 
Ashley Cooper qui a vecu de 1768 a 1841 
preconisait egalement la transsection du 
sphincter pour permettre la guerison de la 
fistule. II a insiste sur un autre point 
toujours important aujourd’hui, soit eviter 
une fermeture precoce des bords de la plaie 
afin de favoriser la guerison tissulaire a 
partir du lit de la fistule.
On connait moins de choses sur l’histoire 
de la fissure anale. Le baron Guillaume 
Dupuytren (1777-1835) fut 1’un des chi- 
rurgiens dont le succes et l’influence ont 
ete considerables a cette epoque. Dupuy­
tren avait note que l’incision du sphincter 
anal amenait generalement la guerison de 
la fissure; neanmoins, a cause de la douleur 
provoquee par cette intervention, peu de 
malades se soumettaient a ce traitement. 
Tous les traitements chirurgicaux qui ame- 
nent la guerison des fissures anales s’accom- 
pagnent d’une dechirure du sphincter, faite 
aveuglement lors de la dilatation ou de fa­
gon precise, lors des incisions medianes ou 
sous-cutanees laterales. Pourtant en 1975, 
l’Assurance-Maladie du Quebec reconnait 
encore une operation de fissurectomie sans 
sphincterotomie et bien des medecins ne 
sont pas au courant que la sphincterotomie 
ne doit toucher que le sphincter interne et 
non le sphincter externe.
Le terme pilonidal provient du latin 
“pilus nidus”, nid de poils. Nous ne savons 
toujours pas si son origine est congenitale 
comme le suggere 1’existence de kystes 
asymptomatiques decouverts a l’autopsie de 
jeunes enfants ou si, comme d’autres Font 
propose elle est acquise dans 90% des cas. 
Plusieurs arguments plaident en faveur d’une
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origine acquise tels que la presence de poils 
dans un sinus, ou la localisation de sinus au 
crane, a l’ombilic, aux moignons d’amputa- 
tion, a l’anus et a la commissure des doigts 
chez les coiffeurs.
Face aux defis socio-economiques de la
societe contemporaine, il est essentiel de 
rationaliser la medecine et d’en evaluer les 
benefices en face de son cout. Une approche 
scientifique est le meilleur moyen qu’on peut 
employer pour arriver a ce but. En procto- 
logie, il y a un besoin criant de cette ap­
proche!
2. LES FISSURES ANALES*
JACQUES POISSON, MD, FRCS[C]
L'etiologie de la fissure anale reste controver- 
see et les diverses theories avancees demon- 
trent que plusieurs causes sont possibles. Des 
etudes manometriques de la region ano-rectale 
confirment une atteinte du sphnicter interne de- 
ja constatee a I’histopathologie. Les caracteris- 
tiques cliniques de la fissure anale sont decrites 
brievement. A propos du traitement medical de 
la fissure anale, I’argumentation releve plus du 
bon sens que des etudes objectives bien con- 
trolees. Le traitement chirurgical, sous diverses 
modalites, consiste en une laceration du 
sphincter interne. A la revue de la litterature, 
il apparait que la sphincterotomie laterale don- 
ne les meilleurs resultats du point de vue taux 
de recidive et troubles de continence; la sphinc­
terotomie posterieure, associee a la deforma­
tion en trou de serrure, semble provoquer le 
plus haut taux d'incontinence, mais les series 
publiees ne permettent pas de distinguer entre 
sphincterotomie posterieure totale et sphincte­
rotomie posterieure a la demande.
The etiology of anal fissure remains controver­
sial and the multiplicity of theories suggests a 
number of different causes. Histologic and 
manometric studies have shown abnormalities 
of the internal anal sphincter in this condition. 
The clinical features are described briefly. Gen­
erally accepted principles of medical manage­
ment have been arrived at by common sense 
rather than through well-controlled studies. 
Surgical treatment in its various forms consists
*Presente sous le titre “Les fissures anales: pa- 
thogenie, symptomatologie, traitement” au con- 
gres annuel du College royal des medecins et 
chirurgiens du Canada, Quebec, PQ, le 23 janvier, 
1976.
Les demandes de tires-a-part doivent etre adres- 
sees au: Dr J. Poisson, Departement de chirurgie 
generate, Centre Hospitalier Universitaire, Univer­
sity de Sherbrooke, Sherbrooke, PQ J1H 5N4.
in producing a laceration of the internal sphinc­
ter. Lateral sphincterotomy gives the best re­
sults from the point of view of recurrence or 
incontinence; posterior sphincterotomy, which 
leads to a key-hole deformity, appears to pro­
duce the highest incidence of incontinence. It 
is not possible to determine from published 
reports the respective advantages of complete 
versus partial posterior sphincterotomy.
Une fissure anale est une ulceration super- 
ficielle au niveau du canal anal accompagnee 
de rectalgies. Cette definition, bien qu’im- 
parfaite, a le merite de souligner les elements 
importants de la fissure anale; l’ulcere et 
la douleur.
Genese
Il est difficile de parler des causes pre- 
disposantes d’une maladie dont on connait 
mal la pathogenese. Neanmoins, la consti­
pation, la diarrhee, la presence de patholo­
gies anales (hemorroides, prolapsus) et l’u- 
sage de purgatifs violents sont des causes 
possibles. Parmi les theories susceptibles 
d’expliquer la pathogenese des fissures ana­
les, il y en a trois qui meritent une certaine 
attention, mais qui n’ont pas ete prouvees.
La theorie vasculaire fait des fissures 
anales des ulceres variqueux. Ainsi, a la 
Clinique Mayo, entre 1940 et 1952, 6058 
fissures anales montraient une association 
d’hemorroides internes dans 50% des cas.1
La theorie mecanique, elle, fait intervenir 
des notions anatomiques du canal anal. Pre- 
mierement, l’angulation du canal anal ferait 
porter la pression sur sa paroi posterieure 
au moment de la defecation. Deuxiemement,
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les deux branches du faisceau superficiel du 
sphincter externe viennent se fixer sur le 
coccyx en forme de “Y”, laissant ainsi un 
espace retro-anal plus faible, dit de Brick, 
qui amenerait une diminution de la force 
structural du canal anal en posterieur. 
Troisiemement, l’absence de decussation an­
terieure des fibres striees chez la femme 
cause une faiblesse de support sur la ligne 
mediane anterieure. Cette theorie explique- 
rait la frequence plus elevee des fissures 
anales posterieures en general et celle du 
sexe feminin pour les fissures anterieures.
La troisieme theorie est de nature infec- 
tieuse.2 On sait que toutes les glandes ana­
les ne traversent pas le sphincter interne. II 
y en a qui restent superficielles. Une infec­
tion dans ce cas ne conduirait pas a un abces 
fistuleux mais a une cryptite qui s’ulcere 
secondairement. II est probable que la veri­
table etiologie, plus complexe, englobe en 
fait les trois theories precedentes.2 Ainsi la 
dysenterie, les selles alcalines, l’usage de pur- 
gatifs violents, les cryptites et la congestion 
aboutissent a une parakeratose inflamma- 
toire au niveau du canal anal, parakeratose 
qui aboutit ensuite a une rupture de la peau 
et a une myosite du sphincter interne.
L’atteinte du sphincter interne parait etre 
le facteur responsable de la chronicite de 
la fissure anale. Ou bien il s’agit d’un 
spasme entretenu par les stimuli irritants 
mentionnes anterieurement, ou bien il 
s’agit d’une fibrose qui s’accentue avec les 
annees et qui aboutit a un anus stenose et 
inextensible.2
E pidemiologie
Les donnees epidemiologiques sont tres 
incompletes. La seule statistique disponible 
nous vient d’un groupe de praticiens gene- 
raux de Londres qui font etat de 1 cas/ 
annee • 1000 patients en 1970.3 L’age 
moyen de ces malades est de 42 ans4 et 
l’incidence des fissures culmine entre 30 et 
50 ans.2 Chez les vieillards, sans avoir de 
statistiques disponibles, on croit que l’in- 
cidence est faible. Cette faible incidence 
s’explique peut-etre par l’hypotonie sphinc- 
terienne.5 Chez l’enfant, les statistiques 
sont aussi a peu pres inexistantes. Rete­
nons une etude de 500 jeunes enfants af- 
fiiges de constipation et de rectorragie ou 
on trouve 95 fissures anales6. Meme si a
litterature abonde de statistiques contradic- 
toires, il semble que les fissures anales 
soient aussi frequentes chez les deux sexes.
La distribution geographique des fissu­
res anales demeure, elle aussi, pour le 
moins obscure en raison du manque de sta­
tistiques. Dans une etude groupant 83 pa­
tients affliges de fissure ou de fistule, on 
notait 80 citadins et 3 villageois.7 Faut-il 
attribuer cette preponderance de citadins a 
une plus grande disponibilite des soins? Les 
citadins ont-ils une alimentation differente? 
Et enfin, peut-etre y a-t-il des contraintes 
hygieniques en ville qu’on ne retrouve pas 
dans les villages?
Localisation
La localisation des fissures prete peu a 
controverse. Une statistique de 6058 fis­
sures faisait etat de 82% de localisation 
posterieure, 17% anterieure et 0.3% late- 
rale1. Il est egalement vrai que les fissures 
anterieures sont plus frequentes chez la 
femme a raison de 5 a 8 pour l 2' 5.
H istologie
A l’histologie, la fissure anale se caracte- 
rise par un tissu de granulation au fond de 
l’ulcere. On retrouve une parakeratose in- 
flammatoire, de meme qu’une myosite fi- 
breuse. On a rapporte, aussi, une augmen­
tation du nombre des fibres nerveuses, de 
meme qu’un grossissement de certains 
axones.2
La myosite fibreuse ne semble pas un 
phenomene degeneratif relie a l’age puis- 
qu’elle n’existe pas chez le vieillard comme 
le souligne Marliere dans ses etudes sur ses 
cadavres de sujets ages.8
Pathophysiologie
On a souvent pretendu que la fissure 
anale devait sa chronicite a une atteinte du 
sphincter anal. Y a-t-il done anomalie mo- 
trice au niveau des sphincters anaux dans la 
fissure anale et cette anomalie, si elle est 
presente, est-elle la cause ou la conse­
quence de la fissure? A l’aide d’un disposi- 
tif a trois canaux relie a trois ballonnets, on 
peut eludier la pression des sphincters 
anaux, au repos et apres distension du rec­
tum. Chez un individu normal, la disten­
sion subite et temporaire du rectum en- 
traine une relaxation du sphincter interne
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et une contraction du sphincter externe. 
C’est le reflexe recto-anal inhibiteur et 
celui d’inflation. Dans un groupe de pa­
tients affliges de fissure anale, par contre, la 
pression de repos est plus grande, le reflexe 
recto-anal inhibiteur est suivi d’un “over­
shoot”, ou la pression anale remonte plus 
haut qu’elle n’etait avant le reflexe recto- 
anal inhibiteur pour finalement retourner 
a la normale; il y a disparition de cet “over­
shoot” dans trois patients sur trois apres 
guerison de la fissure.'1
Clinique
Les elements cliniques a retenir sont la 
douleur, les rectorragies, la constipation et 
le prurit anal.
La douleur est l’element le plus constant. 
Elle est souvent severe, survenant a la de­
fecation ou tout de suite apres, durant 1 ou 
2 heures et s’attenuant progressivement. La 
clinique nous apprend que la douleur 
peut etre cyclique, parfois avec des inter- 
valles libres de semaines ou de mois. Enfin, 
occasionnellement, un patient se plaindra 
de douleur constante avec de la difficulte a 
s’asseoir.
Les rectorragies sont frequentes, en par- 
ticulier chez l’enfant, peu abondantes, sur- 
tout lors de la defecation, et se traduisent 
par une ligne de sang sur le papier.
La constipation est souvent volontaire, le 
patient cherchant a retarder les defecations 
douloureuses. Dans d’autres cas, la consti­
pation semble preceder a symptomatologie 
et constitue probablement la cause pre- 
disposante de la fissure.
L’irregularite du canal anal rend (’hy­
giene difficile et permet un ecoulement 
sero-muqueux ou fecal qui irrite l’epiderme 
peri-anal. Ceci peut done amener le qua- 
trieme symptome de la fissure, le prurit 
anal. Sans ce facteur d’irritation peri-anale, 
la seule presence d’une fissure peut causer 
du prurit si on tient compte que les memes 
fibres nerveuses transportent le signal du 
prurit et celui de la douleur en fonction de 
l’intensite du stimulus. II convient de s’at- 
tarder aux mini-fissures. Elies sont lineai- 
res, superficielles, diffidles a visualiser et 
se manifestent par du prurit anal. Pour ces 
fissures, il faut examiner l’anus avec un 
instrument dont le diametre est plus large
que le proctoscope conventionnel de 19 
mm de diametre, tel un gros anuscope.
A l’examen clinique, une fissure anale 
peut revetir plusieurs aspects. Au stade 
aigu, il s’agit habituellement d’un ulcere 
superficiel, longitudinal, qui respecte la ligne 
dentee. Il y a peu de fibrose, les fibres du 
sphincter n’etant pas visible et on peut ne 
pas y trouver une papille hypertrophiee, ni 
une marisque anale. Au stade chronique, 
on assiste souvent a la fameuse triade clas- 
sique: ulcere, marisque, papille hypertro- 
phiee. Dans ce cas, l’ulcere est plus pro- 
fond, ses bords sont epaissis et on distingue 
souvent les fibres transverses du sphincter 
interne au fond de 1’ulcere.
Il faut se rappeler que la fissure anale 
peut parfois creer une fistule sous-cutanee, 
a ne pas confondre avec un abces fistuleux, 
en passant sous la marisque.
T raitem ent
Le traitement medical, dont on n’a pas 
evalue la valeur objective par des etudes 
controlees, consiste en l’usage d’emollients, 
d’anesthesiques locaux tels dibucai’ne ou 
lidocame, des bains de siege chauds deux 
a trois fois par jour. Il est logique de penser 
que le soulagement de la douleur puisse 
diminuer ou abolir le spasme sphincterien 
et favoriser ainsi la guerison de la fissure. 
De meme, il est evident que le traitement 
medical est voue a l’echec lorsque le 
sphincter interne a atteint un etat de fibrose 
qui l’empeche de se dilater.
On peut signaler en passant l’etude de 
1970, faite par 45 practiciens de Londres, 
portant sur le Proctosedyl (hydrocortisone- 
framycetine).3 Ils ont note en 3 semaines 
une guerison de 80.4% des fissures aigues. 
De meme Nwako,6 chez 86 enfants, a obte- 
nu 83 guerisons par traitement medical au 
dibucai'ne. Dans ces deux cas, il ne s’agit 
pas d’etudes aleatoires et on ne peut pas 
tirer de conclusions solides. Ces guerisons 
ne sont peut-etre pas reliees au traitement 
si on tient compte de 1’evolution naturelle 
et cyclique de la maladie.
En regie generale, on s’accorde un delai 
de 4 a 6 semaines avant de penser au trai­
tement chirurgical; encore la, il semble 
s’agir d’une conclusion gratuite qui ne s’ap- 
puie sur aucune etude controlee.
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TABLEAU I.—R esultats de T raitements
Operation
No.
patients
Recidive,
%
Jours
hopital
Jours
guerison
Trouble
continence,
%
Complication,
%
DA: Ceulemans et Van Baden, 19728 
W atts, Bennett e t Goligher, 1964:
70
11 99
54
16
— —
28
—
Moore, 196412 41 5 1 ____ 15
SP:
Hawley, 196910 18 28 4 21 0 0
Hawley, 196910 32 8 4 49 8 0
Bennett et Goligher, 196213 127 7 — 49 28
SL:
Magee et Thompson, 196614 139 3 0 42 41 0
Hawley, 196910 24 0 5 25 0 0
SL, sc:
Abcarian, 197515 22 0 2-3 21 5 0
Notaras, 197116 85 0 21 8 1
Millar, 197117 105 0 0 14 3 8
SP et A:
Rudd, 197518 200 0.5 0 14 0 2
Parnaud, 197119 Douleur vite soulagee, pas de recurrence, continence 
satisfaisante
DA = dilatation anale; SP = sphincterotomie posterieure; SL = sphincterotomie laterale; SL, sc =  sphinc- 
terotomie laterale sous cutanee; SP et A = sphincterotomie et anoplastie.
Le traitement chirurgical des fissures 
anales chroniques comporte comme prin- 
cipe de base l ’ablation de la papille hyper- 
trophiee et de la marisque en association 
avec differentes techniques chirurgicales qui 
ont toutes en commun une laceration du 
sphincter interne: dilatation anale forcee 
(DA), sphincterotomie posterieure (SP), 
sphincterotomie laterale (SL), sphinctero­
tomie laterale sous-cutanee (SL, sc), sphinc­
terotomie avec anoplastie (SP et A) et 
cryochirurgie.
Pour evaluer les resultats des differents 
traitements, deux facteurs sont d’importance 
majeure: le taux de recidives et les troubles 
de continence. A  la lumiere des resultats 
qui figurent au tableau I8- 10'19 on est 
tente de deduire que la sphincterotomie la­
terale est la meilleure technique. A ce point 
de vue, les statistiques de Hawley10 parais- 
sent assez convaincantes. Meme si son 
etude a ete prospective, il reste qu’elle n’a 
pas ete faite de fagon aleatoire. On sait que 
les sphincterotomies laterales ont pour ob- 
jectif d’eviter la deformation en “trou de 
serrure”, deformation qui serait responsa- 
ble des troubles de continence dans la 
sphincterotomie posterieure. A cet egard, la 
litterature ne fait pas de distinction entre 
la sphincterotomie posterieure totale et la 
sphincterotomie posterieure a la demande. 
Les fibres du sphincter interne dans ce cas 
sont sectionnees de fagon a obtenir une 
relaxation de l’anus, sans pour autant viser 
une section totale du sphincter interne. 
Ceci ne semble pas associe a un taux eleve 
de troubles de la continence.
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3. LES FISTULES AN ALES*
DENIS BERNARD, MD, FRCS[C]
Les fistules anales representent une entite pa- 
thologique bien definie. On peut en determiner 
I’origine, Devolution et les classifier en plusieurs 
types, les uns frequents, d'autres plus rares, 
selon des criteres anatomiques. Leur identifica­
tion et leur traitement necessitent une approche 
systematique, basee sur des connaissances se- 
meiologiques, anatomiques, pathologiques et 
sur des principes physiologiques et chirurgi- 
caux. L'application des connaissances et de ces 
principes constitue un gage de reussite dans le 
traitement. On peut egalement en deduire les 
facteurs d'echec therapeutique.
It is now possible to define with precision the 
pathogenesis of anal fistulous abscesses. Com­
mon as well as rarer types of fistulas can be 
classified according to the anatomy of the anal 
canal. Identification and proper treatment of 
these conditions need a thorough systematic 
approach; knowledge of their symptomatology, 
anatomy and pathology is of paramount im­
portance, and successful treatment is based on 
accepted surgical principles. A detailed descrip­
tion of the management of these fistulas is 
presented. Factors explaining recurrences are 
also mentioned.
Les fistules anales representent une patho- 
logie assez commune, facile a diagnostiquer, 
traitable et guerissable. Toutefois, il per- 
siste au sujet des fistules plusieurs mythes 
sur la complexite des trajets, sur le danger 
d’incontinence resultant du traitement, sur
*Departement de chirurgie, Hopital Saint Luc, 
Montreal, PQ.
* Presente sous le titre “Orifices fistuleux peria- 
naux” au congres annuel du College royal des 
medecins et chirurgiens du Canada, Quebec, PQ, 
le 23 janvier, 1976.
Les demandes de tires-a-part doivent etre adres- 
sees au: Dr D. Bernard, Ste. 101, 235 est blvd 
Dorchester, Montreal, PQ H2X 1N8.
le taux eleve de recidive et sur la necessite 
d’operations multiples; tout ceci contribue 
a amplifier la mauvaise reputation de cette 
pathologie et a discrediter et meme decou- 
rager toute manoeuvre therapeutique. Ceci 
peut s’expliquer par certaines mauvaises 
conceptions de l’anatomie, du mecanisme 
de production et du type de chirurgie ne- 
cessaire pour les traiter. Les considerations 
mentionnees au cours de cet expose sont le 
fruit d’une experience de 175 fistulotomies 
au cours des 5 dernieres annees.
Fistule vient du latin “fistula” qui signifie 
“pipe” ou “flute”, deux termes tres descrip- 
tifs de cette pathologie. L’etiologie d’une 
fistule est generalement un abces anal dont 
le drainage spontane ou chirurgical a cree 
l’orifice fistuleux, qu’on retrouve a la peau 
autour de l’anus. Le terme “abces fistuleux” 
est souvent utilise a bon droit: l’abces re­
presente la phase aigue ou initiale, et la 
fistule, la phase chronique d’un meme pro­
cessus. Le terme “crypto-glandulaire” s’uti- 
lise egalement avec justesse a la fois pour 
l’abces et pour la fistule. En effet Hermann 
et Desfosses,1 en 1880, ont ete les premiers 
a decrire des structures glandulaires dont 
l’embouchure se retrouve au fond des cryp- 
tes anales et dont les ramifications proxima- 
les s’etendent a la sous-muqueuse et au 
sphincter interne. On attribue generalement 
a Parks2 d’avoir defini avec precision le 
nombre, l’extension et le role exact de ces 
glandes dans la genese des abces et des 
fistules. Parks a etudie 44 specimens d’anus 
et a demontre des glandes anales dans tous 
les specimens dont le nombre varie entre 
6 et 10 autour de l’anus. Dans deux tiers 
des specimens, les ramifications s’etendent 
dans l’epaisseur du muscle sphincter interne;
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Fig. 1 .—Schema de l’anus, coupe frontale. (a) 
Abces intermusculaire (inter-sphincterien) et trois 
extensions possibles; vers le bas et vers le haut 
(inter-sphincterien) et vers la fosse ischio-rectale 
(trans-sphincterien). (b) Anatomie normale—glan­
de anale, sphincter interne, sphincter externe et 
jonction ano-rectale.
dans la moitie des cas, elles se poursuivent 
jusqu’a l’espace dit inter-musculaire (i.e., 
entre les sphincters interne et externe), mais 
dans aucun cas les glandes ne penetrent le 
sphincter externe (Fig. 1).
A natom ie  des F istules A nales
Des selles et des debris alimentaires sont 
parfois retrouves au niveau du canal excre- 
teur et de l’orifice de ces glandes; une obs­
truction ou une stenose de l’orifice du canal 
excreteur est frequemment rencontree, ex- 
pliquant de fa$on tres logique l’infection 
possible des glandes et la formation d’abces. 
Probablement a cause de la resistance rela­
tive du sphincter interne et de l’extension 
de la glande dans le plan inter-sphincterien, 
l’abces qui se forme est toujours initialement 
localise a cet espace. Le drainage de cet 
abces par l’orifice naturel de la glande ne 
peut generalement pas se faire pour les 
raisons deja invoquees: stenose de l’orifice, 
obstruction du trajet, resistance du sphincter 
interne. II se cherche done une voie de sor­
tie dans toutes les directions qui s’offrent 
(Fig. 1). II y en a essentiellement trois a 
partir de l’espace inter-musculaire;
(1) L’extension de l’infection vers le haut 
produit F abces inter-musculaire haut,3 pal­
pable au dessus du muscle releveur de l’anus 
par toucher rectal et longtemps confondu 
et mepris pour un abces sous-muqueux du 
rectum, ce qui n’existe pas (Fig. 2). Le 
drainage spontane ou chirurgical de cet 
abces inter-musculaire haut se fait presque
Fig. 2.—(a) Abces inter-musculaire haut. (b) 
Fistule inter-sphincterienne haute secondaire au 
drainage, intra-rectal d’un abces, inter-musculaire 
haut.
toujours dans la lumiere du rectum; il en 
resulte un trajet fistuleux intra-mural, inter- 
musculaire dans la paroi meme du rectum, 
trajet dont Forifice primaire est au niveau 
d’une crypte anale et dont Forifice secon­
daire est situe dans le rectum plus haut 
(Fig. 2). Cette variete de fistule est rare, 
se rencontre dans 3% des cas (5 sur 175) 
et ne se presente pas comme la majorit6 
des fistules anales parce qu’il n’y a pas 
d’orifice externe a la peau.
(2) L’extension de l’infection vers le bas 
dans le plan inter-musculaire est de loin la 
plus commune, et produit l’abces peri-anal 
conventionnel, qui apparait a la peau peri- 
anale, comme une tumefaction douloureuse, 
visible et palpable. C’est l’abces commune- 
ment appele de la “marge anale” (Fig. 3). 
Le drainage de cet abces cree un orifice 
cutane secondaire, Forifice externe, et le 
trajet ainsi forme entre cet orifice et Fori­
fice primaire de la glande est strictement
Fig. 3.—(a) Abces inter-musculaire et peri-anal, 
(b) Abces inter-musculaire et abces ischio-rectal.
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Fig. 4.—(a) Fistule inter-sphincterienne secondai- 
re a un abces inter-musculaire et peri-anal, (b) 
Fistule trans-sphincterienne secondaire a un abces 
ischio-rectal.
inter-sphincterien. C’est la fistule inter- 
sphincterienne et elle represente environ 
80% des fistules (Fig. 4).
(3) Dans environ 15% des cas, Fexten- 
sion de l’infection ne se fait ni vers le haut 
ni vers le has mais radialement — a travers 
le sphincter externe pour deboucher dans 
la fosse ischio-rectale, espace cellulaire et 
graisseux lache ou l’infection a vite fait de 
constituer un gros abces avec une zone 
importante de cellulite en peripherie (Fig. 
3). C’est l’abces ischio-rectal dont le drai­
nage trans-cutane cree un orifice secondaire 
ou externe. Le trajet reliant ce nouvel ori­
fice a l’orifice primaire est plus complexe: 
il se fait a partir de l’espace inter-muscu- 
laire, a travers le sphincter externe et la 
fosse ischio-rectale. On Fappelle trans- 
sphincterien (Fig. 4). Pour ce qui est de 
cette troisieme voie de direction, il faut 
considerer une nouvelle dimension qui est 
circonferentielle et qui peut exister a cause 
de Fanatomie de l’appareil sphincterien cy- 
lindrique et des espaces celluleux derriere 
et de chaque cote de l’anus, tels qu’illustres 
a la Fig. 5. Cette derniere dimension cir­
conferentielle s’ajoute a la complexite des 
abces et des fistules. Elle est responsable 
des abces en “fer a cheval”, de l’extension 
bilaterale des fistules et de leur trajet cur- 
viligne.
Ces trois types d’extension que nous ve- 
nons de decrire, soit: inter-musculaire haut, 
inter-sphincterien et trans-sphincterien, ex- 
pliquent au dela de 95% des fistules.
Il existe quelques autres types de fistules 
anales qui sont rares, complexes et qui heu-
Fig. 5.—Schema de l’anus, coupe transversale, 
pour demontrer la dimension circonferentielle pos­
sible des trajets fistuleux. A =  sphincter interne, 
B =  sphincter externe (complement a Fig. 1).
reusement constituent moins de 2% des 
cas. 11 y a la fistule trans-sphincterienne 
classique mais avec extension de l’abces au 
dessus du muscle releveur de l’anus (Fig. 
6). Le probleme de cette fistule est le dan­
ger de rechercher un trajet inexistant vers 
le haut, et de creer un faux trajet avec un 
orifice intra-rectal, ce qui en fait alors une 
fistule supra-sphincterienne compliquee, 
tres difficile a guerir et impossible a traiter 
par les moyens usuels comme nous verrons 
plus loin. Il y a aussi la fistule vraiment 
supra-sphincterienne sans trajet inter- ou 
trans-sphincterien (Fig. 7). Cette fistule 
resulte en general d’une infection intra- 
pelvienne habituellement secondaire a une
Fig. 6.—(a) Fistule trans-sphincterienne avec ex­
tension au dessus du releveur de l’anus, offrant 
la possibilite de creation iatrogenique d’un faux 
trajet et d’orifice interne situe dans le rectum—a 
droite. (b) Fistule trans-sphincterienne transformee 
en fistule supra-sphincterienne par le mecanisme 
ci-haut.
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diverticulite du colon sigmoi'de, a une ma- 
ladie de Crohn ou meme a une infection 
consecutive a une dehiscence d’anastomose. 
Cette variete n’est pas a proprement parler 
une fistule anale, quoiqu’il est possible 
qu’elle existe en association avec une fis­
tule anale vraie comme nous avons deja vu 
(un cas) dans un Crohn rectal et anal. II 
ne faut pas oublier en dernier lieu la fistule 
dite sous-cutanee ou sous-muqueuse. Ce 
type se rencontre habituellement comme 
evolution ultime d’une fissure anale me- 
diane, anterieure ou posterieure non-traitee. 
Cette fistule sous-cutanee est facile a iden­
tifier et a traiter. Se basant sur l’anatomie 
de 1’appareil sphincterien de l’anus, il est 
ainsi possible d’etablir une nomenclature 
et une classification des fistules en quatre 
types: sous-cutanee, inter-sphincterienne,
trans-sphincterienne et extra-sphincterienne.
D iagnostic et  T ra item en t  des
F istules A nales
Le malade se presente au medecin soit 
a la phase aigue, lors d’un premier abces 
ou avec une histoire d’abces recidivant, soit 
a la phase chronique, en accusant un ecou- 
lement persistant ou intermittent. II faut 
parfois reconnaitre d’autres etiologies aux 
orifices fistuleux: la maladie de Crohn, le 
sinus pilonidal, Fhydradenite suppuree, la 
fistule uretrale. Chacune de ces pathologies 
peut se differencier par des caracteristiques 
propres: histoire anterieure, aspect des le­
sions, palpation, cannulation et direction des
Fig. 7.—(a) Fistule supra-sphincterienne secon- 
daire a une pathologie intra-abdominale. (b) Tres 
rare fistule supra-sphincterienne originant initia- 
lement d’un abces inter-musculaire haut.
trajets, sigmoi'doscopie, et biopsie. Une des­
cription detaillee de chacune de ces entites 
est hors de portee de cet expose.
Dans tous les cas, le malade doit etre 
conduit a la salle d’operation, anesthesie, 
et mis en position de lithotomie afin de 
completer et de preciser l’identification de 
la fistule avant de la traiter. II faut recon­
naitre et retrouver pour chaque fistule, trois 
elements: l’orifice primaire ou interne, le 
trajet, et l’orifice secondaire ou externe.
L’orifice secondaire ou externe est la plu- 
part du temps evident a l’inspection et le 
plus facile a retrouver. II est generalement 
indure, de coloration rosee (neo-epithe- 
lium) et il s’en ecoule un liquide sero-puru- 
lent. L’orifice peut etre frais si un abces 
s’est draine spontanement recemment, an- 
cien, sans reaction inflammatoire, double: 
ipsi ou contralateral, surtout si la fistule a 
une dimension circonferentielle, ou meme 
inexistant s’il s’est referme. Il peut etre 
situe plus ou moins loin de 1’anus; en ge­
neral la distance entre l’orifice et l’anus est 
proportionnelle a la complexity du trajet. 
La localisation de l’orifice externe par rap­
port a la circonference de l’anus renseigne 
habituellement sur la direction du trajet et 
sur le site de l’orifice primaire ou interne. 
C’est la loi de Goodsall et Miles (Fig. 8).4 
Cette loi est assez fiable, il a bien quel- 
ques exceptions, mais elles sont plutot rares.
Le processus d ’identification debute par 
la recherche de l’orifice interne. Il se re- 
trouve a la fois par palpation avec le bout 
de l’index, par visualisation a l’aide d’un 
ecarteur anal, et en appliquant la loi de
Fig. 8.—Schema illustrant la loi de Goodsall et 
Miles. Si I’orifice externe est posterieur a une 
ligne transversale, le trajet est curviligne et se 
termine a un orifice interne median et posterieur. 
Si l’orifice externe est anterieur a cette meme 
ligne, le trajet est assez direct. Par exception, il 
peut-etre curviligne et se diriger vers un orifice 
median anterieur.
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Goodsall. Si l’orifice interne n’est pas ap­
parent, il peut etre aussi retrouve par cannu- 
lation du trajet avec un stylet. Cet orifice 
interne est parfois microscopique, comme 
celui d’une glande anale normale. L’impor- 
tance de son identification certaine vient du 
fait que la guerison de la fistule necessite 
la mise a plat du trajet dans son entier et 
F experience demontre que c’est precisement 
cette portion du trajet entre l’orifice pri- 
maire et l’espace inter-sphincterien qui est 
le plus difficile a retrouver. De ce fait, si 
on reussit a retrouver l’orifice interne et a 
identifier le trajet a partir de celui-ci, la 
guerison de la fistule est quasi assuree.
L’instrumentation essentielle a la recher­
che des trajets fistuleux comprend un ecar- 
teur de Sims, quatre sondes cannelees a 
courbure variable (Lockhart-Mummery), un 
stylet mousse et des sondes lacrymales. 
Quant au trajet, on peut en predire la direc­
tion de deux fagons: en le palpant, ou en 
y introduisant un stylet par Forifice externe. 
Si le trajet est palpable, on est en presence 
d’une fistule simple, superficielle, directe et 
inter-sphincterienne; c’est la fibrose autour 
du trajet resultant de la guerison de l’ancien 
abces peri-anal. Si le trajet n’est pas pal­
pable, la fistule est plus complexe, profonde 
et trans-sphincterienne. On peut aussi intro- 
duire par l’orifice externe, un stylet dans le 
trajet. Si ce stylet est perpendiculaire au 
doigt du chirurgien introduit dans l’anus, la 
fistule a un trajet simple et direct. Si par 
contre le stylet est relativement parallele au 
doigt du chirurgien, attendez-vous a retrou­
ver un trajet plus complexe avec une exten­
sion haute et aussi circonferentielle.
La cannulation de Fun ou de l’autre ori­
fice peut ne pas conduire directement a 
Fautre orifice, pour deux raisons: premiere- 
ment, la courbure ou Fangulation parfois 
aigue du trajet ne peuvent etre cannulees 
par un stylet droit. II faut alors utiliser une 
sonde a courbure variable, ou encore in- 
ciser la partie du trajet qui est deja cannu- 
lee et poursuivre la recherche du trajet plus 
loin. Deuxiemement, il y a des retrecisse- 
ments fibreux ou stenoses du trajet, princi- 
palement au niveau du sphincter interne. Le 
canal excreteur de la glande est parfois de 
petite dimension. Un stylet mousse ordi­
naire ou une sonde cannelee ne peuvent y
penetrer librement et il faut utiliser les son­
des lacrymales de plus petit calibre pour 
retrouver le trajet.
Lorsqu’on a finalement identifie le trajet, 
on l’incise au bistouri. Cette fistulotomie 
inclut tout le tissu qui est superficiel a la 
fistule, soit la peau, les tissus sous-cutanes, 
et une portion variable de muscles sphinc- 
teriens; pour une fistule inter-sphincterienne, 
la moitie inferieure du sphincter interne est 
incisee. Pour une fistule trans-sphincte­
rienne, la moitie inferieure du sphincter 
interne et le tiers ou la moitie inferieure du 
sphincter externe sont incises. Une telle 
entaille des sphincters est sans consequence 
puisque la portion importante de l’appareil 
sphincterien responsable de la continence 
est situee plus haut a la jonction ano-rectale 
qu’il est capital de respecter. Dans les rares 
cas ou le trajet a une extension supra- 
sphincterienne (i.e., au dessus de cette jonc­
tion ano-rectale), avec un orifice interne 
dans le rectum, le trajet doit etre excise et 
non incise, en respectant la jonction ano- 
rectale, en refermant la paroi rectale, de 
preference sous couverture d’une colostomie 
proximale de derivation.
11 est facile de reconnaitre exactement le 
trajet lorsqu’il est incise. Sa paroi est fi- 
breuse et sa lumiere contient du tissu de 
granulation lache qu’il faut curetter. Il est 
preferable de laisser le trajet fibreux au fond 
de la plaie et de ne pas l’enlever (i.e., de 
ne pas completer la fistulotomie en fistulec- 
tomie). Cette fibrose autour de la fistule 
empeche une retraction plus importante des 
faisceaux de sphincter incises.
Le temps chirurgical est complete par 
l’excision des bords escarpes de la plaie 
afin de realiser une mise a plat (“saucerisa- 
tion”) plus complete et de faciliter la gue­
rison par granulation a partir du fond de 
la plaie, plutot qu’un accollement prematu­
re des bords avant que la granulation ne 
soit suffisamment amorcee au fond de la 
plaie. Le resultat d’une fermeture precoce 
pourrait etre une reconstitution du trajet et 
une recidive. Afin de prevenir ceci, la plaie 
doit etre soigneusement recouverte de pan­
semen ts humides, bien etales au fond sur 
le trajet incise. Ces pansements sont chan­
ges frequemment et repetes pendant deux ou 
trois semaines, jusqu’a ce que la plaie soit
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moins profonde. Toutefois pour les fistules 
simples et superficielles, l’excision des ber- 
ges cutanees suffit, les pansements etales 
peuvent etre cesses le lendemain et la plaie 
laissee a granuler secondairement sans su­
pervision.3
Lorsque la fistule est finalement epithe- 
lialisee et guerie, les recidives sont rare. Si 
elles surviennent, il faut invoquer un ou 
plusieurs des facteurs suivants: identification 
incomplete du trajet, orifice interne non 
retrouve, glande anlae pathologique non in- 
cisee ou excisee, fermeture precoce des
bords de la plaie, infection a partir d’une 
autre glande, et autre etiologie, par exem- 
ple la maladie de Crohn.
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VACA NCY FOR HEAD OF HOSPITAL 
DEPARTMENT OF SURGERY
The Halifax Infirmary will require a 
Head for its Department of Surgery.
The hospital has the capacity of four to 
five hundreds beds. It is a University-affi­
liated Teaching Hospital and is involved in 
undergraduate, Intern and Resident Training 
Programs.
The Head of the Department will be 
responsible for the direction of the Depart­
ment of Surgery in clinical matters, and all 
matters concerning administration. He will 
be responsible for the organization and 
supervision of the undergraduate, Intern, 
Resident Training Programs in the Institu­
tion. He will be directly responsible for 
hospital matters to the Administrator of 
the hospital, and all other matters to the 
Head of the University Department of 
Surgery.
The candidate would be a Certified Spe­
cialist in General Surgery and/or a Sub­
specialty. He should have attained recogni­
tion among his peers as a competent and 
experienced practitioner of his Specialty. 
Experience as an administrator or director 
of a teaching unit would be desirable.
For further information, write 
Doctor Gordon W. Bethune,
Head, Department of Surgery, 
Dalhousie University, 
c /o  Victoria General Hospital, 
Halifax, Nova Scotia.
CRITIQUE OF ITEM 520 (SESAP II)
The most common benign lesion of the 
breast is cystic mastitis. A clinically evident 
cyst presents itself as a mass. A cyst dis­
tended with fluid can easily be differentiated 
from a solid mass by a simple office pro­
cedure: aspiration. If the cyst does not recur 
within two weeks, an unnecessary operation 
for the purpose of biopsy has been avoided. 
In contradistinction, a solid tumor does call 
for a biopsy.
_D
Reference
520/1. Rosemond GP, Maier WP, Brobyn 
TJ: Needle aspiration of breast cysts. Surg 
Gynecol Obstet 128:351-354 (Feb) 1969
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PROPHYLACTIC NODE DISSECTION FOR MALIGNANT MELANOMA*
S. T. NORVELL, Jr., MD, FRCS[C], J. J. McCLEAVE, MD,
A. J. BODURTHA, MB, BS, FRCS[C] and A. C. IRWIN, MD, DPH
The value of prophylactic node dissection was 
studied in 147 patients with nonsuperficial ma­
lignant melanoma of cutaneous origin; all had 
clinical stage I disease. Seventy-three patients 
had prophylactic node dissection and 74 did not. 
Survival rates were calculated by the actuarial 
method and were age and sex adjusted. Five- 
year crude survival rates for these two groups 
were 62 and 29%, respectively, and the adjusted 
rates were 70 and 33%, respectively. These sig­
nificant differences (P <  0.001) were maintained 
at 10 years. The difference in survival in the 
two groups cannot be explained on the basis of 
age, sex, year of operation, size or location of 
the primary tumour, or previous incisional biop­
sy. It is concluded that prophylactic node dissec­
tion contributed appreciably to increased survival 
in this study.
La valeur de la dissection ganglionnaire a visees 
prophylactiques a ete etudiee chez 147 patients 
atteints de melanome malin profond d’origine 
cutanee; tous souffraient de maladie au stade I. 
Soixante-treize patients ont beneficie d'une dis­
section ganglionnaire a visees prophylactiques 
et 74 n’en ont pas eu. Les taux de survie ont 
ete calcules selon des methodes actuarielles 
avec ajustement pour I’age et le sexe. Les taux 
de survie bruts a 5 ans pour ces deux groupes 
ont ete de 62 et de 29% respectivement et les 
taux ajustes ont ete 70 et 33% respectivement. 
Ces differences significatives (P <  0.001) se sont 
maintenues apres 10 ans. La difference des taux 
de survie pour ces deux groupes ne peut etre 
expliquee par I'age, le sexe, I'annee de ('opera­
tion, I'etendue ou la localisation de la tumeur 
principale ou des biopsies precedentes. On 
conclut que la dissection glanglionnaire a visees 
prophylactiques a contribue de facon appreciable 
a I’augmentation de la survie au cours de cette 
etude.
T here are wide differences of opinion con­
cerning the indications for regional lym- 
phadenectomy in clinical stage I malignant 
melanoma of cutaneous origin. Some1 10 
have questioned whether prophylactic node 
dissection is ever indicated; others11"21 
have advocated node dissection only in se­
lected cases; and others22'37 practise rou-
*From the departments of surgery and preventive 
medicine, Dalhousie University, Halifax, NS.
Reprint requests to: Dr. S. T. Norvell, Jr., De­
partment of surgery, Victoria General Hospital, 
1240 Tower Rd., Halifax, NS B3H 2Y9.
tine lymph-node dissection in stage I mela­
noma, excluding only superficial melanoma, 
tumours with ambiguous lymphatic drain­
age and patients who are elderly or who 
have medical contraindications to the proce­
dure.
This paper reports a retrospective and 
continuing study of 147 patients with clin­
ical stage I, nonsuperficial malignant mela­
noma. Patients were not randomized and 
patient selection was based on the prefer­
ence of the physician or surgeon managing 
the case. Possible sources of bias in case 
selection will be discussed.
Study Population
The 147 patients are a subset of the Nova 
Scotia Melanoma Series (NSMS). The 293 
patients composing the NSMS were seen in 
the Nova Scotia Tumour Clinic and the 
Halifax teaching hospitals from 1953 to 
1974 and included only those who were 
resident in Nova Scotia at the time of diag­
nosis. The diagnosis of melanoma was 
based on the opinion of the pathologist at 
the time of treatment; a separate study to 
correlate the histologic characteristics of the 
lesions with the clinical course of the patient 
is being undertaken. The NSMS is limited 
to patients with melanoma arising from skin 
and mucous membranes.
The incidence of melanoma in Nova 
Scotia is approximately 2.5 new cases per 
100 000 population (Myrden JA: Personal 
communication, 1976), and it is estimated 
that the NSMS includes 75% of all new 
cases seen in the province. Since patients 
were managed by a variety of physicians and 
surgeons in the province, the experience is 
that of a geographic area rather than of a 
single individual or institution. Virtually all 
patients have been followed to death or to 
the close of the present study (1975).
The clinical stage was ascertained in 280 
patients in the NSMS. Of these, 201 had 
clinical stage I melanoma, defined as mela­
noma confined to the primary site. No pa­
tients with satellite lesions, in-transit me- 
tastases, or recurrent primary lesions were 
classified as stage I.
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Of the 201 stage I melanomas, 33 were 
superficial; this term was defined initially 
as melanoma confined to the outer one- 
third of the dermis,38 later as tumour su­
perficial to the sweat glands of the dermis,39 
and recently as Clark’s level 2.40
Of the remaining 168 patients with a 
stage I, nonsuperficial melanoma, 15 were 
not suitable for a study on the value of 
prophylactic node dissection, because ex­
cision of the primary lesion was not easily 
classifiable; for example, they underwent 
amputation, lymph-node biopsy without 
dissection, or prophylactic node dissection 
more than 8 weeks after excision of primary 
lesion. A further six patients were dropped 
from the study because the primary lesion 
arose on the genitalia or mucous membranes; 
these sites of origin are associated with a 
particularly poor prognosis. There remained 
147 patients available for study, 74 (group 
1) who underwent excision only and 73 
(group 2) who had prophylactic node dis­
section within 8 weeks of excision of the 
primary lesion.
M eth o d s
The date of entry into the study was the 
date of the histologic diagnosis, and the 
exit date was the date of death or the 
date of last follow-up; survival is based on 
these dates. The recorded age of the patient 
was the age, at last birthday, when the his­
tologic diagnosis was made. Crude survival 
estimates were calculated with the aid of a 
computer using the actuarial or life-table 
method.41 Adjusted survival estimates were 
derived from the above and corrected for 
the expected overall mortality in a mari­
time population of comparable age and sex 
distribution; they are in fact survival ratios. 
The accompanying standard errors (SE) are 
those of the age- and sex-adjusted survival 
ratios, which were adjusted by means of 
population life tables.
“Complete” excision of the primary le­
sion is defined for the purposes of this 
study as an excision in which: (a) there 
was no tumour at the edges of the micro­
scopic sections, and (b) there was no local 
recurrence within 4 months. We do not 
imply that this constitutes adequate resec­
tion; it is simply a method of standardizing 
the excision for this study.
TABLE I.—Cumulative Survival (%) of Pa­
tients who had E xcision only (Group 1) and 
Patients who had E xcision plus Prophylactic 
N ode D issection (Group 2)
Year Group
Cumulative survival (and SE)
Crude Adjusted
1 1 92.8 (3.1) 95.5 (3.2)
2 95.7 (2.5) 96.4 (2.5)
2 1 80.1 (5.0) 84.8 (5.2)
2 85.8 (4.4) 87.1 (4.5)
3 1 68.6 (5.9) 74.8 (6.4)
2 76.7 (5.5) 78.6 (5.6)
4 1 46.9 (6.5) 52.7 (7.4)
2 71.0 (6.0) 73.5 (6.2)
5 1 28.5 (6.0) 33.1 (7.0)
2 67.0 (6.3) 70.0 (6.6)
6 1 22.0 (5.5) 26.3 (6.5)
2 67.0 (6.3) 70.7 (6.7)
7 1 20.5 (5.3) 25.3 (6.5)
2 64.6 (6.5) 69.0 (6.9)
8 1 14.9 (4.7) 19.0 (6.0)
2 64.6 (6.5) 69.9 (7.0)
9 1 12.6 (4.5) 16.6 (6.0)
2 64.6 (6.5) 70.8 (7.1)
10 1 12.6 (4.5) 17.2 (6.2)
2 64.6 (6.5) 71.8 (7.2)
*AU primary lesions were clinical stage I, nonsuper­
ficial, and none involved genitalia or mucous mem­
branes.
No attempt was made to differentiate 
types of node dissection, such as radical or 
superficial, and in continuity, synchronous 
or asynchronous, as these distinctions would 
create subgroups too small for meaningful 
analysis.
R esu lts
Table I details the survival of patients in 
groups 1 and 2. There is a great difference 
in favour of patients who had prophylactic 
node dissection: crude survival rates are 
67% compared with 28.5% at 5 years and 
are 64.4% compared with 12.6% at 10 
years. The crude survival curves of these 
two groups of patients (Fig. 1) show a sig­
nificant difference in favour of node dis­
section at 5 years (P <  0.001) and at 10 
years (P <  0.0001), using the summary chi- 
square Mantel-Haenszel formula.42
Table I also shows the age- and sex-ad­
justed survival of the same groups of pa­
tients. Fig. 2 differs from Fig. 1 only in 
that adjusted values are used. The differ­
ence in survival in favour of patients who 
had prophylactic node dissection and the 
statistical significance at 5 and 10 years 
remain essentially unchanged.
-
-4
t
*
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Fig. 1.—Crude survival. Solid and broken lines 
show survival in groups 1 and 2, respectively. 
Vertical lines through each point extend from  
two standard errors above to two standard errors 
below, and define 95%  confidence limits with 
respect to each point.
D isc u ssio n
Comparison of the Two Groups of
Patients
While the demonstration of statistical 
significance affords reasonable protection 
against random error, there is no such as­
surance against a systematic error. We there­
fore compared the two groups of patients
Fig. 2.—Adjusted survival. Solid and broken 
lines show survival in groups 1 and 2, respective­
ly. Vertical lines through each point extend from  
two standard errors above to  two standard errors 
below, and define 95% confidence limits with 
respect to each point.
TABLE II.—C omparison of F requency of Se ­
lected P rognostic Characteristics in P atients 
with Stage I M alignant M elanoma with E xci­
sion only (Group 1) and with E xcision plus 
P rophylactic Node D issection (Group 2)
Characteristic Group 1 Group 2
Median age, y r .......... 54.5 46.2
M ean age, y r .............. 53.5 45.0
No. of men (and %
of to ta l) ................... 38 (51) 29 (40)
M ean year of histo-
logic diagnosis........ 1962 1966
No. with incisional
biopsies.................... 10 12
No. with lesions >  2
cm ............................. 25 21
No. of histologically 
positive nodes (and
% ) ....................... ? 17 (23)
Prim ary site of lesion
Head and neck. . . . 25 13
T ru n k ....................... 25 13
Upper lim b ......... 11 14
Lower lim b ......... 13 33
to determine whether there was bias in case 
selection.
Table II compares the two groups of pa­
tients with respect to several important 
prognostic characteristics. Patients who had 
no node dissection (group 1) tended to be 
older, the difference in median age being 
8 years, and in mean age, 9 years. One 
might suppose that the survival ratio ad­
justed for the age and sex distribution of 
the population at risk would compensate 
for this. We found, however, that the prog­
nosis for stage I, nonsuperficial melanoma, 
is poorer for patients 50 years of age and 
older than for patients under 50. This could 
be related to increased aggressiveness of 
the tumour, to decreased host resistance in 
older patients and also to a difference in 
treating older and younger patients. Nine­
teen patients were over 70 years of age, and 
only one of these had a prophylactic node 
dissection.
To eliminate any possible bias due to 
age, we then considered only patients 70 
years of age or under. The median age of 
patients in group 1 was 44.5 years (mean, 
45.8 yr), and in group 2, 46.0 years (mean, 
44.6 yr). The cumulative survival of the two 
groups of patients was then compared again 
(Table III). There was still a substantially 
longer survival in group 2 patients (with 
node dissection).
Of the group 1 patients 51%  were male, 
while in group 2 only 40% were male (Ta-
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TABLE I I I —C umulative Survival (%) of 
P atients 70 Y ears of Age or Less, who had 
E xcision only (Group 1, n =  56) and who had 
E xcision plus P rophylactic N ode D issection 
(Group 2, n  =  71)
Cumulative survival (and SE)
Year Group Crude Adjusted
1 1 94.3 (3.2) 95.3 (3.2)
2 95.6 (2.5) 96.2 (2.5)
2 1 86.1 (4.9) 88.0 (5.0)
2 87.3 (4.2) 88.5 (4.3)
3 1 75.2 (6.2) 77.7 (6.4)
2 78.1 (5.4) 79.8 (5.5)
4 1 51.3 (7.6) 53.7 (7.9)
2 72.3 (6.0) 74.5 (6.1)
5 1 29.3 (7.0) 31.1 (7.4)
2 68.2 (6.3) 70.9 (6.5)
6 1 23.1 (6.4) 24.8 (6.9)
2 68.2 (6.3) 71.6 (6.6)
7 1 21.1 (6.1) 23.0 (6.7)
2 56.8 (6.5) 69.9 (6.9)
8 1 16.4 (5.6) 18.2 (6.2)
2 65.8 (6.5) 70.7 (7.0)
9 1 13.4 (5.3) 15.1 (6.0)
2 65.8 (6.5) 71.5 (7.1)
10 1 13.4 (5.3) 15.4 (6.1)
2 65.8 (6.5) 72.5 (7.2)
*No lesion involved the genitalia or mucous mem­
branes.
ble II). We were unable to demonstrate any 
difference in prognosis by sex in these pa­
tients. The mean year of diagnosis and 
treatment was 4 years later in group 2 pa­
tients. It seems unlikely that 4 years’ pro­
gress in surgery could account for the im­
proved results in this group; more likely 
this represents an increasing appreciation 
of the value of node dissection by physi­
cians of the province.
Incisional biopsy could have an effect on 
5-year survival. The proportion of incisional 
biopsies was about equal in the two groups 
under study (Table II) and should not affect 
the results. In general, patients with lesions 
greater than 2.0 cm in diameter have a 
poorer prognosis. When we limit our frame 
of reference to clinical stage I, nonsuper- 
ficial melanoma, however, the prognosis is 
no worse for patients with lesions greater 
than 2.0 cm in diameter than for those with 
lesions 2.0 cm or smaller.
The proportion of patients with primary 
lesions at the four major sites (head and 
neck, trunk, upper limb and lower limb) 
varied considerably in the two groups. The 
site of the primary lesion has a decided in­
fluence on survival in the NSMS. Clinical
TABLE IV — C umulative 5-Year Survival (%) 
by M ajor Body R egions in P atients who had 
E xcision only (Group 1) and who had E xcision 
plus P rophylactic N ode D issection (Group 2)
Cumulative survival
Body area Group No. Crude Adjusted (and SE)
Head and 
neck........ . . 1 25 50.9 63.5 (13.9)
2 13 74.8 81.7 (13.8)
Trunk......... .. 1 25 9.5 10.4 ( 7.9)
2 13 47.8 49.3 (16.8)
Upper limb. . . 1 11 0.0 0.0 ( - )
2 14 48.0 50.7 (17.3)
Lower limb. . . 1 13 40.7 48.5 (18.6)
2 33 76.9 76.9 ( 8.6)
stage I, nonsuperficial melanoma of the 
head and neck and the lower limb has a 
better prognosis than that of the upper limb 
or the trunk.
To simplify the analysis, 5-year survival 
estimates are shown for each major region, 
for the two groups (Table IV). The number 
of patients in each group is so small that 
the results cannot be considered statistically 
significant. Nevertheless, the consistent su­
periority of outcome at 5 years in group 2 
patients, for all sites, is striking.
Finally, it might be supposed that some 
patients in the group 1, whether old or 
young, were denied lymphadenectomy be­
cause of concomitant disease or debility. Of 
the whole group of 74 patients, 54 were 
dead at the date of exit from the study. Of 
these, the probable cause of death was mela­
noma in 44 (81%). Thus, melanoma ap­
pears to have been the principal medical 
problem of these patients.
Disadvantages of Retrospective Analysis
Any retrospective analysis of data pre­
sents problems in interpretation. One ob­
vious problem, to which we have alluded 
already, is that our study encompasses only 
75% of patients with melanoma in Nova 
Scotia. We have no reason to suppose that 
this 75% is representative of the whole, and 
indeed, we suspect that our series tends to 
include some less favourable cases, since 
Halifax is the referral centre for the prov­
ince.
The 25% not included would constitute 
about 75 patients. If it is assumed that all 
75 patients had stage I, nonsuperficial mela­
noma, that all were treated by adequate
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excision only, and that the survival curve 
generated was as favourable as that for our 
group 2 patients, the survival curve pro­
duced for all patients with excision would 
be almost exactly intermediate in position 
between the two curves shown in Fig. 1. 
The superiority of node dissection would 
continue to be apparent, although the in­
terpretation of significance might be dif­
ficult.
A second possible source of error is in 
the interpretation of clinical stage. We sub­
divided stage I cases into “definite” and 
“probable”, depending on whether regional 
nodes were clearly stated to be normal or 
were not mentioned as abnormal. The sur­
vival curves generated by the “definite” 
stage I cases were essentially the same as 
the ones we have shown, except that the 
number of patients was reduced.
Even if the patient’s record indicated 
normal regional lymph nodes, the surgeon 
would surely be more inclined to remove 
them if he were in any doubt. Since our 
patients with stage II melanomas had a 5- 
year survival of about 15%, this kind of 
unrecorded suspicion would make for a less 
favourable outcome in the node-dissection 
group.
The poorer survival noted in our patients 
over 50 years of age, particularly at 10 
years, is also open to interpretation. While 
this could be related to increased aggressive­
ness of the tumour or decreased host re­
sistance with advancing age, we suggest 
that it may be due to reluctance of surgeons 
to carry out a potentially beneficial opera­
tion on older patients.
The incidence of clinically negative but 
histologically positive nodes in our group 2 
patients was 23% (Table II). The corre­
sponding rate from most reported series 
varies from 15 to 50% .15 The incidence 
of unsuspected micrometastases found in 
regional nodes is often used as an index of 
the benefit derived from prophylactic node 
dissection. This concept is not entirely 
valid, since some patients with positive 
nodes may already have distant metastases 
that are not clinically apparent, and it is 
possible that some nodal metastases may 
lie dormant for many years. The real issue 
is survival. Nevertheless, it does not seem 
to be a sound practice to leave almost a
quarter of the patients with melanoma in 
their regional lymph nodes.
The Queensland experience with cutane­
ous melanoma9’ 10 has been that excellent 
survival is obtained without resort to pro­
phylactic node dissection. The Queensland 
melanoma may be quite different from that 
found in Nova Scotia: it occurs six to seven 
times more often, has only a 5% rate of 
clinically unsuspected positive nodes, ap­
pears to be related to tropical sunlight and 
has a more favourable outcome.
Conrad6 reported 640 cases of stage I 
melanoma and concluded that there is no 
benefit from prophylactic node dissection. 
Dellon and Ketcham43 criticized Conrad’s 
study because of a built-in bias by depth of 
invasion —  patients with lesions extending 
into subcutaneous fat were much more like­
ly to have node dissection.
Both Block and Hartwell1 and Thurston 
and Couves3 concluded on the basis of 
small series of patients that prophylactic 
node dissection is not worth while. In both 
series, however, the patients who had node 
dissection fared better in terms of survival 
than those who had only excision of the 
primary lesion. Because of the small num­
bers of patients, the case for node dissection 
could not be proven statistically, but neither 
could it be disproven.
Polk and Linn5 have suggested that a 
study showing a marked advantage to pa­
tients with prophylactic node dissection may 
be a result of poor follow-up in those pa­
tients having excision only. It is possible 
that a subset of the NSMS, composed of 
patients not followed through the Nova 
Scotia tumour clinic, had suboptimal fol­
low-up care. However much one might spe­
culate about a different outcome had condi­
tions been altered, it is difficult to deny 
that, given this geographic area and patterns 
of patient management, patient survival is 
markedly improved by prophylactic node 
dissection.
C o n clusion
In view of the morbidity associated with 
node dissection, particularly of the groin, 
many authors5’ 39’ 44’ 45 have at­
tempted to define subgroups of patients who 
will and will not benefit from prophylactic
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node dissection. We can only applaud these 
efforts, and we strongly suspect that patient 
and tumour characteristics will be deline­
ated, so that a larger number of patients can 
safely avoid prophylactic node dissection. 
Our present results, however, lead us to 
conclude that, overall, prophylactic regional 
lymphadenectomy has been highly beneficial 
to patients with clinical stage I, nonsuperfi- 
cial malignant melanoma in Nova Scotia.
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WOUND INFECTION AFTER GASTRODUODENAL OPERATIONS:
A 10-YEAR REVIEW*
R. T. LEWIS, MB, FRCS[C]t
A review of 444 gastric operations performed 
over a 10-year period revealed striking dif­
ferences in wound infection rates when the 
operations were categorized according to the 
major indication for surgery. On this basis, low- 
intermediate- and high-risk groups were re­
cognized. A subsequent prospective randomized 
study confirmed the predictive value of this 
categorization and showed that the administra­
tion perioperatively of prophylactic systemic 
antibiotics in high-risk patients will protect 
them from postoperative wound infection.
L’etude de 444 operations de I’estomac effec- 
tuees au cours d’une periode de 10 ans a revele 
des differences marquees entre les taux d e ­
fection, lorsque les operations ont ete classi­
f ie s  d'apres les principales indications de la 
chirurgie. De cette facon, on a pu mettre en 
evidence des groupes a risques faibles, moyens 
ou eleves. Subsequemment, une etude prospec­
tive avec randomisation des sujets est venue 
confirmer la valeur de prediction de cette clas-
*From the department of surgery, Queen Elizabeth 
Hospital of Montreal Centre, Montreal, PQ.
tAssistant professor of surgery, McGill University, 
Montreal, PQ.
Reprint requests to: Dr. R. T. Lewis, Department 
of surgery, Queen Elizabeth Hospital of Montreal 
Centre, 2100 Marlowe Ave., Montreal, PQ H4A
sification et a montre que i’emploi d'antibioti- 
ques generaux en prophylaxie chez les patients 
a risque eleve les protege des infections post- 
operatoires.
I n the last 15 years improved understanding 
of absorption and the disposition kinetics 
following drug administration has led to a 
new pattern of systemic antibiotic prophy­
laxis in gastrointestinal surgery.1’4 Peri­
operative systemic administration of anti­
biotics may play an important adjuvant role 
in preventing postoperative infection in 
clean-contaminated, contaminated and dirty 
wounds.5 There is strong evidence in favour 
of the use of antibiotics in the management 
of penetrating abdominal injuries,4’ 6 in 
colon surgery and in certain biliary opera­
tions,7 but whether antibiotic prophylaxis 
should be used for all gastric operations or 
reserved for selected procedures is not clear.
M aterials and M ethods
Gastric operations performed at the 
Queen Elizabeth Hospital of Montreal Cen­
tre over a 10-year period (July 1, 1964 to 
June 30, 1974) were reviewed. Excluded 
from the study were operations in which 
the gastrointestinal tract was not opened, in 
which gastrostomy was the only procedure 
and those in which a concomitant large-
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TABLE I.—Indication for Operation in 444 
Gastric Operations*
No. of
Indication operations
Chronic duodenal ulcer—intractable
or previous history of bleeding. . . 165
Gastric ulcer............................................  66
Gastric tumours......................................  61
Pyloric or stomal obstruction......... 50
Emergency operation!
Gastroduodenal bleeding....................  41
Perforation........................................... 45
Incidental or prophylactic operation 25
*In some patients more than one indication was 
present.
f Includes 9 patients with gastric ulcer or tumour.
bowel procedure was done. The 444 
operations that remained were categorized 
into seven groups according to the in­
dication for operation (Table I). Each 
group was analyzed to establish the inci­
dence of wound infections and other abdo­
minal infections such as intraperitoneal and 
drain site infections. Urinary tract infections, 
pneumonia and blood-stream infections were 
also included to calculate the total frequency 
of infectious complications.
The effects of age, severity of hemorrhage 
and malignant disease on wound infection 
rates were also assessed.
Wounds discharging pus were regarded as 
infected, as were those with a serous dis­
charge that was positive on culture and as­
sociated with fever that subsided following 
drainage. Although Robertson8 graded 
wound infections to take special account of 
wound induration and cellulitis without 
purulent discharge and stitch abscesses, this 
method is not suited to retrospective review. 
It was preferable to classify wounds simply 
according to whether they discharged pus or 
not. Similarly, follow-up beyond 1 month 
was not available for all patients, so the 
frequency of late infections could not be 
assessed.
R esults
The overall wound infection rate for the 
study period was 16%; in the 5-year period 
from July 1, 1964 to June 30, 1969 the 
overall rate was 23.03%, but this decreased 
to 13.7% in the following 5-year period 
(P < 0.01). No attempt was made to match 
patients in these two periods. Perioperative
systemic administration of prophylactic an­
tibiotics was more frequent in the second 5- 
year period following the report of Polk and 
Lopez-Mayor in 1969.4
Patients ranged in age from 18 to 91 
years. The effect of age on frequency of 
wound infection was not notable, but a 
substantial increase in the total infection rate 
occurred with age, mainly because of in­
creased pulmonary and urinary tract infec­
tions in the older patients (Fig. 1).
Wound cultures were obtained in 84% 
of the 80 infected wounds. Anaerobes were 
rarely isolated; peptostreptococci were iso­
lated on only two occasions, one of these 
being a mixed anaerobic-aerobic infection. 
Bacteroides sp. were never identified, but 
negative cultures were obtained from five 
obviously infected wounds. Aerobic organ­
isms included staphylococci and strepto­
cocci, and enterococci, Escherichia coli, 
Proteus sp. and Klebsiella sp. Intestinal 
organisms were the cause of infection in only 
11% of operations for chronic intractable 
duodenal ulcer, but accounted for 44% of 
wound infections in the other categories 
(P <  0.05). The distribution of organisms 
causing infection according to the indication 
for operation is outlined in Table II.
The effect of indication for operation on 
frequency of infection is shown in Fig. 2 and 
Table III. The low infection rate in elective 
operations for intractable chronic duodenal 
ulcer and in prophylactic gastric operations 
is obvious and is not significantly different 
from that in refined clean operations. Most 
(82.4%) elective surgery for intractable 
duodenal ulcer was resectional, involving 
removal of one-half to two-thirds of the 
stomach, but there was no significant dif-
O
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Fig. 1.—Effect of age on wound infection, infec­
tion at other abdominal sites and total infection 
rate in 444 operations.
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TABLE II.—Indication for Operation and Organisms Causing Wound Infection
Indication for 
operation
Organism causing infection*
Strepto­
cocci
Staphylo­
cocci
Pepto
strepto­
cocci
Escherichia
coli
Klebsiella
sp.
Proteus
sp.
Entero­
cocci
Intractability i 3 2 1 — _ —
Prophylaxis — 1 — 1 — — —
Obstruction i 6 — 2 — — —
Perforation — 4 — 4 2 — —
Gastric ulcer — 6 — 3 1 — i
Gastric tumour 2 3 — 6 1 1 —
Hemorrhage 3 8 — 5 — — i
*More than 1 organism was cultured from some of the infected wounds; negative cultures were obtained from 
5 obviously infected wounds.
ference between the infection rate in these 
patients (4.4%) and that in patients treated 
without gastric resection (6.4%). Gastric 
surgery for gastroduodenal or stomal ob­
struction and perforated ulcer showed an in­
termediate risk of wound infection. The 
highest rates of wound infection were seen 
in operations for gastric tumours and in 
emergency operations for gastroduodenal 
bleeding.
There was no remarkable effect of age, 
severity of hemorrhage or malignant dis­
ease on the wound infection rate (Table IV).
it has long been believed that a low in­
cidence of infection follows all gastric sur­
gery. On the other hand, Polk and Lopez- 
Mayor4 in their double-blind study reported 
a 30% wound infection rate in elective gas­
tric operations on patients randomly re­
ceiving a placebo, but no infection in those 
receiving systemic cephaloridine periopera- 
tively; and they suggested on this basis that 
prophylactic antibiotics be prescribed rou­
tinely in such patients.
TABLE III .—R elation of Indication for Oper­
ation and Wound Infection
D iscu ssio n
The main source of wound and intra- 
abdominal infections following gastrointes­
tinal operations is the gastrointestinal re­
servoir of organisms.9 Since gastric acid 
is the main deterrent to bacterial colonization 
of the stomach,10- 11 high or normal gastric 
acidity might be expected to protect some 
patients against the development of wound 
infection following gastric surgery. Indeed,
t f ?
Fig. 2. —Effect of indication for operation on 
wound and total infection rates.
Wound infections
Indication for 
operation
No. of 
operations*
No. of 
patients
Rate, % 
(mean, %)
Intractability
1964-69 59 4 00
00 00 
CD CO1969-74 106 4
Prophylaxis
1964-69 14 1
C
D
^
00 o1969-74 11 1
Obstruction
1964-69 16 3 18.7 /i£* /-»+\ U  7 (16.0J)1969-74 34 5
Perforation
1964-69 29 5 17.2
1969-74 16 3 18.7 (17.71)
Gastric ulcer
1964-69 27 10 (22.7*)1969-74 39 5
Gastric tumour
1964-69 30 11 III (3L1*>1969-74 31 8
Gastroduodenal
hemorrhage
1964-69 16 10 85 <48-™1969-74 25 10
*In some patients there was more than one indi­
cation for operation.
fP  = 0.3, not significantly different from refined 
clean operation. 13>19
JP <  0.01, significantly different from operations for 
intractability.
§P <  0.005, highly significantly different from oper­
ations for intractability.
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TABLE IV.—E ffect of M alignant D isease, Severity of Hemorrhage and Age on Wound Infections
Group t
No. of 
patients
No. of 
patients
Wound infections
Infection 
rate, % P value
Benign gastric ulcer.............................................. 66 15 22.70
0.50
Gastric cancer........................................................ 60 17 30.00
Hemorrhage,
<  10 units, 24 h ............................................ 23 11 48.00
> 10 units/24 h ............................................. 18 9 50.00
0.35
Elective operation for chronic duodenal ulcer
Age <  60 y r .................................................. 131 6 4.58
Age >  60 y r .................................................. 33 2 6.03
0.72
The overall wound infection rate (16%) 
in the present study conforms to that noted 
in previous reports,12 but a significant de­
crease in the frequency of infection was 
noted in the second 5-year period of the 
study (P<0.01). When wound infection rates 
were compared within individual categories 
in these two 5-year periods (Table III), a 
similar reduction of wound infection rate 
was seen in each category, but the dif­
ference was significant only in the gastric 
ulcer group (P <  0.05). This probably results 
merely from the reduced numbers for sta­
tistical analysis within each category. Assess­
ment of the factors involved in this de­
creased rate of wound infection was not pos­
sible. Antibiotics were administered peri- 
operatively more often in the second 5-year 
period than in the first, but the method of 
administration was not sufficiently consistent 
and the drugs employed were too varied to 
be submittedi to statistical analysis. Since 
completion of this retrospective study, peri­
operative administration of antibiotics has 
been used in a prospective randomized 
manner in 41 patients with gastric ulcer, 
stomach tumours, active upper gastro­
duodenal bleeding, perforated ulcer and 
pyloric stenosis. Wound infection has been 
noted in 4 of the 20 patients receiving no 
antibiotic, but no infection has been noted 
so far in the 21 patients receiving antibiotics.
The method of assessment used in this 
retrospective study slightly underesti­
mates the wound infection rate, in two ways. 
It fails to recognize the additional 15% of
overall wound infections that appear late, 
usually after discharge of the patient from 
hospital.13 Further, the simple method of 
classification of wound infections disregards 
nonsuppurative infections, usually less sig­
nificant, that have been included in previous 
studies.8 As colonic operations carry a sub­
stantial risk of infection,4 patients undergo­
ing concomitant colonic procedures were 
excluded from the study.
Intestinal organisms were of little im­
portance in wound infection following opera­
tions for chronic intractable duodenal ulcer, 
but assumed greater importance in the 
other groups studied, which is in keeping 
with the suggested “intestinalization” of 
gastric flora in these situations. The 
finding that wound infection after opera­
tion for chronic duodenal ulcer rarely in­
volves aerobic coliforms has not, however, 
been emphasized previously. The low rate 
of isolation of anaerobes, in marked contra­
distinction to the findings of Nichols and 
Smith,14 undoubtedly relates to the method 
of collection of specimens and routine cul­
ture employed in the present study. The 
techniques for optimal isolation and identifi­
cation of anaerobes have only recently been 
generally available.15 This deficiency does 
not, however, detract from the validity of the 
overall findings. As Stone, Kolb and 
Geheber16 have pointed out, most anaerobic 
infections represent polymicrobial syner- 
gisms, and are usually adequately treated by 
altering the local environment so as to impair 
or kill the infecting anaerobes. Only in
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special circumstances are antibiotics for 
specific action against anaerobes required. 
Intraoperative cultures of the stomach 
mucosa were not available in sufficient num­
bers to permit analysis of their significance 
with respect to subsequent wound infection.
Statistically significant differences in in­
fection rates were noted among patients 
categorized by indication for operation. This 
finding has not previously been reported in 
large numbers of patients. Since the com­
pletion of this study, Nichols and Smith14 
have reported on 49 patients undergoing 
gastric operations. Wound infection rates 
were zero in 18 patients with chronic 
duodenal ulcer, 11% in 9 patients with 
pyloric obstruction, 16% in 6 patients with 
gastric ulcer, 25% in 4 patients with carci­
noma of the stomach and 33% in 12 
patients with bleeding duodenal ulcers.
The low incidence of wound infection in 
operations for intractable chronic duodenal 
ulcer (only 3.7% in the second 5-year 
period of this study) suggests that prophy­
lactic antibiotic therapy is not indicated in 
this group. Indeed, since completion of this 
review, a further 30 patients have been 
operated upon for intractable chronic 
duodenal ulcer in a prospective study with­
out the perioperative use of antibiotics. No 
wound infection has developed. Since 
elective operation for intractable chronic 
duodenal ulcer is the most common reason 
for gastric surgery (nearly 40% of operations 
in the present study) it is important to realize 
that these patients, like those undergoing 
surgery for clean surgical operations, do not 
require antibiotic prophylaxis. The wound 
infection rate was slightly increased in pa­
tients undergoing prophylactic gastric opera­
tions. Since these were patients usually un­
dergoing duodenal and biliary bypass for 
periampullary lesions producing obstructive 
jaundice, antibiotic prophylaxis may already 
have been indicated for the biliary proce­
dures.7 Patients with pyloric obstruction and 
perforated duodenal ulcer showed an inter­
mediate risk of wound infection. Nichols 
and Smith14 and others,11 have found in­
creased colonization of the stomach in 
gastric obstruction despite increased gastric 
acidity. Most perforations were repaired 
within 6 hours of the historical onset of per­
foration. A significant increase in wound in-
TABLE V.—R isk of Wound Infection in 
Gastric Surgery
Low risk......... Elective operations for intractable
chronic duodenal ulcer 
Prophylactic gastric operations
Intermediate
risk............. Pyloric or stomal obstruction in
peptic ulcer
Perforated duodenal ulcer
High risk....... Gastric tumour
Benign gastric ulcer 
Emergency operation for gastro­
duodenal hemorrhage
fection in these two groups suggests the need 
for a trial of antibiotic prophylaxis in the 
patients.
The highest wound infection rates were 
found in patients undergoing operation for 
gastric ulcer and gastric tumour, and fol­
lowing emergency operation for bleeding 
peptic ulcers. In the last group, and in those 
undergoing emergency operation for per­
forated duodenal ulcer, there was a notable 
increase in the number of extra-abdominal 
infections, especially pulmonary and urinary 
tract infections. The suggested degrees of 
risk of wound infection and gastric surgery 
are listed in Table V. In the high-risk and 
intermediate-risk groups the prospective 
randomized trial of antibiotic prophylaxis 
that was clearly necessary is now in progress 
at our hospital. Preliminary results in the 
41 patients studied to date have been noted 
above.
Nichols and Smith14 have recently pro­
vided bacteriologic data on 49 patients un­
dergoing gastric operations. They found 
mixed aerobic and anaerobic growth in the 
gastric contents of each of four patients with 
carcinoma of the stomach who had a low 
gastric acid concentration; and among six 
patients with gastric ulcer, five who had 
low gastric acid concentration had mixed 
infection and the one with a normal acid 
concentration had no infection. Fifteen of the 
18 patients with duodenal ulcer and in­
creased gastric acid values had no infection, 
and the remaining three had aerobic infec­
tion only. This supports the idea that colo­
nization of the stomach is encouraged by 
low gastric acid concentrations and is the 
main cause of high risk of infection in 
patients with gastric ulcer and tumour.
Age, severity of hemorrhage and malig­
nant disease were selected for study as re-
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cognized systemic causes of decreased host 
resistance. 17 No significant associated in­
creases in wound infection were found. The 
effect of these factors is usually slight, and 
is most obvious at extremes of age, 18  when 
hemorrhage is severe enough to produce 
hemorrhagic shock, 10 and in terminal ma­
lignant disease. 20  MacLean and colleagues21 
have demonstrated that impairment of cell- 
mediated immunity in patients preoperatively 
correlates closely with the development of 
significant postoperative infection, but no 
attempt was made to examine this aspect 
of host resistance in the present study.
Conclusions
Patients undergoing gastroduodenal opera­
tions may readily be categorized by indica­
tion for operation into low- intermediate- 
and high-risk groups for subsequent wound 
infection.
The high-risk group includes patients un­
dergoing elective operation for gastric ulcer 
or gastric tumour, or emergency operations 
for gastroduodenal bleeding. The interme­
diate-risk group includes patients undergoing 
operation for perforated ulcer or pyloric 
stenosis. Preliminary results of a prospective 
randomized study of prophylactic antibiotic 
administration in these groups indicated that 
high-dose, short-course, perioperative anti­
biotic administration will substantially reduce 
wound infection in these groups of patients.
Patients undergoing elective operation for 
intractable chronic duodenal ulcer have a 
low risk of wound infection— too low to 
warrant the prophylactic use of antibiotics.
The organisms producing wound infection 
are generally gram-positive cocci, but in­
creasing numbers of gram-negative bacilli 
are involved in the high-risk groups.
Age, severity of hemorrhage and malig­
nant disease do not appear to play an im­
portant role in the frequency of wound in­
fection in routine gastric surgery.
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Fig. 1.—Selective celiac angiogram, 2 seconds after injection of contrast medium, demonstrates extravasation of contrast medium within liver after gunshot wound.
Bullet fragment
- Catheter
Fig. 2 .—Selective celiac angiogram from same patient as in Fig. 1, 6 seconds after injection of contrast medium showing appearance of solitary vein in right hepatic lobe.
Fig. 3.—Repeat celiac angiogram 12 weeks after ligation of proximal hepatic artery.
venously for 5 days through a catheter placed 
in the superior vena cava, and gentamicin 
(160 m g/24 h) and clindamycin (2.4 g/24 h) 
were administered for 7 days. In this period 
the highest values recorded for serum bili­
rubin, alkaline phosphatase and aspartic 
transaminase were 1.9 mg/dL, 185 IU /L  and
180 IU/L, respectively. Fifteen days after 
hepatic artery ligation, these serum values 
were within normal limits and the patient was 
discharged.
Twelve weeks later, a repeat celiac angio­
gram confirmed proximal occlusion of the 
hepatic artery (Fig. 3), but showed that filling
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of the distal hepatic arterial system occurred 
readily by retrograde flow through the gastro­
duodenal artery. No abnormality was detected 
within the liver substance on angiography.
D iscussion
The diagnosis of hemobilia should be 
entertained when gastrointestinal hemor­
rhage is accompanied by upper abdominal 
pain and jaundice.1"3 In our case, evidence 
that melena was secondary to bleeding 
through the biliary tree consisted of: (a) 
known hepatic injury; (b) angiographic 
demonstration of extravasation of contrast 
material within the liver and an arterioven­
ous communication within the right hepatic 
lobe; (c) absence of any source of hemor­
rhage above the pylorus; (d) aspiration of 
clots from the gallbladder at laparotomy; 
and (e) a favourable response to hepatic 
artery ligation.
According to Sandblom,1 trauma is the 
most important cause of hemobilia. In this 
subgroup, penetrating trauma occupies a 
minor role compared with hepatic injury 
secondary to blunt external trauma, as in 
motor vehicle accidents. The basic mechan­
ism is thought to be the creation of a cavity 
or potential cavity within the liver substance, 
which is filled with clot or ischemic hepatic 
tissue; further necrosis may produce arterial 
hemorrhage, which can erode into the 
biliary tree to produce hemobilia.3 Erosion 
into either portal or hepatic veins results 
in an arteriovenous fistula: simultaneous 
development of an arteriovenous fistula with 
hemobilia is rare.
Over 600 cases of hemobilia have been 
recorded in the world literature, but there 
have been only two reports of associated 
arteriovenous fistula. Both cases were 
secondary to penetrating trauma, as in our 
case. Markgraf4 reported portal hyperten­
sion secondary to an arteriovenous fistula 
following a 0.22-calibre bullet wound to 
the liver; the patient died of hemorrhage 
into the biliary ducts. Another patient had 
an arteriovenous fistula with hemobilia fol­
lowing a stab wound to the left lobe of the 
liver, and was successfully treated by left 
hepatic lobectomy.5
In our case, the simultaneous demonstra­
tion of multiple vascular defects involving 
both lobes of the liver appeared to preclude 
resection, and we therefore elected tO' ligate 
the hepatic artery. Similarly, ligation of 
either right or left branch might not have 
controlled the origin of the bleeding into 
the bile ducts, so the common hepatic artery 
was ligated. The postoperative angiogram 
(Fig. 3) demonstrates the value of ligation 
proximal to the origin of the gastroduodenal 
branch, since an adequate hepatic arterial 
inflow (as demonstrated angiographically) 
was restored by 12 weeks after arterial 
ligation.
The isolated vein visualized in the right 
lobe of the liver earlier than expected on 
the celiac angiogram is presumptive evidence 
of a traumatic arteriovenous fistula. The 
angiogram did not permit identification of 
this vein as a branch of the portal or hepatic 
venous system, but the absence of any 
evidence of portal hypertension at the time 
of laparotomy for hepatic arterial ligation 
suggests that it was a branch of hepatic 
rein. Both Markgraf4 and Cleveland and 
associates5 emphasized that communication 
between the hepatic artery and the portal 
venous system produces serious portal hy­
pertension, which was clearly evident at 
surgery in the cases they described.
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LEIOMYOSARCOMA OF THE RECTUM AND PROSTATE*
GEORGE STALLWOOD, BSc, MScf and J. W. DAVIDSON, MD, FRCP[C]
A 47-year-old man with leiomyosarcoma involving 
the rectum and prostate was treated by radical 
abdominoperineal resection. This case appears 
to be unique in that leiomyosarcoma was pres­
ent in both the rectum and the prostate. The 
literature is reviewed, highlighting some inter­
esting clinical features of this condition. The 
prognosis for leiomyosarcoma of both rectum 
and prostate is poor.
Un homme de 47 ans souffrant d’un lei'omyosar- 
come touchant le rectum et la prostate a ete 
traite par resection abdomino-perineale com­
plete. Ce cas ou le leiomyosarcome a ete re- 
trouve aussi bien dans le rectum que dans la 
prostate semble unique. La litterature perti- 
nente est passee en revue, soulignant les ca- 
racteristiques cliniques interessantes de cette 
affection. Le pronostic d'un leiomyosarcome du 
rectum et de la prostate est reserve.
L eiomyosarcoma represents only 0.1% of 
all malignant lesions of the rectum and 
prostate.1'3 Nevertheless, leiomyosarcomas 
must be considered in the differential diag­
nosis because they often differ from primary 
carcinomas in their mode of clinical pre­
sentation, prognosis and management. For 
this reason, we report the case of a 47-year- 
old man with a leiomyosarcoma of the rec­
tum and prostate and review the literature 
on this topic.
Case R eport
A 47-year-old Caucasian man was admitted 
to hospital with constipation, impotence, lower 
abdominal pains and pain on defecation; the 
pains had increased in severity over the pre­
vious 4 months. On admission, the patient’s 
appetite was good and he had lost no weight. 
Serum electrolyte, blood sugar and urea values 
were normal. Routine hematologic investiga­
tions yielded normal results. The general physi­
cal examination was unremarkable. However, 
on rectal examination a large, smooth mass 
was palpated adjacent to the prostate and 
anterior to the rectum; 4 years earlier when
*From the department of diagnostic radiology, 
Chedoke Hospitals, Hamilton, Ont. 
fRecipient of a medical student scholarship from 
Physicians Services Incorporated, 1976.
Reprint requests to: G. R. Stallwood, 690 Re­
gency Court, Apt. 322, Burlington, Ont.
the patient had been admitted with a myo­
cardial infarction, a suspicious thickening ad­
jacent to the anterior rectal wall had been 
noted. Investigation of the bowel and bladder 
had disclosed no abnormalities; there were no 
symptoms pertaining to these areas and no 
further investigation was considered necessary 
by the attending urologist.
Intravenous pyelography revealed the pres­
ence of a large, soft-tissue lesion within the 
left side of the pelvis, displacing the bladder 
anteriorly and to the right (Fig. 1). No ureteral 
obstruction was present and the cystogram 
showed no intrinsic bladder lesions. Bilateral 
seminal vesiculography via each vas deferens 
was normal; no vesicular cysts were demon­
strable. From the mass 400 to 500 ml of old 
blood was aspirated; afterwards the mass ap­
peared smaller and the symptoms less intense, 
but within 3 to 4 days, the mass enlarged 
again and lower abdominal discomfort re-
Fig. I.—Intravenous pyelogram demonstrating 
displacement of bladder to right due to mass in 
left side of pelvis.
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Fig. 2.—Rectum is displaced to left and rectal lumen is markedly narrowed by pelvic mass.
curred. A barium enema showed displacement 
of the rectum to the left; the rectal lumen was markedly narrowed by the pelvic mass (Fig. 2). Two weeks after admission a transverse colostomy was performed to relieve severe
constipation. On exploration a large pelvic mass was found extending between the bladder and the rectum, pushing the peritoneum ahead of it. Blood-stained material was obtained on biopsy; the histologic appearance was com­patible with leiomyosarcoma.
Aortography 3 days later revealed displace­ment of small arteries around a large pelvic mass that appeared to be relatively avascular. On selective internal iliac angiography there appeared to be a greater number of small vessels on the right side of the pelvis than on the left (Fig. 3). Subtraction films confirmed these findings. In addition, early venous filling within the right side of the pelvic mass was 
noted.
One month after admission, a radical ab­dominoperineal resection was performed, in­cluding the pelvic mass, the rectum, the distal sigmoid colon, the prostate and a portion of the prostatic urethra. A permanent sigmoid colostomy replaced the temporary transverse colostomy. The patient recovered from surgery 
and was discharged 1 month after operation.
Fig. 3a Fig. 3b
Fig. 3.—Composite selective right (a) and left (b) internal iliac angiograms. There is increase in number of small vessels within right side of pelvis compared with left side.
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P a t h o l o g y
The tumour mass measured 10 x 9 x 7 
cm; an irregular ulcer (diameter, 2.5 cm) 
had penetrated the rectal wall and com­
municated with the centre of the large mass. 
On microscopic examination interlacing 
whorls and bundles of elongated smooth 
muscle cells were seen (Fig. 4). There was 
a great deal of pleomorphism and these cells 
were spindle-shaped. Smaller cells con­
tained irregular nuclei; giant cells exhibited 
large, bizarre, hyperchromatic nuclei. Mito­
tic figures were not abundant (one to two 
per high-power field, magnification x 10); 
this suggested a low grade of malignancy. 
A large amount of collagen separated the 
cells in some areas and there were large 
necrotic areas of tumour with an associated 
inflammatory response.
Apart from the ulcerated area, the rectal 
mucosa appeared normal. The major part 
of the tumour was outside the external mus- 
cularis of the rectum; however, some neo­
plastic cells intermingled with the smooth 
muscle of the internal and external mus- 
cularis. By contrast the normal cell structure 
of the prostatic gland was completely re­
placed by neoplastic cells. The seminal vesi­
cles and the small lymph nodes were normal 
histologically.
It was not possible to determine whether 
the lesion arose in the prostate or in the 
outer muscular layer of the anterior rectal 
wall.
D is c u s s io n
This case reveals some important features 
of interest to surgeons and internists. Asun­
cion1 described the rapid growth of such 
tumours, but the fact that in our patient a 
mass was first suspected 4 years before ad­
mission indicates that these tumours may 
also progress slowly and metastasize late, 
as described by Diamante and Bacon.2 It 
is emphasized that a leiomyosarcoma may 
present as a suprapubic mass in men. Ar­
teriography is a valuable aid in diagnosis.
Tumour Origin
Although we cannot be certain, two 
points suggest that the prostate was the site 
from which the tumour originated in our 
patient. First, the cell structure of the pros-
Fig. 4 .—Section of prostate gland shows inter­
lacing whorls and bundles of elongated, spindle- 
shaped and fusiform smooth muscle cells (hema­
toxylin and eosin, x 100).
tate gland was no longer recognizable be­
cause of the infiltration of neoplastic cells. 
In the rectum, there were fewer invasive 
cells and the normal cell architecture could 
still be observed. Second, in the small num­
ber of similar cases of rectal leiomyosarco­
ma, the majority have shown involvement 
of the posterior or lateral walls of the rec­
tum.4 In our case, however, the tumour 
was found in the anterior rectal wall. Both 
points suggest that the tumour arose in the 
prostate and then spread to the rectum. Some 
authors1'3 believe that leiomyosarcoma is a 
malignant tumour of smooth muscle cells 
arising from the muscularis of the bowel or 
in the walls of blood vessels. Its incidence is 
0.1% of all malignant lesions of the rectum 
and prostate.1'3 In 84% of cases, the lesion 
is within reach of the examining finger.2
Age of Onset
Diamante and Bacon2 reviewed 89 cases 
and found an average age incidence of 55.7 
years (range, 21 to 82 yr) for rectal leiomyo­
sarcoma. Leiomyosarcoma of the prostate 
is considered by Prince and Vest5 to be a 
disease of the young, since 60% of cases 
occurred before the age of 50 years. How­
ever, Fitzpatrick and Stump0 reviewed 25 
reported cases and found that 80% of such 
leiomyosarcomas occurred after the age of 
50 years; the youngest patient was a 24- 
year-old man. In support of the latter view­
point, Smith and Dehner7 reviewed 14 cases
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of patients with leiomyosarcoma ranging in 
age from 42 to 71 years; the mean age was 
58 years. While prostatic carcinoma is gen­
erally considered to be a disease of older 
men, it appears that primary leiomyosar­
coma of the prostate may, as in our case, 
present in younger men.
Sex Distribution
Asuncion1 reported that rectal leiomyo­
sarcoma occurs more frequently in men than 
in women. However, a study of 26 cases 
by Hishida and Ishida8 revealed a male:fe­
male ratio of 11:15. Thus, predisposition 
of sex to rectal leiomyosarcoma is inde­
finite.
Symptoms
The severity of symptoms associated with 
rectal leiomyosarcoma is directly related to 
the size and location of the tumour. Symp­
toms include increasing constipation, local­
ized pain, rectal pressure, change in bowel 
habit and rectal bleeding due to mucosal 
ulceration. Loss of weight and generalized 
weakness may also occur.1' 2' 8 Most fre­
quently patients with prostatic leiomyosar­
coma complain of frequency, urgency, dif­
ficulty in urination and nocturia.7
Pathological Findings and Spread
Leiomyosarcomas are usually reddish- 
grey in colour and of dense consistency.2 
Histologically, interlacing whorls and bun­
dles of elongated and fusiform smooth 
muscle cells are found. Pleomorphism is a 
striking feature and hyperchromatic nuclei 
are characteristic.9 According to Mindich 
and colleagues,9 each tumour should be 
considered malignant if mitotic figures are 
present. The actual grade of malignancy 
varies from 1 to 4 depending upon the mi­
totic rate, the degree of pleomorphism and 
the number of bizarre nuclei present.2- 9 
Metastases of leiomyosarcomas are blood 
borne and commonly arise in the liver. 
Lymph nodes are rarely involved.4’ 9 
Mindich and colleagues present a convincing 
argument that there is no transformation 
from a benign leiomyoma to a leiomyosar­
coma.
Treatment
Rectal leiomyosarcomas are considered
highly radioresistant.2’ 4 However, Torres, 
Estrada and Esquivel10 have reported that 
prostatic leiomyosarcoma is sensitive to 
therapeutic irradiation, and Longley11 
found that patients with leiomyosarcoma of 
the prostate survived following radiotherapy 
an average of 2 years longer than patients 
who were not irradiated. Radical abdomino­
perineal resection is the treatment of choice 
for both rectal and prostatic leiomyosar­
coma.2’ 4’ 9’ 10 Radical excision is preferred 
to local removal because the recurrence rate 
for the former is 25% compared with 80% 
for local excision alone.2, 9
Prognosis
Long-term survival or cure for rectal or 
prostatic leiomyosarcomas is uncommon. 
Diamante and Bacon2 reported that 13 of 
53 patients with rectal leiomyosarcoma were 
alive after 5 years, and 7 of the 13 died 
later from metastases. Similarly, the prog­
nosis for prostatic leiomyosarcoma is poor, 
the average survival being 3.5 years;11 in 
patients with highly malignant lesions, sur­
vival has been less than 7 months.3
We wish to thank Drs. W. H. Barnes, F. G. 
Marson, J. B. Murray, J. Zikman and K. J. M. 
Cunnane of Chedoke General Hospitals, Hamil­
ton, Ont. for information and assistance in the 
preparation of this manuscript.
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ROLE OF ASPIRATION BREAST BIOPSY*
J. E. DEVITT, MD, FRCS[C] and R. H. CURRY, MD, FRCP[C]
Review of the results of 100 consecutive aspira­
tion breast biopsies disclosed that this technique 
failed to identify 11 of the 33 breast cancers in 
the series; however, it identified 3 breast can­
cers that were not recognized by clinical ex­
amination. In one patient who had a fibro­
adenoma, suspicious cells were seen in the ma­
terial sent for cytologic examination. It is con­
cluded that a negative aspiration biopsy does 
not contraindicate tissue biopsy when the 
clinical findings suggest cancer. Aspiration 
biopsy can uncover clinically unsuspected can­
cers. When the lesion appears to be malignant 
on a clinical basis, aspiration biopsy can obviate 
formal biopsy. In this way time is saved for 
all those involved and the fashioning of the 
mastectomy flaps is facilitated.
L'etude des resultats de 100 biopsies du sein par 
aspiration consecutives, a revele que cette tech­
nique avait echoue dans I’identification de 11 des 
33 cancers du sein de cette serie; toutefois, il 
a permis d'identifier 3 cancers du sein qui 
n'avaient pas ete reconnus a I’examen clinique. 
Chez une patiente souffrant d'adeno-fibrome, des 
cellules douteuses ont ete vues dans I'echantil- 
lon envoye pour examen cytologique. On con- 
clut qu’une biopsie par aspiration n’est pas une 
contre-indication a une biopsie tissulaire lorsque 
les observations cliniques indiquent un cancer. 
La biopsie par aspiration peut decouvrir des can­
cers cliniquement silencieux. Quand, a I’examen 
clinique, la lesion semble maligne, la biopsie par 
aspiration peut remplacer une biopsie complete. 
II en resulte une epargne de temps pour tous 
ceux qui sont concernes, et la preparation des 
lambeaux de mastectomie s'en trouve facilitee.
A spiration  biopsy of solid breast lesions to 
obtain material for cytologic examination 
has been reported by a number of au­
thors;1'4 the procedure, however, has not 
been widely practised by surgeons in North 
America. This report summarizes the ex­
perience with 100 consecutive aspiration 
biopsies of noncystic breast lesions in a pri­
vate consulting practice.
*From the departments of surgery and laboratory 
medicine, Ottawa Civic Hospital, and University of 
Ottawa, Ottawa, Ont.
Reprint requests to: Dr. J. E. Devitt, Associate 
dean, Department of continuing medical education, 
University of Ottawa, Ottawa Civic Hospital, 1053 
Carling Ave., Ottawa, Ont. K1Y 4E9.
M aterial and T echnique
The 100 patients were seen consecutively 
in private consultation. They were a selected 
group in that patients with cysts and those 
without complaints sufficiently localized or 
suspicious to justify aspiration biopsy were 
excluded.
The material used for the aspiration 
biopsy includes an alcohol swab, a 10 mL 
syringe with an ordinary no. 20 needle, a 
plaster to cover the injection site and 5 mL 
of 50% alcohol fixative solution. After 
cleansing the skin with the alcohol swab, the 
area to be biopsied is steadied between the 
thumb and index finger and the needle in­
troduced directly into the lesion. With suc­
tion on the syringe, the needle is rotated and 
advanced through the area of concern. While 
suction is maintained the needle is then 
withdrawn through the lesion, but not the 
skin. A second advance is made through the 
lesion and the procedure repeated. The 
needle and syringe are then withdrawn and 
flushed out twice with the 50% alcohol 
fixative solution. The needle is removed and 
the syringe flushed out twice more with the 
fixative. Upon completion of the procedure 
a slightly cloudy fixative solution is indica­
tive of a successful aspiration.
In the cytology laboratory, a single milli- 
pore filter (pore size, 5 /x) is prepared using 
the entire specimen. The filter is rinsed with 
saline and fixed in 80% ethyl alcohol for 
at least 20 minutes. The filter is stained by 
the Papanicolaou technique for millipore 
filter preparation, coverslipped and ex­
amined.
R esults
The relation between the ultimate diag­
nosis and the cytologic diagnosis is sum­
marized in Table I.
In two patients (the second and fifth 
aspirations in the series) no cells were found 
on cytologic examination.
Five of the 11 cancers missed by the 
technique were 1.5 cm in diameter or less. 
On the other hand, three patients without 
clinical features suspicious of cancer were
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TABLE I.—R elation Between Ultimate D iag­
nosis and Cytologic D iagnosis
Cytologic
diagnosis*
Ultimate diagnosis
Benign Malignant
N egative.......................... 52 8
Mild atypia..................... 12 3
Suspicious........................ 1 3
Highly suspicious........... 0 1
Malignant cells............... 0 18
*2 specimens were acellular.
found to have cancer; these lesions were less 
than 2 cm in diameter, and positive cytologic 
examination resulted in earlier definitive 
treatment.
D isc u ssio n
By our criteria, Zajdela and associates1 
missed 9% , Kline and Neal2 12%, Rimsten 
and colleagues3 13%, and Furnival and col­
leagues4 missed 29% of the carcinomas in 
their series. Our experience with 100 aspi­
ration breast biopsies indicated that aspira­
tion biopsy is a useful but not a perfect 
diagnostic aid. Eleven of the patients with 
carcinoma were not recognized by the tech­
nique. However the clinical findings in the 
11 patients whose cancer was not recognized 
were sufficiently suggestive of a malignant 
condition to warrant tissue biopsy. Thus, 
appropriate clinical findings justify the deci­
sion to take a tissue biopsy when the cyto­
logic diagnosis is negative.
On the other hand, in three patients later 
proved to have breast cancer, a clinical 
decision to observe the patient was reversed 
by the positive cytologic reports. This factor 
was the main reason for this study. If rela­
tively conservative indications for breast 
biopsy are practised,5 the diagnosis will be 
delayed in a few patients. Aspiration biopsy 
will reduce the number of these instances.
Two other unexpected benefits were ob­
tained from the use of aspiration breast 
biopsy. First, when the clinical findings were 
typical of carcinoma a positive cytologic 
diagnosis obviated the need for tissue biopsy. 
This saved a great deal of professional time 
and hospital expense. Second, in some
instances the lesion was so located that a 
tissue biopsy would have interfered with the 
1 'tion or mobilization of the mastectomy 
L ps; open biopsy in these cases was not 
done when the aspiration biopsy indicated a 
malignant lesion.
In one instance the cytologic report of a 
“suspicious” lesion led to a breast biopsy in 
a patient with a benign condition in whom 
a biopsy would) not otherwise have been 
taken. As in other areas, the surgeon must 
learn the terminology used by his cytology 
colleagues; the term “suspicious” is used 
frequently by some cytologists and rarely by 
others. Also the cytologist must be provided 
with an adequate specimen, and this is not 
always possible with small, deep-seated or 
relatively acellular lesions.
C o n c l u s io n
Aspiration breast biopsy is a useful addi­
tion to the methods of diagnosing breast 
cancer. This technique will occasionally 
help to uncover unsuspected carcinomas. It 
will, under appropriate circumstances, save 
the time of those involved in formal breast 
biopsy and facilitate the fashioning of the 
mastectomy flaps. However, the known in­
cidence of false-negative diagnoses with aspi­
ration biopsy obligates the surgeon to con­
tinue to take a tissue biopsy of all lesions 
that clinically appear suspicious.
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Since earliest recorded times Q U ACKERY has 
existed with orthodox medicine and by the Roman 
era quacks had established a hold on society they 
have never loosed. As Southey observed, “Man 
is a dupable animal . . . There is scarcely any­
one who may not like a trout, be taken by tick­
ling.” Quackery seems almost to serve a human 
need.
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This need is for answers to questions, and for 
solutions to problems, that man cannot always 
provide. Take stone, about which surgeons are 
still learning, and think back to the 18th century, 
when the wealthy and successful Mrs. Mapp, 
bonesetter, flourished. She claimed to have a 
cure for stone. She seemed so successful that 
the British government purchased her remedy, for 
the astounding sum of £.5000, for the public 
good. So convincing was she that even the great 
Cheselden vouched for her. What was her reme­
dy? No more than egg shells, snails, swine cresses, 
soap, seeds and hips and haws. But after the death 
of a man who had supposedly been cured by Mrs. 
Mapp, what was found in his bladder? A stone.
The success of Mrs, Mapp and her like, many 
of whom were recognized by the highest individu­
als in the land, is explained by two of their per­
sonal attributes: business acumen and power of 
persuasion. Quacks have always been able to out­
weigh scientific evidence through appealing, in 
Anatole France’s words, to “our passions, our 
prejudices, our interests”. Quacks manipulate 
people. And they do so unscrupulously, as the 
history of cancer treatment all too shamefully 
shows.
The road surgeons have had to take in curing 
their patients has not been easy, because knowl­
edge has always been incomplete —  and it has 
been made unnecessarily tortuous because of the 
activities of quacks and charlatans. But things are 
different from the days of 3 centuries ago, when 
the tailor William Read set up as an oculist —  
after he had hired a hack writer to produce a 
book on eye diseases, under Read’s name of 
course. Read became Sir William  —  such was 
his ability to understand human nature, if not 
eye diseases. A t least surgeons now practise their 
peer-recognized skills with commendable re­
sponsibility and dedication. Y et human nature 
changes little, and one is forced to call for the 
standards of surgical practice that we are for­
tunate enough to uphold in Canada today to be 
carefully preserved.
FBA-94-77
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CARCINOMA OF THE ESOPHAGUS: A NEW PROPOSAL FOR THE 
EVALUATION OF TREATMENT*
JULIUS L. STOLLER, MB, FRCS(Edin), FRCS(Glas), FRCS[C], KURT J. SAMER. MD, 
DENNIS I. TOPPIN, MD, FRCS[C] and ALBINO D. FLORES, MD, FRCP[C]
An 8-year study of the records of 127 patients 
with carcinoma of the esophagus revealed that 
the data necessary to make an evaluation of 
various methods of palliative treatment frequent­
ly were not recorded on the charts. Therefore, 
it was not possible to recommend one parti­
cular palliative treatment for carcinoma of the 
esophagus. The authors believe that a prospec­
tive study is required to evaluate objectively 
the various modes of treatment for this disease. 
They propose a grading system with numbered 
values, so that future studies can be made more 
objective: in addition such a system would 
allow comparison of series from different treat­
ment centres.
L'etude des dossiers de 127 patients souffrant 
d'un carcinome de I'oesophage et vus au cours 
d’une periode de 8 ans, a revele que I’informa- 
tion necessaire pour faire une evaluation des 
diverses methodes de traitement palliatif man- 
quait frequemment des dossiers. II n'etait done 
pas possible de recommander un traitement 
palliatif particulier pour le carcinome de I’oeso- 
phage. Les auteurs croient qu'une etude prospec­
tive est requise pour evaluer objectivement les 
diverses modalites de traitement de cette ma- 
ladie. Ils proposent un systeme depreciation  
avec vaieurs numeriques, de fagon a rendre les 
futures etudes plus objectives; de plus, un tel 
systeme permettrait de comparer des series 
provenant de differents centres de traitement.
In an attempt to assess the efficacy of 
various modes of palliative treatment for 
patients with cancer of the esophagus, we 
reviewed the records of 127 patients with 
this disease. These patients were treated at 
the Vancouver General Hospital from Jan. 
1, 1963 to Dec. 31, 1970. In this paper we 
report our findings, which have led us to 
conclude that a proper assessment requires 
a prospective study rather than a historical 
one.
*From the division of general surgery, department 
of surgery, University of British Columbia, Van­
couver General Hospital, and the Cancer Control 
Agency of British Columbia, Vancouver, BC.
Reprint requests to: Dr. J. L. Stoller, Laurel 
Medical Centre, 316-888 W 8th Ave., Vancouver, 
BC V5Z 3Y1.
M aterials and M ethods
The records of all patients with a diag­
nosis of carcinoma of the esophagus ad­
mitted to the Vancouver General Hospital 
in the years 1963 to 1970 inclusive were 
studied. Cases of mesodermal tumour and 
postcricoid epithelial tumour, and cases in 
which a malignant tumour had grown into 
the esophagus from an adjacent organ, such 
as the lung or stomach, were not included 
because we believe that these tumours re­
quired a different philosophical or clinical 
approach. In some patients the diagnosis 
was made at other institutions, but all were 
admitted to the Vancouver General Hospi­
tal for primary treatment or for subsequent 
treatment of problems developing during 
the course of their disease. The records of 
127 patients (81 men, 26 women) were 
reviewed.
Follow-up was achieved by four methods. 
First, the records of all subsequent admis­
sions to the Vancouver General Hospital 
were examined. Second, the records of pa­
tients later followed up at the British Co­
lumbia cancer control agency were ex­
amined. Third, where gaps existed, the 
various surgeons and family physicians who 
had treated or referred the patients were 
contacted by letter for information. We 
attempted to obtain the records of all pa­
tients to their time of death, but some could 
not be traced. Therefore, the British Colum­
bia Provincial Register of Deaths was ex­
amined; all but 12 patients had been traced 
at the arbitrary closure date of June 30, 
1975. These patients may be alive, or may 
have died outside the province of British 
Columbia.
The data obtained from the case records 
were collected on forms designed for com­
puter use. Although the small number of 
cases in this review did not require com­
puter evaluation, certain benefits were ob­
tained by using this method.
The data were evaluated with respect to 
histologic diagnosis, level of the lesion, form 
of therapy used, length of survival and
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30-39 40-49 50-59 60-69 70-79 30-89 Uncertain
Age at Diagnosis
Fig. 1.—Age of 127 patients with esophageal 
cancer at time of diagnosis.
cause of death, and the occurrence of gas­
troesophageal reflux, dumping, diarrhea, 
wound pain, weight changes and new com­
plications, and swallowing ability, work 
habits, the enjoyment of leisure and sleep 
habits. Lesions were classified according to 
the level at which they were located: the 
upper, middle and lower thirds (to 25 cm, 
26 to 32 cm and 33 to 40 cm from the 
incisor teeth, respectively).
R esults and D iscussion
The demography of this series showed 
little difference from other published stud­
ies.1'3 The age spread for the 127 patients 
was as expected (Fig. 1). The histologic 
diagnosis and the level of the lesion are 
shown in Table I. The term “uncertain 
level” indicates that in seven cases the diag­
nosis was made by cytology only; radio­
graphs showed extensive tumour so that 
the starting point was indeterminate. In six 
of these cases the exact histology was also 
indeterminate but was probably anaplastic 
squamous cell carcinoma. The various 
forms of therapy used are tabulated in Ta­
ble II. In this table, the term “other” refers 
to terminal care, such as sedation and gen­
eral nursing measures. The length of sur-
TABLE II.—M ethods of T reatment
No. of patients
Treatment (and %)
Radiotherapy alone................  53(41.7)
Surgery alone.............................  30 (23.6)
Surgery and radiotherapy........ 24 (18.9)
Other...........................................  20 (15.7)
TABLE III.—Survival 6 M onths to 5 Years*
Treatment
Survival, Surgery Radiotherapy Surgery and 
yr alone alone radiotherapy Other
0.5 14 11 11 2
1 10 4 4 1
2 5 2 2 1
3 4 1 1 0
4 3 0 0 0
5 1 0 0 0
*12 untraced at 5 years.
vival is shown in Table III; only 1 patient 
was still alive 5 years after primary treat­
ment (12 could not be traced).
The results of our review indicate that, 
as has been reported previously,1' 4’ 5 can­
cer of the esophagus may be termed in­
curable; no one mode of therapy appears to 
have any particular advantage over another. 
Several workers6’ 7 have produced better 
than average results, but criticism has been 
levelled at a number of details in these re­
ports. Whatever the outcome of arguments 
on these anomalies, it can be stated that 
“cures are a curiosity”2 and should be con­
sidered an accidental bonus of what is in 
reality a palliative treatment.
Palliation is a word frequently used by 
physicians, but it is rarely clearly defined. 
We found among the several nuances of 
meaning,8 support for our understanding of 
the word in the terms “mitigation”, “lessen­
ing”, or “toning down” of disease. However, 
where scientific judgements are to be made, 
relief of suffering should be defined accu­
rately. In designing this study we attempted 
to collect information that would allow an
TABLE I.—H istologic D iagnosis and Level of Lesion in 127 Patients with Carcinoma of the
E sophagus
Level of lesion, no. (and %)
Type Upper M iddle Lower Uncertain
Squamous cell carcinoma..................................... 14(11) 40(3.5) 37(29.1) 1(0.7)
Adenocarcinoma.................................................... 1(0.7) 3(2.3) 25(19.6) 0
Uncertain...............................................................  0 0 0 6(4.7)
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assessment of palliation. However, no prior 
criteria were established and no grading 
system was adopted. In reviewing our fol­
low-up data we realized that the correct 
questions had not been asked during the 
study; if appropriate questions had been 
asked, the answers had not been recorded, 
so that objective assessment could not be 
carried out. Further, we found that our own 
follow-up questions were inadequately de­
signed. We hope that the suggestions that 
follow will be a guide to future studies of 
carcinoma of the esophagus.
The use of a computer in this study was 
valuable, because it forced us to ask speci­
fic questions. Answers were less likely to 
be equivocal. We learned that this is crucial 
in the planning of future prospective stud­
ies, and we strongly recommend that this 
method be used even if the results are to 
be hand-calculated.
We collected data on many symptoms 
and post-treatment problems, but, because 
we believe that in this disease relief of the 
primary symptoms ranks highest in im­
portance, we considered only the answers 
to four of our question sections — swallow­
ing ability, work habits, the enjoyment of 
leisure and sleep habits. Information on 
dysphagia was considered of paramount 
importance.
Swallowing Ability
Our question categories with respect to 
swallowing after various methods of treat­
ment and the answers we were able to ob­
tain from the case records at the time of 
the patients’ separation from the Vancouver 
General Hospital are set forth in Table IV. 
Swallowing status (as defined) was poorly 
recorded; the most striking feature was that, 
as judged by our four categories, swallow­
ing status was not recorded in 36.2% of
TABLE V.—Questionnaire on Swallowing for 
Patients with Carcinoma of the Esophagus
1. Is swallowing painful ?. Always
Sometimes
Never
2. If so, how severe
is the pain ?...................Severe
Moderate (poorly res­
ponsive to medication) 
Moderate (responsive to 
medication)
Mild
3. What can the patient
swallow ? .................... Nothing (not even saliva)
Clear fluids only 
Blenderized foods 
All soft foods 
Any foods
cases. In 59 (19.8%) of 297 follow-up in­
terviews with patients who had left the 
hospital, swallowing status was not recorded 
by the interviewer. The answers obtained as 
indicated by Table IV are inadequate. A 
simple questionnaire as outlined in Table V 
is an alternative approach, but the answers 
to these questions can be obtained only by 
a prospective study.
Work Habits
We found that in many patients the ques­
tions on work habits (Table VI) did not 
apply, because patients were in the retired 
age group. Of 297 interviews, answers were 
inapplicable in 127 (42.7%) instances, satis­
factory in only 51 (17.3%) instances and,
TABLE VI.—Questions Asked with Respect to 
Work H abits
After treatment Not working 
was the patient — Doing lighter work (part 
time)
Doing lighter work (full 
time)
Working a t previous or equi­
valent job (part time)
Working at previous or equi­
valent job (full time)
TABLE IV.—Swallowing Status of 127 Patients with E sophageal Cancer at Separation from
Hospital
Treatment
Radiotherapy Surgery Surgery and
Diet alone alone radiotherapy Other Total (and %)
N il...........................................  0 7 4 1 12 ( 9.4)
Liquids..............................................  13 4 4 1 22 (17.3)
Soft foods..........................................  17 4 8 0 29 (22.9)
All foods.................................  8 9 1 0  18(14.2)
Inadequately recorded.........  15 6 7 18 46 (36.2)
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most significantly, not recorded in 119 
(40%) instances. This problem might be 
overcome by including a question such as: 
Has the level of work activity (including 
housework) dropped and, if so, for what 
reason? Probably there would be no change 
in the amount of data collected, but it 
would make recording of the data easier 
and eliminate some confusion.
Enjoyment oj Leisure
With respect to enjoyment of leisure 
activities, one of three answers was sought: 
no enjoyment at all, enjoyment moderately 
reduced, or enjoyment as before therapy. 
Here the results showed that in 278 (93.6%) 
of 297 interviews data were not recorded. 
Considering the predominant older age of 
the affected patients and the poor progno­
sis, this question should rank higher in im­
portance than work status. No doubt this 
area of questioning could be improved by 
subdividing the second possible answer to 
indicate either (a) reduction to sedentary 
inactive types of leisure or (b) activities as 
before but moderately reduced.
Sleep Habits
Finally, the question of sleeping ability 
was answered as: poor (specify cause), nor­
mal to moderate, or normal. In 285 (95%) 
of 297 interviews this answer was not avail­
able. The failure to sleep comfortably with­
out pain or regurgitation is probably second 
only to dysphagia in importance in eso­
phageal carcinoma. This question also 
should be revised to include in the second 
category the possible answers: moderate, 
unresponsive to medication (specify cause), 
and moderate, responsive to medication 
(specify cause). In retrospect, it was unwise 
to exclude certain groups of cases (as noted 
previously) from our study, because though 
the numbers were likely to be small, the 
resultant data almost certainly would have 
added weight to our conclusions. It seems 
most unlikely that the kind of data we 
wanted to find would have been better 
recorded in these case records than in the 
ones we examined.
In the many published papers on car­
cinoma of the esophagus, little information 
is available on the details of palliation. Suc­
cess or failure of treatment is judged by sur­
vival rates at varying intervals. Hankins 
and colleagues0 sought to evaluate quality of 
life, but itemized only fistula formation and 
the need for subsequent gastrostomy. 
McKeown10 discussed the ability to eat and 
the question of biliary reflux regurgitation 
but gave little data. Leon, Strug and Brick- 
man0 stated that “palliation is . . . worth­
while . . .  as indicated by the two and three 
year survival of patients undergoing eso- 
phagogastrectomy”. Thus, palliation has 
been described in terms of survival, but no 
data have been given on swallowing ability 
or any of the other three criteria used in 
our review. Similarly, surveys by Nicks, 
Green and McClatchie4 and Gunnlaugsson 
and colleagues1 gave no data concerning 
the details of palliation. In an excellent re­
port of surgical treatment, Carey, Plested 
and Hughes11 clearly recognized that pal­
liation and not cure is the true goal, but 
gave no details about the criteria used in 
assessing their results. In common with al­
most all others, they regarded relief of dys­
phagia as of greatest importance. However, 
they stated only that relief of obstruction 
was “effective” and “the degree of pallia­
tion was very encouraging”. In his 1975 
Moynihan Lecture on the surgery of unre- 
sectable esophageal cancer, Ong12 sup­
ported the widely held concept that in this 
situation a satisfactory “quality of life”, 
rather than cure, is the aim of treatment. He 
gave some figures on post-treatment ability 
to eat solid or soft foods, and noted that 
early return to work was an important goal. 
However, these comments were anecdotal; 
he did not present detailed data. Ward and 
Collisi:! and Pearson14 showed clearly 
their belief in the palliative nature of their 
different treatment policies, and tried to 
assess their results on that basis, as well as 
on the basis of survival. However, they used 
only descriptive terms —  swallowing “com­
fortably”,14 diet “normal or near nor­
mal”,14 other symptoms “not encount­
ered” .14 In a review of 405 cases Miller13 
assessed the state of 48 patients alive 2 
years after excisional surgery. He published 
a table estimating “good health” with and 
without dyspepsia and called these “satis­
factory” results. The classification, “unsatis­
factory”, was applied to those with severe 
acid or biliary regurgitation or anastomotic
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TABLE VII.—R ecommended Grading System for E valuation of T herapy in Carcinoma of the
E sophagus
A. Pain (whether or not related to swallowing) Points
1. Yes — always present..................................................................................................  0
2. Yes —sometimes present..........................................................................................  5
3. Never present............................................................................................................  40
If answers (1) or (2) complete the following:
1. Moderate — poorly responsive to medication........................................................  10
2. Moderate •— responsive to medication....................................................................  20
3. Mild...........................................................................................................................  25
B. Swallowing ability — the patient can swallow
1. Nothing (not even saliva)......................................................................................... 0
2. Clear fluids only........................................................................................................ 15
3. Blenderized foods......................................................................................................  25
4. All soft foods.............................................................................................................  35
5. Any foods..................................................................................................................  45
C. Sleep
1. Poor...........................................................................................................................  0
2. Moderate — unresponsive to medication................................................................  2
3. Moderate — responsive to medication....................................................................  4
4. Normal (patient has no complaints)........................................................................ 6
D. Leisure activity
1. None..........................................................................................................................  0
2. Reduction to sedentary, inactive types of leisure................................................... 3
3. Activities as before but moderately reduced...........................................................  4
4. As before therapy (normal)......................................................................................  5
E. Work status. Has your level of work activity dropped (including housework) ?
1. Yes . . . state the reason and answer second panel..............................................  0
2. No . . .  do not answer next panel.........................................................................  4
Current work status
1. Not working..............................................................................................................  0
2. Lighter work — part time........................................................................................  2
3. Lighter work — full time.........................................................................................  3
4. Previous or equivalent job part time....................................................................... 3
stricture, or both. All these investigators 
recognized that treatment results should be 
evaluated according to the degree of pallia­
tion achieved, but accurate definition and 
grading of the various symptoms and their 
progression were universally lacking.
In evaluation of the results of surgery for 
peptic ulcer disease in the stomach or duo­
denum, European authors16 have used a 
grading system proposed by Visick in 
1948,17 and it should be possible to con­
struct a similar grading system to evaluate 
therapy in cancer of the esophagus or in 
any other disease. Indeed, Angorn18 used 
a modified Visick grading system in his 
work on esophageal cancer. A wide range 
of questions was asked by an independent 
observer, but these centred on intestinal up­
sets such as vomiting, diarrhea and heart­
burn and did not include questions on sleep, 
leisure and work status. This is understand­
able since the work was aimed at the con­
troversy over the omission of a drainage 
procedure in esophagogastrectomy.
R ecommendations
In cancer of the esophagus we propose
a points system, as shown in Table VII, 
based on the revised questions already out­
lined. An attempt has been made to weight 
the various factors to make dysphagia alone 
capable of overruling all other features. 
Sleeping ability is next in importance, fol­
lowed by leisure enjoyment and work status 
at a roughly equal level. We considered 
using change in weight as a parameter in 
this assessment scheme. Weight measure­
ments have the advantage of being com­
pletely objective, in contradistinction to our 
question panels that depend heavily on 
subjective responses from patients. How­
ever, in esophageal carcinoma, weight 
changes often reflect the advance of distant 
secondary lesions, while swallowing and 
other symptoms remain unchanged.12 We 
have therefore rejected the use of weight 
changes in our grading system. In addition, 
in this presentation we wish to emphasize 
that where cure is so elusive, subjective 
well-being is all that really matters. This 
philosophic approach might be contrasted 
with the palliation index described by Clark 
and Lott.10 Their index was described as 
“that percent of post-therapy life which is
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useful or considered palliated”, but once 
again the criteria were objective features 
such as weight loss, development of fistulas, 
severity of radiation esophagitis and objective 
recurrence of tumour. In their paper the 
criteria used for each of these manifestations 
and how it was graded as to severity were 
not detailed.
In our proposed follow-up data form it 
should be noted that the question panel on 
pain has been further modified since pain 
is fairly often present and is not necessarily 
related to dysphagia. This fact must be 
recognized, and if pain is present the abil­
ity to control it is more important than the 
specific triggering mechanism. Similarly, 
the questions on work status have been 
modified to cover those who did not work 
prior to their operation. The maximum 
score would be 100, with 85 points or over 
, indicating an excellent result.*A score of 
between 65 and 84 can be considered good 
while a score between 40 and 64 is fair. 
Any score 39 and below comes into a fourth 
category of poor and unacceptable.
The proposed scheme awaits trial in 
evaluating treated cases so that possible 
deficiencies can be corrected. We hope, 
however, that this scheme or a modification 
of it will be widely adopted so that clinical 
series from many sources may be easily 
compared no matter what choice of treat­
ment is being evaluated. Clearly, natural, 
geographic, economic and cultural differ­
ences may demand the adoption of quite 
separate and distinctly different criteria 
from those we propose. But by allowing for 
such differences we believe that similar pre­
defined grading systems can be developed.
In conclusion it is urged that, aside from 
the reporting of mortality rates, no further 
statements be made on the efficacy of treat­
ment in cancer of the esophagus unless ob­
jective data are available from suitably 
constructed prospective comparative trials.
We thank Mrs. M. J. Moreton for her assistance 
in typing the manuscript.
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THE RELATION BETWEEN ILEAL RESECTION AND VITAMIN B*.,
ABSORPTION*
W. GRANT THOMPSON, MD, FRCP[C] and ELLEN WRATHELL, MD
4
Over 15 years, 33 patients, who had had 36 ileal 
resections that included the terminal ileum, had 
Schilling tests to measure the absorption of 
vitamin B12. In 11 patients who had 60 cm or 
more of ileum removed, only one test was nor­
mal, while in 25 patients with less than 60 cm 
resected, 17 tests were normal. Seven of the 
patients with over 60 cm of ileum resected had 
stool-fat estimations and none were normal. 
Eight of 10 patients who had less than 60 cm 
of ileum resected had normal stool-fat estima­
tions. Results of the Schilling test, but not of 
the stool-fat estimations, are proportional to 
the length of ileal resection, up to 60 cm. Re­
tention of terminal ileum tends to preserve vita­
min B12 absorption capacity. Thus, if more than 
60 cm of terminal ileum is removed, fat and 
B12 malabsorption are likely. The Schilling test is 
an indicator of the degree of terminal ileal dys­
function.
Sur une periode de 15 ans, 33 patients ayant 
subit un total de 36 resections ileales affectant 
I'ileon terminal, ont ete soumis a des epreuves 
de Schilling afin de mesurer I'absorption de la 
vitamine B12. Sur 11 patients a qui on a enleve 
60 cm d'ileon ou plus, une seule epreuve a 
donne un resultat normal, alors que chez 25 pa­
tients ayant eu une resection de moins de 60 
cm, 17 tests ont ete normaux. Une evaluation 
des lipides fecaux a ete effectuee chez sept 
des patients qui ont subit une resection de plus 
de 60 cm d'ileon; aucune n'a ete normale. 
Huit sur 10 patients qui ont eu une resec­
tion ileale de moins de 60 cm ont presente une 
teneur normale en lipides fecaux. Les resultats 
de I'epreuve de Schilling se sont montres pro- 
portionnels a la longueur de la resection jusqu’a 
concurrence de 60 cm, mais non revaluation 
des lipides fecaux. La conservation de I'ileon 
terminal tend a preserver la capacite d'absorp- 
tion de la vitamine B12. Done, si plus de 60 cm 
d’ileon terminal est enleve, il peut s'ensuivre 
une malabsorption des graisses et de la vita­
mine B12. L’epreuve de Schilling sert d'indica- 
teur du degre de dysfonctionnement de I’ileon 
terminal.
♦From the gastroenterology unit and department 
o f medicine, Ottawa Civic Hospital and University 
of Ottawa, Ottawa, Ont.
Reprint requests to: Dr. W. G. Thompson, Gastro­
enterology unit, 1st Link, Ottawa Civic Hospital, 
1053 Carling Ave., Ottawa, Ont. K1Y 4E9.
T h e  ileum is necessary for the absorption 
of vitamin B12 and bile salts. Ingested 
vitamin B12 combines with intrinsic fac­
tor produced by the gastric parietal cells, 
and the B12-intrinsic factor complex is 
transported to the ileum where B 12 is ab­
sorbed. Resection of the ileum leads to mal­
absorption of vitamin B12.1 Bile salts are 
secreted in bile and reabsorbed in the 
ileum.2 Thus, ileal resection leads to fecal 
wasting of bile salts, bile salt depletion, de­
creased concentration of intraintestinal bile 
salts, and steatorrhea.3’ 4 In a previous re­
port it was suggested that resection of 45 
cm or more of the terminal ileum will lead 
to vitamin B12 and fat malabsorption.4 The 
present study explores the relation between 
ileal resection and absorption of vitamin 
B12 and fat in 33 patients.
M a t er ia l  a n d  M e t h o d s
The files of patients who had Schilling 
tests for the measurement of vitamin B 12 
absorption5 over a 15-year period at the 
Ottawa Chic Hospital were reviewed, and 
those with ileal resection of known length 
were selected for study. Thirty-eight patients 
were found who had had 41 ileal resections. 
Four retained their terminal ileum and one 
had an additional ileojejunal resection. 
These patients were excluded from the 
study. There remained 33 patients who had 
had 36 ileal resections that included the 
terminal ileum.
The length of ileal resection was recorded 
in the pathologist’s report. Only those 
Schilling test results obtained without in­
trinsic factor were considered; the interval 
between surgery and performance of the 
Schilling test ranged from 1 to 216 months 
(average, 34 mo). When more than one 
test was done the first examination after 
surgery was used. Analysis of data suggested 
that the interval between surgery and the 
Schilling test did not affect the result since, 
for long intervals, results are evenly dis­
tributed about the point of 10%.
Nine of the 33 patients had ileal resec­
tion for volvulus, ulcerative colitis, tuber-
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culosis, carcinoma or carcinoid. Residual 
disease in these patients is unlikely. Twenty- 
four had resection for regional ileitis; in four 
of them there was clinical evidence of re­
current disease. Six had a permanent ileos­
tomy. Of the remainder, 12 had ileoascend- 
ing, 13 had ileotransverse, and 5 had ileo- 
sigmoid colostomy. One patient had three 
resections for regional enteritis. Another had 
two resections.
Stool fat was measured from 1 to 201 
months postoperatively (average, 37 mo) 
after 17 of the 36 resections. Daily stool 
fat was measured by a modification of the 
van de Kamer method.6 Although the num­
bers are small, analysis of the data did not 
suggest that the interval between operation 
and stool-fat estimation influenced the 
result.
R esults
The relation between the length of ileal 
resection and the result of the Schilling test 
is shown in Table I. Note that of 11 patients 
in whom 60 cm or more of ileum was re­
moved, only 1 had normal vitamin B12 
absorption (i.e., >  10%). With 60 cm of 
resection as the cut-off point, the data were 
submitted to Fisher’s exact test7 (Table II). 
Malabsorption of vitamin B12 was signifi­
cantly greater in those patients who had at 
least 60 cm of ileum resected, than in those 
with shorter resections (P <  0.002 by 
Fisher’s exact test).
In Fig. 1 the relation between the length 
of ileal resection and the result of the Schill­
ing test is plotted for 25 patients whose 
ileal resection was less than 60 cm. A re­
gression line drawn for these 25 patients 
with a slope significantly different from zero 
(P 0.025) indicates a direct relation be­
tween the length of resection and the degree 
of B12 malabsorption. This relation applied 
only to patients with less than 60 cm of 
ileum resected.
The Schilling test results in the four pa­
tients who had ileal resection for volvulus 
of the small bowel with preservation of the 
terminal ileum are summarized in Table III. 
These results are all higher than would be 
predicted from Fig. 1.
The relation between the length of ileal 
resection and daily stool-fat value is sum-
TABLE I.—Relation of Length of Ileal Re ­
section to Result of Schilling T est
L en g th  o f  
re sec tio n , cm
N o . / to ta l  no . o f  cases 
w ith  n o rm a l resu lt*  ( a n d  % )
0 — 19.9 5/6 (83)
20 — 39.9 6/8 (75)
40 — 59.9 6/11 (55)
60 — 79.9 1/9 (ID
80 + 0/2 ( 0)
‘Normal = urinary excretion of vitamin Bi2 > 10% 
of administered dose.
TABLE II.—E ffect of Ileal Resection of 60
CM OR MORE ON VITAMIN B t2 ABSORPTION
L en gth  o f  resection , cm
1 —  59 60  or m ore T o ta l
Patients with 
urinary Bi2 
excretion > 
10%................ 17 1 18
Patients with 
urinary Bi2 
excretion <  
10%................ 8 10 18
Total............... 25 11 36
20 46 60 80 100 120 140 160
Length of R e se ction  (c m )
Fig. 1.—Vitamin Bl2 absorption after ileal re­
section, plotted according to length of resection.
TABLE III.—Relation Between Result of 
Schilling T est and Length of Ileal R esection 
in F our Patients with Preservation of Termi­
nal Ileum
L en g th  o f  
resec tion , cm
L en g th  o f  te rm in a l 
ile u m  s p a r e d *  cm
B 12 in  u rin e , 
%
125 4 15
34 8 16
80 12 5.5
87 2 7.5
‘Surgeon’s estimate.
marized in Table IV. Again, note that all 
seven patients with 60 cm or more of ter­
minal ileum removed had more than 5 g/d
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TABLE IV.—Relation Between Length of 
Ileal Resection and Daily F at in Stool
Length of resection, 
cm
No. /total no. of cases 
with normal result* (and %)
0 — 19.9 3/3 (100)
20 — 39.9 2/2 (100)
40 — 59.9 3/5 ( 60)
60 — 79.9 0/6 ( 0)
80 + 0/1 ( 0)
*Normal = <  5 g/d fat in stool.
TABLE V.—Effect of Ileal Resection of 60
CM OR MORE ON DAILY AMOUNT OF STOOL FA T
Length of resection, cm
Stool fat ----------------------------------------- -
(g/d) 1 — 59 60 or more Total
> 5 8 0 8
< 5 2 7 9
Total 10 7 17
of fat in the stool. Again 60 cm of resection 
was taken as the cut-off point and the data 
were submitted to Fisher’s exact test (Table 
V). Thus, the likelihood of steatorrhea is 
significantly greater if 60 cm or more of 
terminal ileum is removed than with smaller 
resections (P <  0.002 by Fisher’s exact 
test).
The relation of stool fat to the length of 
resection is plotted in Fig. 2. For those 10 
patients with less than 60 cm of terminal 
ileum removed a regression curve is shown 
whose slope is not significantly different 
from zero. Stool weights in 17 patients 
ranged from 168 to 1430 g/d (mean, 503 ±  
244 g/d). There was no linear relation be­
tween stool weight and length of resection. 
In our laboratory normal stool weight is 
130 ±  78 g/d.
20 40 60 80 100 120 140
Length of Resection (cm )
Fig. 2. —Fat absorption after ileal resection 
plotted according to length of resection.
D isc u ssio n
From the data presented it appears that 
resection of 60 cm or more of terminal 
ileum results in a sharply increased likeli­
hood of vitamin B12 and fat malabsorption. 
When less than 60 cm of terminal ileum is 
removed there appears to be a direct rela­
tion between the length of resection and the 
degree of malabsorption of vitamin B12, but 
not of fat. When some terminal ileum is 
spared, the degree of vitamin B12 malab­
sorption is less than one might expect.
A number of factors might be expected 
to influence the results of the study. First, 
the measurement of ileal resection was re­
corded by different pathologists and the data 
were collected retrospectively. However, 
each pathologist was unaware of the Schil­
ling test result and of stool-fat estimation. 
Second, error might be introduced by includ­
ing patients with recurrent Crohn’s disease, 
but this was evident in only four patients. 
Third, bacterial contamination of the upper 
small bowel might cause malabsorption of 
vitamin B12 or fat, but “stagnant loop” was 
not demonstrated in any of our patients. The 
accuracy and reproducibility of the Schilling 
test also may be questioned, but all urine 
collections contained a minimum of 500 ml. 
The urine radioactivity is expressed simply 
as a percentage of the administered radio­
activity. Unfortunately, not all patients who 
underwent ileal resection at our institution 
had a Schilling test or stool-fat estimation. 
This introduces the possibility of patient se­
lection. Nevertheless, the patients presented 
here represent a sample of patients with ileal 
resection.
In a previous study4 it appeared that re­
section of 45 cm or more of ileum was likely 
to result in vitamin BX2 or fat malabsorp­
tion. Hofmann and Poley,3 reporting on 20 
patients with ileal resection, presented data 
suggesting that greater than 100 cm of ter­
minal ileal resection is necessary for suffi­
cient bile salt malabsorption to cause stea­
torrhea. The present study comprised 33 
patients and 60 cm appeared to be a more 
accurate cut-off point for both vitamin B 12 
and fat absorption.
A breath test in which the rate of ex­
cretion of labelled carbon dioxide is meas­
ured has been described as an indicator of
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ileal dysfunction8' 9 and appears to be more 
sensitive than the Schilling test in detecting 
its presence or absence. Fromm, Thomas 
and Hofmann9 presented the results of the 
Schilling test in 17 patients who had resec­
tion of the terminal ileum. The length of 
ileum resected in their series was measured 
in an undisclosed number of patients by the 
surgeon. Because of contraction when speci­
mens are placed in formalin, the stated 
length may have been greater than if the 
measurement had been made by a pathol­
ogist. Analysis of their data revealed that 
more than 60 cm was removed in 12 patients 
and in only 1 did the Schilling test give 
a normal result. Three of the five patients 
with shorter resections excreted less than 
10% of the administered dose of vitamin 
B12- When these figures are considered with 
our data, it appears that the Schilling test 
may reflect the length of nonfunctioning 
ileum. The Schilling test is inexpensive and 
should be a routine procedure following 
ileal resection to predict those patients who 
will require regular injections of vitamin
b 12.
The four additional patients with ileal 
resection who retained some terminal ileum 
(Table III) and five similar patients reported 
by Fromm, Thomas and Hofmann9 dem­
onstrated better vitamin B12 absorption than 
would be expected from other results. This 
suggests that the final few centimetres of 
ileum may be an effective site of vitamin 
B12 absorption. This conclusion is sup­
ported in studies of radioactive B12 uptake 
in the intestines of four patients by Booth 
and Mollin.1 However, Hagedorn10 found 
that the terminal 60 cm of ileum in three 
patients had less intrinsic factor-B]2 bind­
ing capacity than a more proximal segment. 
This discrepancy requires further investiga­
tion. It is possible that the ileocecal valve 
is important for vitamin B12 absorption 
either by slowing transit or by minimizing 
contamination of ileum by colon contents.
The amount of stool is also an indicator 
of the extent of ileal resection. In our ex­
perience and that of Fromm and colleagues9 
stool weight is usually increased with ileal 
resection, but bears little relation to either 
stool fat or the length of resection.
Surgeons should be aware that resection 
of 60 cm or more of terminal ileum will 
likely result in malabsorption of vitamin B12 
and fat. Preservation of a few centimetres 
of terminal ileum, if possible, may preserve 
BJ2 absorbing capacity. When less than 60 
cm of terminal ileum was resected the de­
gree of B12 malabsorption was found to be 
approximately proportional to the length of 
resection.
We thank Dr. George Lynch, department of 
epidemiology and community medicine, University 
of Ottawa, for statistical advice, and Miss Diane 
Moore and Mrs. Jean Buzza who assisted in the 
preparation of the manuscript.
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POSTOPERATIVE FLEXION CONTRACTURE OF THE KNEE:
A SIMPLE TECHNIQUE FOR ITS TREATMENT*
R. PETER WELSH, MB, ChB, FRCS[C]1 and DAVID L. MaclNTOSH, MD, FRCS[C]t
F lex ion  contractu re  is  not a com m on prob lem  
fo llow in g  knee surgery, but it  can be seve re  
enough to jeopard ize  the su cce s s  of the ope ra ­
tion. W ith  the Beath techn ique a stove-pipe ca s t 
is  w indow ed an te rio rly  and the ca s t is padded 
beh ind the leg, w h ich  is  then gen tly  wedged in to  
extension . In th is way many flex ion  con tractu res 
can be gen tly  and e a s ily  overcom e. In add ition , 
the need fo r se r ia l cas ting  or fo rc ib le  m an ipu la­
tion  is  obvia ted and the overa ll rehab ilita tion  
program  is  unim peded. In th is  paper the au thors 
report tw o illu s tra t ive  cases, and d iscu ss  the  
advantages and app lica tion s o f the  Beath te ch ­
nique.
La con tractu re  de flex ion  ne rep resente  pas un 
prob lem e frequent a la su ite  d 'une in te rven tion  
ch iru rg ica le  au genou, m ais e lle  peut e tre  su f- 
fisam m en t grave pour redu ire  a neant le 
su cce s  de I’operation. Dans la technique de 
Beath, une ouverture an te rieu re  e st p ratiquee 
dans un p la tre  cy lind rique  et le p la tre  est couss i- 
ne de rrie re  la jambe, laque lle  e s t  a lo rs douce- 
m ent rep liee  en extension . De ce tte  facon, plu- 
s ie u rs  con tractu res de flex ion  peuvent e tre  dou- 
cem ent et fac ilem en t su rm ontees. De p lus, on 
ev ite  le  beso in  de repeter le s p la tre s  en se r ie  ou 
de re cou rir a des m an ipu lations brutales, e t le  
program m e global de readaptation n 'est pas re ­
tards. Dans cette  com m unica tion , les au teu rs 
de criven t deux cas types, et d iscu ten t des avan- 
tages e t des ind ica tion s de la techn ique de 
Beath.
D e s p it e  the best intentions, some patients 
fail to regain full extension of the knee after 
knee surgery. While limitation of extensor 
capability up to 10° is compatible with 
normal function, a flexion contracture 
greater than 15° produces a marked altera­
tion in gait.
It is therefore necessary to consider treat­
ment of this condition early, for, once 
established, a flexion contracture can be dif-
*From the department of surgery, University of 
Toronto, Toronto, Ont.
tOrthopedic surgeon, The Wellesley Hospital, and 
lecturer in surgery, University of Toronto.
tOrthopedic surgeon, Toronto General Hospital, 
and associate professor, department of surgery, 
University of Toronto.
Reprint requests to: Dr. R. P. Welsh, Division 
of orthopedic surgery, The Wellesley Hospital, 160 
Wellesley St. E, Toronto, Ont. M4Y 1J3.
Fig. 1.—Conventional stove-pipe cast is applied 
with knee in maximal extension.
ficult to correct. An effective method of cor­
recting fixed flexion deformity was pro­
pounded some years ago by T. Beath (un­
published data), and since then we have 
used this technique successfully to resolve 
problems arising from postoperative flexion 
contracture of the knee.
T e c h n iq u e
A well-padded stove-pipe cylinder cast is 
applied from just below the groin to just 
above the malleoli, the knee being main­
tained in the fullest extension possible (Fig. 
1). Particular care is taken to pad the area 
of the tibial tubercle. This cast is allowed to 
harden and is then windowed, by removing 
the portion from the anterior half of the 
thigh and knee to the level of the tibial tu­
bercle (Fig. 2). Padding is then applied 
posteriorly between the splint and the skin. 
Successive layers are inserted over 2 to 3 
days easing the splint gradually backward
Fig. 2.—Cast is windowed anteriorly as outlined.
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Fig. 3.—Padding inserted posteriorly between 
thigh and cast gently levers knee into full ex­
tension.
from the thigh and gaining easy extension 
as more padding is added (Fig. 3). When 
the padding becomes bulky a further cast 
can be applied starting from the position of 
advantage achieved. The success achieved is 
illustrated in two typical case reports.
Case R eports
Case 1.—A 32-year-old woman with juvenile 
rheumatoid arthritis for 28 years had been 
unable to walk for 18 years. In April 1975, she 
underwent bilateral total hip replacement, and 
6 weeks later bilateral total knee arthroplasty. 
Shier hinges were used to overcome a fixed 
flexion deformity of 85 and 90°, respectively, 
in each knee. At operation, extension to —5° 
and flexion to 90° were achieved bilaterally.
Over the next 6 weeks, a flexion deformity 
gradually progressed so that she was unable to 
extend either knee beyond 40° flexion.
Three Beath casts were applied over a period 
of 12 days and correction to —5° extension was 
achieved. The patient suffered no discomfort 
by this method and was able to continue gait 
training with the splints applied. On removal 
of the casts the range of movement of the knee 
was from 5 to 85° flexion and her rehabilita­
tion was therefore greatly expedited.
Case 2 .—An 18-year-old man. struck across 
the left knee while felling trees, presented with 
a locked knee and massive hemarthrosis. At 
arthrotomy both anterior and posterior cruciate 
ligaments were partially torn, but no meniscal 
pathology was identified. Postoperativeiy, the 
patient was protected in a Jones bandage for 
3 days and mobilized on crutches; he was 
restricted to non-weight-bearing movement. 
Active rehabilitation began at 10 days, but 
despite this a 45° flexion contracture of the 
knee developed. The patient’s knee was ex­
amined under general anesthesia 4 weeks after 
the initial operation; the knee could be flexed 
to 130° but could not be extended beyond 40°. 
Arthroscopy was therefore performed but no 
intra-articular obstruction was found. Follow­
ing arthroscopy the patient’s knee was placed 
in three Beath casts over a 10-day period. He 
regained extension of the affected knee to —5° 
while preserving a 90° flexion range. Con­
ventional rehabilitation was then reinstituted 
and recovery followed.
Discussion
This technique is useful in the manage­
ment of any postoperative knee flexion de­
formity. Whether it follows a reconstructive 
procedure such as joint arthroplasty or the 
treatment of a traumatic problem there are 
several advantages to this technique: (a) it 
is simple; (b) it is readily accepted by the 
patient for it engenders no major discom­
fort; (c) the rehabilitation program may be 
continued in the splint; (d) the continued 
weight bearing accelerates resolution of the 
problem; (e) the risks of forced manipula­
tion with possible fracture are avoided. As 
illustrated in the second case, extension 
could not be obtained under anesthetic but 
was achieved with the Beath technique. This 
method of bolstering each cast also greatly 
reduces the number of cast changes neces­
sary. On the other hand, with the conven­
tional techniques the knee is forced into ex­
tension and serial stove-pipe casts are ap­
plied to obtain correction. The Beath techni­
que of gentle stretching makes it unnecessary 
to apply sudden pressure on the articular 
cartilage of the joint surfaces. The applica­
tion of such pressure can be very damaging 
to the articulation.
Conclusion
The Beath technique should be considered 
in the treatment of any flexion contracture 
of the knee resulting from trauma, infection, 
or inflammatory arthritis. The simplicity of 
the technique, the gentle gradual reduction it 
affords and the ready acceptance by the 
patient make it particularly appropriate.
R eference
1. M urray DG: Some thoughts on flexion de­
formity of knee. Orthop Rev 5: 1, 1976
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FUTURE OF ANESTHESIA*
J. R. A. RIGG, MD, FFARACS and J. D. HARRIES, MDt
The authors present an account of some of the 
problems facing the specialty of anesthesia, 
which suggests that the interdependence of 
these problems and of their solutions should 
be recognized. Recruitment, job satisfaction 
and clinical standards will be improved as a 
result of greater involvement by anesthetists 
in preanesthetic care as part of the health care 
team. Teaching programs require appropriate 
expansion and modification. The incorporation 
of a physician-assistant program is essential to 
the future of anesthesia.
Les auteurs relevent quelques un des problemes 
que rencontre I'anesthesie en tant que specia- 
lite; ce releve suggere que I’interdependance de 
ces problemes ainsi que celle de leurs solutions 
se doivent d’etre reconnues. Le recrutement, la 
satisfaction au travail et les normes cliniques 
se trouveront ameliores lorsque les anesthesistes 
prendront une plus grande participation aux 
soins pre-anesthesiques au sein de I’equipe des 
professionnels de la sante. Les programmes 
d'enseignement necessitent une expansion et 
une modification appropriees. L’incorporation 
d'un programme de formation d'assistants-mede- 
cins est essentielle au futur de I’anesthesie.
E vidence of increased concern for the wel­
fare of anesthesia as a specialty in Canada 
was reflected by the retreat for university 
anesthesia department heads held in King­
ston, Ontario in February 1975 and by an 
editorial published in the Canadian Anaes­
thetists’ Society Newsletter of July 1975.1 
The problems underlying this concern are 
complex and not unique to this country;2' 3 
indeed, some extend beyond the specialty 
and threaten the future of medical practice 
as a whole.2 In examining the issues in­
volved authors tend to restrict their discus­
sion to one or two areas of concern only. 
Wynands1 in his editorial concentrated on 
the importance of maintaining high stand­
ards in postgraduate education programs,
*From the department of anesthesia, McMaster 
University, Hamilton, Ont.
tAssociate dean for educational affairs, Eastern 
Virginia medical school, Norfolk, VA.
Reprint requests to: Dr. J. R. A. Rigg, Depart­
ment of anesthesia, McMaster University Medical 
Centre, 1200 Main St. W, Hamilton, Ont. L8S 
4J9.
Parkhouse2 emphasized the importance of 
motivation and job satisfaction, and Moya4 
and Greene5 emphasized standards of pa­
tient care in an active research milieu.
We believe that the problems facing the 
specialty are interdependent. If appropriate 
solutions are to be found, they must be dealt 
with concurrently rather than individually. 
In this paper we discuss the problems that 
we believe are most important and outline 
possible solutions.
T he  P roblem s
Recruitment
We believe that there is a chronic short­
age of physician-anesthetists in Canada.1’ 6 
We have examined data prepared by the 
education committee of the Canadian 
Anaesthetists’ Society (unpublished data) 
and conclude that two main factors con­
tribute to this shortage. First, the number 
of graduates of Canadian medical schools 
undertaking residency training in anesthesia 
remained stationary (at about 30/yr) from 
1962 to 1975. During the same period, the 
number of students graduating from Cana­
dian medical schools increased. Therefore, 
a smaller proportion of Canadian graduates 
are entering residency training programs in 
anesthesia. Second, the number of foreign 
and Canadian graduates who have received 
certification as specialists in anesthesia by 
the Royal College of Physicians and Sur­
geons of Canada decreased from an aver­
age of 67/yr for the period 1963 to 1971 
to an average of 54/yr for the period 1972 
to 1974. If we consider an attrition rate of 
3.5% and a population increase, the number 
of newly qualified anesthetists required to 
maintain the same proportion in active prac­
tice is 90 to 100/yr. The experience of pro­
grams in the United States for the period 
1961 to 1970 was comparable to the ex­
perience in Canada. However, in the last 
5 years there has been a 50% increase in 
the number of North American graduates 
undertaking anesthesia training in the US. 
This is probably due to the success of the 
National Preceptorship Program, which be­
gan in the US in 1966.
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A major obstacle to adequate recruitment 
in Canada is that the anesthetist is perceived 
to occupy a secondary, technical role in the 
operating room. A study of medical stu­
dents’ attitudes before and after an obliga­
tory 2-week clerkship in anesthesia showed 
that a majority of students placed anesthesia 
near the bottom of the medical specialty 
hierarchy, which was usually headed by 
surgery.7 In interviews after the clerkship, 
it was clear that the students’ low ranking 
of the anesthetist before the clerkship had 
been reinforced by their perception of the 
relation between the anesthetist and the sur­
geon. The students also regarded unfavour­
ably the anesthetist’s relative lack of contact 
with the patient; it seems clear that most 
students choose a career in medicine that 
involves more extensive and continuing in­
teraction with patients. Following this clerk­
ship experience, most students felt that the 
level of patient contact and continuing re­
sponsibility were less than they wanted from 
a career in medicine.7
Job Satisfaction
The demand for specialist service in anes­
thesia by surgeons, radiologists, obstetricians 
and others is not matched by appropriate 
administrative control by the specialty of 
anesthesia over the deployment of staff. It 
is difficult to reconcile heavy service de­
mands, usually determined at the con­
venience of surgical colleagues, with the 
need for continuing education and profes­
sional advancement. This situation generates 
considerable frustration in the day-to-day 
management of anesthesia practice. The 
one-to-one physician-patient ratio is the 
standard that has been adopted; it allows 
little flexibility in the performance of clin­
ical activities. Consultation and attention 
to detail in the preparation of patients for 
anesthesia may require hurried telephone 
calls between cases.
Preanesthetic assessment is limited often 
to a brief contact late in the evening before 
surgery. This situation is not conducive to 
optimal preanesthetic management and 
makes it difficult for the anesthetist to estab­
lish an appropriate rapport with his patient. 
A patient who is known to have several 
serious medical problems and who is sched­
uled for elective surgery requires a thorough 
preanesthetic assessment. Logically, this as­
sessment should be performed by the anes­
thetist who is to administer the anesthetic. 
However, in Ontario there is no financial 
inducement to perform a consultative assess­
ment unless it is conducted more than 72 
hours before anesthesia, or, if within 72 
hours of surgery, by another anesthetist.
The obviation of pain and the mainte­
nance of homeostasis during the operative 
period are major responsibilities for the 
anesthetist. Full recovery from the effects 
of anesthesia is also important. In most in­
stances the intraoperative course is unevent­
ful; the anesthetist monitors the patient in 
a well-controlled “steady stage” of anesthe­
sia, and occasionally maintains this by drug 
administration. At least two physicians, the 
anesthetist and the surgeon, are in constant 
attendance in the operating room, where the 
patient’s cardiovascular and respiratory func­
tions are well controlled and stable. Para­
doxically in the recovery room, where the 
patient undergoes rapid changes in physi­
ologic function, the only monitoring is by 
the recovery room nurse who is often caring 
for several patients at the same time. If a 
life-threatening complication occurs in the 
recovery room, the attending anesthetist is 
usually unavailable as he has commenced 
his next case. The guidelines for minimal 
standards of practice of anesthesia in Can­
ada do not designate specifically who is 
responsible in this situation. The problem 
is that with the present design of anesthesia 
services it is often not possible to identify 
a particular anesthesiologist who is respon­
sible for emergencies in the recovery room. 
This situation highlights the problem of 
physician-manpower shortage.
Som e Possible Solutions
The problems of recruitment and job 
satisfaction are closely interrelated. Before 
discussing possible solutions, we should first 
ask, What does the medical student expect 
of a career in medicine today? Evidence is 
accumulating that student expectations have 
changed considerably during the past 
decade.8 In general, the student wants to 
establish satisfying interpersonal relations 
with patients and other health professionals.
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Another important factor for the student is 
the perception of a suitable degree of con­
tinuing intellectual challenge. Our sugges­
tions for change as presented in this paper 
are based on attempts to meet these needs.
Our first suggestion is that anesthetists 
endeavour to become more integrated into 
the health-team approach to patient care. 
They must become more actively involved 
in preanesthetic assessment and manage­
ment, and emphasize to students and col­
leagues the importance of these aspects of 
anesthesia care to intraoperative and post­
operative progress and management. If this 
is to be implemented in a meaningful way, 
it is clear that, as a group, anesthetists must 
devote more time to both the practice and 
teaching of these aspects of anesthesia care. 
Since anesthetists are already excessively 
burdened by demands for operating-room 
services, it is clear that they must expand 
and reorganize their operating-room man­
power. An expanded residency teaching 
program should be implemented. This ex­
pansion would come in part from trainee 
specialists in anesthesia and in part from 
trainees in other specialist programs who 
use anesthesia services; for the latter group 
an understanding of the patient’s responses 
to anesthesia must be an important part of 
the student’s postgraduate education. Such 
a program would facilitate improvement in 
communication among personnel involved 
in anesthesia. We agree with Greene5 that 
good communication is essential to advanc­
ing the quality of both the art and science 
of anesthesia.
At the same time we believe a compre­
hensive physician-assistant program is es­
sential. Such physician-assistants could take 
over many minor tasks now performed by 
anesthetists, thus freeing anesthetists for the 
application of skills for which they alone 
have been trained. Gravenstein, Steinhaus 
and Volpitto0 have documented many of 
the responsibilities that could be assumed 
by physician-assistants. Physician-assistant 
programs have been attempted before, but 
without measurable success,3' 10> 11 We 
sympathize with the views of McIntyre10 
who has described some of the problems of 
developing skilled health professionals as 
physician-assistants. He stated that “al­
though the theoretical knowledge necessary
may be small, the responsibility for making 
a decision is great”. The physician—assistant 
must have the ability to maintain constant 
vigilance over long periods of time and a 
temperament that can tolerate periods of 
physical inactivity.
An important aspect is the development 
of an attractive work situation for the 
physician—assistant. The incorporation of 
physician—assistants into the service of 
anesthesia would also help to improve the 
image and status of the specialty, which, as 
we have indicated, is an important con­
sideration in future recruitment of anesthet­
ists.
In a survey of net income published by 
Health and Welfare Canada, anesthetists 
ranked 18th among 22 medical and surgical 
specialties. This indicates that the broad 
spectrum of clinical acumen, responsibility 
and difficult working conditions, including 
the heavy demands for night and weekend 
work, are not recognized in Canadian pro­
vincial tariffs. We believe that this fact also 
has a substantial adverse bearing on both 
recruitment and job satisfaction.
The Boone committee report12 has iden­
tified anesthesia as a specialty in which there 
will be a continuing shortage of personnel 
during the next decade. About 60% of 
trainees in the specialty are foreign medical 
graduates. We believe that this proportion 
will fall because of the recent change in 
provincial immigration policies; inevitably 
the total number of trainees will also fall • 
and exacerbate the problem. >
Physician-assistant programs in anesthe­
sia are, we believe, opposed by most special­
ists in Canada. Therefore it is important 
that stringent policy guidelines be estab­
lished for both development and imple­
mentation of such programs; the role of 
physician-assistants must be broadly based 
in order to overcome the current problems 
of recruitment and job satisfaction. We rec­
ognize that training large numbers of physi­
cian-assistants in anesthesia would change 
the organization and structure of a vital 
component of the present system of surgical 
care. This fact has two major implications: 
first, the success of programs must depend 
on the acceptance of physician-assistants by 
all health-care professionals involved, in­
cluding anesthetists themselves, surgeons,
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obstetricians, radiologists, family practition­
ers and nurses. If attitudes are to change, 
long-range planning is required. Second, a 
formal comprehensive evaluation system 
must be devised. It is imperative that pro­
grams be established that will enable un­
biased observers to compare the system with 
the models of delivery of anesthesia care 
presently available in Canada.
T h e  C o n f l ic t s  o f  C h ang e
The development of subspecialization 
within anesthesia is a natural and inevitable 
consequence of maturation of the specialty;4 
it is also natural that philosophical conflicts 
will result. For example, some believe that 
a full-time effort in a subspecialty area is 
essential. Others believe that anesthetists 
must spend at least some of their profes­
sional time practising all forms of anesthesia. 
The anesthetist’s primary responsibilities are 
in the operating room, but we agree with 
Moya4 that anesthesiologists working full 
time in a special unit in or outside the oper­
ating room should not have to prove their 
credentials by occasionally administering all 
forms of anesthesia.
Our views may appear threatening to 
those who prefer to spend most of their time 
in the operating room without having spe­
cialized interests; they are not so intended. 
There has been a rapid development in the 
physiologic and pharmacologic sciences re­
lated to the practice of anesthesia. In addition, 
improved understanding of the interac­
tion of anesthesia with the pathophysiologic 
problems of disease has made the practice 
of anesthesia more complex. If they are 
to adapt to the changing needs of patients, 
surgeons and medical undergraduates, it is 
clear that anesthetists must change. They
must establish an educational and career 
infrastructure in keeping with the intellectu­
al needs of today’s graduates; only in this 
way can they be attracted to the specialty.
In conclusion, we quote Parkhouse:2 “It 
is in the care of patients before and after 
operations that anesthetist’s contributions 
have been most commonly and persistently 
underused.” There is a common impression 
that the anesthetists’ opinion is frequently 
either ignored or given insufficient weight; 
this can be especially disillusioning to stu­
dents and residents in training. We believe 
that most surgeons and physicians would 
welcome more comprehensive participation 
from anesthetists.
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dien de chirurgie”.
Manuscrits. Les texts originaux des articles 
et des autres communications y compris un 
nombre limite de rapports sur des cas spe- 
ciaux doivent etre rediges en double exem- 
plaire, en frangais ou anglais, et accompagnes 
d’une lettre demandant leur publication dans 
le Journal. Veuillez les dactylographier sur une 
seule face d’une feuille normal avec double 
interligne et grandes marges.
Illustrations. Les illustrations telles que des 
photographies d’appareils cliniques, des ra- 
diographies, des photomicrographies, des gra- 
phiques et des digrammes doivent etre four- 
nies sous la forme d’epreuves sur papier glace 
sans montage, les bordures intactes, d’un format 
ne depassant pas 12 x 17 cm. Chaque illustra­
tion doit etre munie d’une legende dactylo- 
graphiee sur une page separee du texte de 
Particle. S’il s’agit d’une photomicrographie, 
expliquez le contraste et l’echelle de l’agran- 
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les elements d’une illustration doivent etre d’u­
ne dimension suffisante afin de demeurer visi­
bles lorsque les necessites de l’impression im- 
posent une reduction de l’image fournie. II 
ne faut pas qu’on puisse identifier un patient 
grace a une illustration a moins qu’il n’y ait 
expressement consenti par ecrit; faute de per­
mission les traits de sa physionomie doivent 
etre obliteres. Les illustrations en couleur ne 
seront publiees qu’aux frais de leur auteur. 
Si 1 illustration provient d’une autre source que 
celle de l’auteur, il convient d’obtenir tant de 
l’auteur que de l’editeur de l’ouvrage dont elle 
est tiree, l’autorisation de s’en servir aux fins 
de la publication.
Tables. II faut en les etablissant se conformer 
au format rectangulaire du Journal et les 
rediger sur des feuilles separees du texte, une 
table par feuille.
References. Celles-ci doivent etre citees dans 
le texte au moyen d’un chiffre et groupees 
dans l’ordre a la fin de votre article en vous 
conformant a la maniere de faire adoptee par 
ce Journal. Les references a des periodiques 
doivent etre conformes a celles qu’adopte 
1’Index Medicus.
Un resume qui ne doit pas depasser 125 mots 
doit accompagner chaque article sur une page 
separee.
A titre d approbation, un exemplaire du ma- 
nuscrit redige sera envoye aux auteurs mais 
non les epreuves.
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CO RRESPO N D EN CE
A MODIFIED SURGICAL 
NEEDLE-DRIVER
To the editor: Surgical tools are fashioned 
for specific purposes and the needle-driver 
is one of the most important of the sur­
geon’s tools. Occasionally, however, the 
coupling of the tool to the user is not 
optimal. Use of the standard needle-driver 
sometimes requires a change in hand position 
between grasping the needle and forming 
the stitches. One position often used with 
the standard needle-driver has been 
described by Weiss (Fig. I).1 To adapt the
Fig. l.-H and  position often used with standard 
needle-driver.
standard needle-driver for more efficient 
use in this position, a new needle-driver 
was designed and a prototype made. An 
18.5-cm needle-driver was used as the 
standard. One handle was shortened by 3.5 
cm to act as the thumb arm, and the position 
of the latching mechanism was altered cor­
respondingly. For more stability and con­
trol, a 2-cm hook was incorporated 5.5 cm 
from the tip on the finger arm (Fig. 2). Fig. 
3 illustrates a natural hand position for the 
modified needledriver.
Fig. 2.-M odified needle-driver and standard 
needle-driver.
Fig. 3.—Hand position used with modified 
needle-driver.
In my opinion, this modified needle- 
driver should require less repositioning of 
the hand than does the standard model and 
therefore will save time during operative 
procedures, although it has not been tested 
quantitatively for time-saving potential. The 
basic design of the modified needle-driver 
is applicable to needle-drivers smaller or 
larger than the prototype.
J. S. D o r se y , m d
Resident in surgery,
University of Toronto,
Toronto, Ont.
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CHOLECYSTECTOMY IN A 
REGIONAL HOSPITAL
To the editor: We reviewed the results of 
689 consecutive cholecystectomies per­
formed over a 10-year period (Jan. 1, 1960 
to Dec. 31, 1969) in Battlefords Union 
Hospital, North Battleford, Saskatchewan, 
a regional hospital with 160 beds.
The cholecystectomies were performed 
by certificated surgeons and by noncertifi- 
cated physicians with surgical privileges in 
the hospital. During the 10-year period 16 
medical practitioners performed this pro­
cedure.
Operative cholangiography was per­
formed in 117 (17.03%) of the 689 cases. 
The common bile duct was explored in 72
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(10.5%) cases and stones were found in 28 
(38.8%). The cholecystectomy was asso­
ciated with other surgical procedures in 16 
cases. The frequency of complications was 
13.9% and increased with age, the greatest 
frequency (24.3%) being in the 7th decade. 
The mean postoperative stay in hospital 
was 11.2 days; for patients who underwent 
exploration of the common bile duct it was 
15 days.
The mean age of patients in the series was 
48 years. The mortality was 0.87% . The 
age range of the patients who died was 59 
to 74 years. All the deaths were thought 
to be due to cardiovascular catastrophe. In 
patients whose death was considered clinic­
ally to be due to myocardial infarction, 
autopsy did not indicate the direct cause of 
death,1 although pre-existing ischemic 
changes in the heart were apparent.
The reported mortality following chole­
cystectomy has ranged from 0.3 to 2 % .2-4 
Glen and McSherry4 recorded a mortality 
rate of 0.3% in 1444 cases of chronic 
cholecystitis and 2.3% in 266 cases of acute 
cholecystitis. In our series, of 63 patients 
with acute cholecystitis 1 (1.6%) died 
following surgery.
Although the postoperative hospital stay 
was longer as a result of common bile duct 
exploration, no patient died following the
procedure.2’ 4
It seems fair to contend that under 
present-day conditions a variety of physi­
cians with differing surgical skills and ex­
perience can still contribute to optimal 
results in terms of morbidity and mortality 
of cholecystectomy performed in a relatively 
small hospital.
We thank the members of the Board of 
Battlefords Union Hospital for their assist­
ance and appreciate the help of Mr. W. B. 
Stefaniuk, the hospital administrator. Partic­
ularly we thank the surgeons who performed 
the cholecystectomies and the medical staff 
of the hospital for their cooperation.
P. K. Chakrabartty, md , frcs( ed in ),
FRCS, FRCS[C]
Battlefords Union Hospital,North Battleford, Sask.
S. R. Chadwick , cert , cchra
Department of health records,Battlefords Union Hospital.
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CANADIAN CRITICAL 
CARE SOCIETY
To the editor: Over the past few months, 
interested individuals have been attempting 
to initiate the formation of a Canadian 
Critical Care Society. This society will be 
open initially to all medical practitioners 
interested in critical care medicine, includ­
ing physicians, surgeons, pediatricians, anes­
thetists and others. Close liaison with the 
Royal College of Physicians and Surgeons 
of Canada is anticipated and, indeed, the 
inaugural meeting of this subsection of the 
Royal College will be at the annual meeting 
of the college in Vancouver in January 
1978. A half-day program is anticipated. 
The scientific meeting will include an 
inaugural address by Dr. Bryan Kirk on the 
history and future of critical care medicine 
in Canada. It is hoped that there will be a 
response in the form of abstracts, which 
will be included in the Royal College call 
for abstracts; we will follow their format.
Any person interested in participating in 
this new organization may contact me at 
the address below. Further information will 
be available as the society becomes more 
concrete in form and function.
R. L. H olliday, md , f r c s [c ]
Acting secretary,Canadian Critical Care Society,Department of surgery,Victoria Hospital,391 South St.,London, Ont. N6A 4G5.
PRIMARY MALIGNANT MELANOMA
To the editor: We appreciate the opportunity 
to preview Dr. R. E. Falk’s editorial in this 
issue of the Journal (page 399), in which 
he discusses our paper on prophylactic 
lymph-node dissection for malignant mela­
noma (page 429).
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Surgeons often hold divergent views on 
management methods, and Dr. Falk cer­
tainly is entitled to his preference, if he can 
justify it on the basis of fact rather than 
opinion. A choice should be made and 
evaluated in the light of end results. This 
we have done in terms of the most meaning­
ful index of outcome: patient survival. The 
data show that, in Nova Scotia, prophylactic 
node dissection resulted in a far larger num­
ber of survivors than did surgery directed 
only at the site of the primary melanoma.
Dr. Falk correctly points out that 147 
patients with malignant melanoma is not a 
large number. But the series is large enough 
that, coupled with the marked difference in 
outcome, the superiority of node dissection 
cannot reasonably be attributed to chance.
Reports from “more cosmopolitan” or 
single-hospital referral centres usually deal 
with selected patients. Selection is com­
pounded when a series is limited to patients 
who receive their primary treatment in a 
particular institution. Our study deals with 
75% of the melanomas in a well-defined 
geographic area with a fairly stable popula­
tion and may more accurately reflect the 
natural history of the disease. We see many 
referred patients from the other Atlantic 
provinces, but none of these are included in 
the Nova Scotia melanoma series.
We acknowledge the problems inherent in 
a retrospective study. We conscientiously 
searched our data and methods for a sys­
tematic error, and we found none. We would 
welcome examination of our primary data 
by an outside observer for any possible 
error in our methods.
Dr. Falk notes the low survival rate in 
patients who did not have prophylactic node 
dissection. This is precisely the observation 
that we felt obligated to bring to the atten­
tion of our surgical colleagues.
Dr. Falk also implies that our findings 
are an isolated phenomenon, unsupported 
by the surgical literature. We believe that 
the references we have cited are a fair and 
representative sample from both sides of an 
admittedly controversial subject, one on
which there is no clear-cut predominant 
opinion.
Nowhere in our paper do we discuss 
therapeutic node dissection. The number 
of our cases is too small to allow us to draw 
conclusions on that subject. We do know 
that, of patients in this province with stage 
II disease (regional node enlargement on 
initial presentation), the 5-year survival is 
only 10%; this dampens our enthusiasm 
for waiting until the nodes enlarge. Never­
theless, we acknowledge that there are some 
patients with Clark’s level 3 melanoma for 
whom prophylactic node dissection may not 
be necessary. In practice we limit this ap­
proach to patients who are reliable and 
available for frequent follow-up examination 
and whose lesions have a measured depth of 
invasion of less than 0.76 mm.
It was not our intent to discuss treatment 
programs or to advise others on the man­
agement of their patients. We simply showed 
the outcome of two courses of action; each 
surgeon must draw his own inferences and 
apply them to his own situation.
In 1977 there is no cure for malignant 
melanoma except appropriate surgery. It is 
therefore mandatory that the patient undergo 
complete assessment and clinical staging at 
the time of initial presentation, that the 
lesion be evaluated for position with respect 
to lymphatic drainage, Clark’s level, Bres- 
low’s depth of invasion and histologic ag­
gressiveness, and that treatment be carefully 
planned and adequate at the time when the 
histologic diagnosis is established. For 
clinical stage I malignant melanoma, we 
now carry out wide local excision of the 
primary site plus prophylactic node dissec­
tion for virtually all Clark’s levels 4 and 5 
lesions and for the majority of Clark’s level 
3 melanomas. In the light of the experience 
reported in our paper, we could not justify 
a policy of less thorough treatment for our 
patients.
S. T. NORVELL, JR, MD, FRCS[C]
A. J. B o durtha , m b , b s , f r c s[c]
Department of surgery,
Victoria General Hospital,
Halifax, NS.
A local anaesthetic  
that gives you  
MORE TIME...
More time surgically before regression.
More time post-operatively before onset of pain.
MARCAINE
0.50%  0 .257.1 ( B U P I V A C A I N E  H Y D R O C H L O R I D E  I N J E C T I O N )
PLAIN or with Epinephrine 1:200,000 
In multiple dose vials of 50 ml.
0.25% is recommended for infiltration and nerve block. 
0.50% is recommended for nerve block.
A U RO RA  ON TA R I O
M A R C A I N E ,  T. M.  r e g ' d  C a n a d a
81
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Books R eceived
Anthropological and Cross-Cultural Themes in 
Mental Health. An Annotated Bibliography, 
1925-1974. Armando R. Favazza and Mary 
Oman. 386 pp. University of Missouri Press, 
Columbia, 1977. $30.00. ISBN 0-8262-0215-2. 
Backache. Ian Macnab. 135 pp. Must. The Wil­
liams & Wilkins Company, Baltimore; Burns 
& MacEachern Limited, Don Mills, 1977. 
$20.00. ISBN 0-683-05353-1.
Breast Cancer. Edited from the Proceedings of the 
International Breast Cancer Conference held in 
Lucerne, Switzerland, July 31st-August 4th,
1976. Edited by Albert C. W. Montague, Geary 
L. Stone and Edward F. Lewison. 549 pp. Must. 
Alan R. Liss, Inc., New York, 1977. $38.00. 
ISBN 0-8451-0012-2.
Breast Reconstruction Following Mastectomy for 
Carcinoma. William M. Cocke, Jr. 91 pp. Must. 
Little, Brown and Company, Boston; J. B. 
Lippincott Company of Canada Ltd., Toronto,
1977. $27.50. ISBN 0-316-14920-9.
Chirurgie Plastique de I'Abdomen. J. S. Elbaz
and G. Flageul. 118 pp. Must. Masson, Paris, 
1977. $22.00. ISBN 2-225-46442-1.
Chirurgie du Tube Digestif. Oesophage — Esto- 
mac — Duodenum — Jejuno-Ileon — Colon 
— Rectum — Anus. Cl. Oliver. 365 pp. 
Must. Masson, Paris, 1977. $14.62. ISBN 2- 
225-45716-6.
Cicatrix Optima. Techniques for Ideal Wound 
Healing. Janos Zoltan, E. F. Shaw Wilgis, 
Frederik Hansen and others. 215 pp. Must. 
University Park Press, Baltimore, 1977. $39.50. 
ISBN 0-8391-0815-X.
Clinical Paediatric Surgery. Diagnosis and Man­
agement. 2nd ed. Peter G. Jones. 586 pp. Must. 
Blackwell Scientific Publications, Oxford; J. B. 
Lippincott Company of Canada Ltd., Toronto,
1976. Price not stated, paperbound. ISBN 0- 
632-00436-3.
Congenital Adrenal Hyperplasia. Edited by Peter 
A. Lee, Leslie P. Plotnick, A. Avinoam 
Kowarski and others. 532 pp. Must. University 
Park Press, Baltimore, 1977. $37.50. ISBN 0- 
8391-0974-1.
Current Management of Acute Gastrointestinal 
Hemorrhage. Edited by Teruo Matsumoto. 
256 pp. Must. Charles C Thomas, Publisher, 
Springfield, IL, 1977. $19.75. ISBN 0-398- 
03582-2.
A Diagnostic Approach to Chest Diseases. Dif­
ferential Diagnosis Based on Roentgenographic 
Patterns. 2nd ed. Glen A. Lillington and Robert 
W. Jamplis. 608 pp. Must. The Williams & 
Wilkins Company, Baltimore; Burns & Mac­
Eachern Limited, Don Mills, 1977. $62.00. 
Early Care of the Injured Patient. 2nd ed. The 
Committee on Trauma. American College of 
Surgeons. 443 pp. Must. W. B. Saunders Com­
pany, Philadelphia, 1976. Price not stated. 
ISBN 0-7216-1161-3.
La Hanche en Croissance. Jean Gabriel Pous, 
Alain Dimeglio, Jose Adrey and others. 216 
pp Must. J. B. Bailliere, Paris, 1976. Price 
not stated. ISBN 2-7008-0009-5. 
Hospital-Acquired Infections in Surgery. Edited by 
Hiram C. Polk, Jr. and H. Harlan Stone. 158 
pp Charts. University Park Press, Baltimore,
1977. $16.50. ISBN 0-8391-1102-9.
Infant and Child Care in Heart Surgery. Clinical 
Manual of the Department of Cardiovascular 
Surgery, Children’s Hospital Medical Center, 
Boston, Massachusetts. Robert M. Sade, Delos 
M. Cosgrove and Aldo R. Castaneda. 190 pp. 
Must. Year Book Medical Publishers, Inc., Chi­
cago, 1977. Price not stated, paperbound. ISBN 
0-8151-7504-3.
Infections of Prosthetic Heart Valves and Vascu­
lar Grafts. Prevention, Diagnosis, and Treat­
ment. Edited by Richard J. Duma. 352 pp. 
Must. University Park Press, Baltimore, 1977. 
$26.50. ISBN 08391-0973-3.
Lymphedema. Supplement to “Lymphology”. 
Edited by Leo Clodius. 192 pp. Must. Georg 
Thieme Verlag, Stuttgart; Stratton Intercontinen­
tal Medical Book Corporation, New York, 1977. 
Price not stated. ISBN 3-13-544901-7.
Morphogenesis and Malformation of the Genital 
System. The Third International Conference on 
Morphogenesis and Malformation. Held at Lake 
Wilderness, Washington, July 1976. Edited by 
Richard J. Blandau and Daniel Bergsma. 161 
pp. Must. Alan R. Liss, Inc., New York, 1977. 
$18.00. ISBN 0-8451-1009-8.
Neurosurgical Treatment in Psychiatry, Pain, and 
Epilepsy. Edited by William H. Sweet, Sixto 
Obrador and Jose G. Martin-Rodriguez. 763 
pp. Must. University Park Press, Baltimore, 
1977. $42.50. ISBN 0-8391-0881-8.
Operative Surgery. Fundamental International 
Techniques. The Hand. Edited by R. Guy Pul- 
vertaft. 407 pp. Must. Butterworths & Co. 
(Publishers) Ltd., London; Butterworths & Co. 
(Canada) Ltd., Scarborough, 1977. Price not 
stated. ISBN 0-407-00618-4.
Outline of Orthopaedics. 8th ed. John Crawford 
Adams. 472 pp. Must. Churchill _ Livingstone, 
Edinburgh; Longman Canada Limited, Don 
Mills, 1976. $13.50, paperbound. ISBN 0-443- 
01167-2.
The Patient’s Guide to Surgery. How to Make 
the Best of Your Operation. Lawrence Galton. 
468 pp. Avon Books, New York, 1977. $2.50, 
paperbound. ISBN 0-380-00683-9.
Physiology of the Heart and Circulation. Robert C. 
Little. 334 pp. Must. Year Book Medical Pub­
lishers, Inc., Chicago, 1977. Price not stated, 
paperbound. ISBN 0-8151-5475-5.
Progress in Pediatric Hematology/Oncology. Vol. 
1. Hemophilia in Children. Edited by Margaret 
W. Hilgartner, Carl Pochedly and Denis R. 
Miller. 213 pp. Must. Publishing Sciences 
Group, Inc., Littleton; Chimera Press Inc., 
Willowdale, Ont., 1977. Price not stated. ISBN 
0-88416-138-2.
Surgical Techniques Illustrated. Vol. 2, No. 2, 
Spring 1977. Anterior Resection of the Rectum. 
Sphincter-Saving Rectal Resections. Edited by 
Ronald A. Malt. 90 pp. Must. Little, Brown and 
Company, Boston, 1977. Annual subscription 
rates, $68.00, US; $75.00, foreign.
Urologic Pathology: The Prostate. Myron Tannen- 
baum. 419 pp. Must. Lea & Febiger Philadel­
phia; The Macmillan Company of Canada Lim­
ited, Toronto, 1977. $32.95. ISBN 0-8121- 
0546-X.
The Year Book of Plastic and Reconstructive Sur­
gery. 1977. Edited by Frederick J. McCoy, 
Reed O. Dingman, Dwight C. Hanna and others. 
405 pp. Must. Year Book Medical Publishers, 
Inc., Chicago, 1977. Price not stated. ISBN 
0-8151-5818-1.
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Three
t"
versatile Lilly antibiotics T
f Keflin I.V. Kefzol I.M.
cephaiothin sodium ceiazolin sodium
neutral
Keflex Oral
cephalexin
■*
ACTION
In-vitro tests demonstrate the cephalosporins 
are bactericidal by the inhibition of cell wall 
synthesis.
INDICATIONS
Keflin may be indicated for the treatment of 
infections of the respiratory tract, skin and soft 
tissues, bones and joints, genito-urinary tract, 
peritoneum, and in septicemia and endocarditis 
when the infection is caused by susceptible 
organisms.
CONTRAINDICATION
Keflin is contraindicated in persons who have 
shown hypersensitivity to cephalosporin 
antibiotics.
WARNINGS
Before cephaiothin therapy is instituted, careful 
inquiry should be made concerning previous 
hypersensitivity reactions to cephalosporins 
and penicillin.
There is some evidence of partial cross-aller­
genicity of the penicillins and cephalosporins. 
Patients have been reported to have had severe 
reactions (including anaphylaxis) to both drugs.
PRECAUTIONS
Prolonged use of Keflin may result in the over­
growth of non-susceptible organisms. To avoid 
unnecessarily high serum concentrations of 
Keflin in patients with impaired renal function, 
the dosage schedule of Keflin should be adjusted. 
Administration of more than 6 g per day of Keflin, 
for more than three days, may be associated with 
thrombophlebitis, and the veins may have to 
be alternated.
A false-positive reaction for glucose in the urine 
may occur with Benedict's or Fehling's solution 
or with Clinitest tablets, but not with Tes-Tape. 
The safety of this product for use during preg­
nancy has not been established.
ADVERSE REACTIONS
The following adverse reactions have been 
reported:
Hypersensitivity- Maculopapular rash, urticaria, 
eosinophilia, drug fever, reactions resembling 
serum sickness, and anaphylaxis.
Blood-Neutropenia, thrombocytopenia, haemo­
lytic anemia, and positive direct Coomb’s test. 
Hepatic and Renal-Transient rise in SGOT,
BUN, and alkaline phosphatase levels without 
clinical evidence of renal or hepatic impairment. 
Other-Pain, induration, tenderness, and 
elevation of temperature with repeated intra­
muscular injections; thrombophlebitis has 
occurred and is usually associated with intra­
venous daily doses of over 6 g for more than 
three days.
DOSAGE RANGE
In adults, a dosage of 500 mg every six hours is 
adequate in uncomplicated pneumonia, furuncu­
losis with cellulitis, and most urinary tract 
infections.
In severe infections, the dose may be increased 
to 1 g every four hours.
In life-threatening infections, doses of up to 2 g 
every four hours may be required.
DOSAGE FORMS
Keflin is available in dry powder form in individual 
rubber-stoppered vials:
1 g (equivalent to cephaiothin) 10 ml size
2 g (equivalent to cephaiothin) 100 ml size 
4 g (equivalent to cephaiothin) 100 ml size 
Further information is available on request.
INDICATIONS
Kefzol may be indicated in the treatment of 
infections of the respiratory tract, genito-urinary 
tract, skin and soft tissues, bone and joint, and 
in septicemia and endocarditis when the 
infection is caused by susceptible organisms.
PRECAUTIONS
Prolonged use of Kefzol may result in the over­
growth of non-susceptible organisms.
To avoid unnecessarily high serum concentra­
tions of Kefzol in patients with impaired renal 
function, the dosage schedule of Kefzol should 
be adjusted.
Safety of this product for use in premature infants, 
in infants under one month of age, or during 
pregnancy has not been established.
A false-positive reaction for glucose in the urine 
may occur with Benedict's or Fehling's solutions 
or with Clinitest tablets, but not with Tes-Tape.
WARNINGS
Before cefazolin therapy is instituted, careful 
inquiry should be made concerning previous 
hypersensitivity reactions to cephalosporins and 
penicillin.
There is some clinical and laboratory evidence of 
partial cross-allergenicity of the penicillins and 
the cephalosporins. Patients have been reported 
to have had severe reactions (including anaphyl­
axis) to both drugs.
ADVERSE REACTIONS
The following reactions have been reported: 
Hypersensitivity-Drug fever, skin rash, vulvar 
pruritus and eosinophilia.
Blood — Neutropenia, leukopenia, thrombocyto­
penia, and positive direct and indirect Coombs' 
tests.
Hepatic and Renal-Transient rise in SGOT, 
SGPT, BUN, and alkaline phosphatase levels 
without clinical evidence of renal or hepatic 
impairment.
Gastrointestinal-Nausea, anorexia, vomiting, 
diarrhea, oral candidiasis (oral thrush), and 
cheilitis.
Other-Pain and phlebitis at the site of injection 
Genital and anal pruritus, genital moniliasis, 
and vaginitis.
CONTRAINDICATION
Kefzol is contraindicated in persons who have 
shown hypersensitivity to cephalosporin 
antibiotics.
DOSAGE RANGE
Adults-From 250 mg to 1 g every 6 to 8 hours. 
Children -  From 25 to 100 mg per kg, divided into 
two to four equal doses.
In patients with renal impairment, see package 
insert for detailed directions.
HOW SUPPLIED
Kefzol is available in lyophilized form in individual 
rubber-stoppered vials:
500 mg (equivalent to cefazolin), 5 ml size 
1 g (equivalent to cefazolin). 10 ml size 
Further information is available on request.
INDICATIONS
Keflex may be indicated in the treatment of 
bacterial infections of the respiratory tract, 
genito-urinary tract, skin and soft tissues when the 
infection is caused by susceptible organisms.
PRECAUTIONS
Antibiotics, including Keflex, should be admin­
istered cautiously to any patient who has demon­
strated some form of allergy, particularly to drugs. 
In penicillin-allergic patients, cephalosporin 
antibiotics should be used with caution. If severe 
reaction, individual idiosyncrasy, or allergy 
should occur, the drug should be discontinued 
and appropriate treatment initiated. Keflex 
should be administered with caution in the 
presence of markedly impaired renal function.
In long-term therapy, periodic monitoring of 
hematology, renal and hepatic functions should 
be done.
Safety of this product for use during pregnancy 
has not been established.
Positive direct Coombs' tests can occur.
In patients being treated with Keflex, a false­
positive reaction for glucose in the urine may 
occur with Benedict's or Fehling’s solutions or 
with Clinitest tablets, but not with Tes-Tape.
ADVERSE REACTIONS
Diarrhea has been reported; it was very rarely 
severe enough to warrant cessation of therapy. 
Nausea, vomiting, dyspepsia and abdominal pain 
have also occurred.
Allergies (in the form of rash, urticaria, and angio- 
edema) have been observed. These reactions 
usually subsided upon discontinuation of the 
drug.
Other reactions have included genital and anal 
pruritus, genital moniliasis, vaginitis and vaginal 
discharge, dizziness, fatigue and headache. 
Esinophilia, leucopenia due to neutropenia, and 
slight elevation in SGOT and SGPT have been 
reported.
CONTRAINDICATIONS
Keflex is contraindicated in patients with known 
allergy to the cephalosporin group of antibiotics.
DOSAGE RANGE
Adults— From 1 to 4 g daily in divided doses. 
Children — From 25 to 50 mg per kg, divided into 
four doses.
HOW SUPPLIED
Keflex is available in pulvules equivalent to 
250 mg cephalexin; in tablets equivalent to 500 
mg cephalexin; for oral suspension equivalent to 
125 mg and 250 mg cephalexin.
Further information is available on request.
ELI LILLY AND COMPANY (CANADA) LIMITED. TORONTO, ONTARIO 
Product information available upon request
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B O O K  R E V I E W S
CHIRURGIE 76. Resumes de la Conference,
des Tables Rondes, des Forums et Com­
munications du 78e Congres Frangais de
Chirurgie. Edited by J.-Cl. Patel. 198 pp.
Masson, Paris, 1976. $14.08. ISBN 2-225-
455073-2.
II s’agit d’un volume paru en juin 1976 et qui 
reunit les resumes de la conference, des tables 
rondes, des forums et des communications du 
78e Congres frangais de Chirurgie, tenu a Paris 
du 20 au 23 septembre 1976.
Les sujets traites sont evidemment tres nom- 
breux. Les grands chapitres des tables rondes 
comprennent: (1) chirurgie abdominale et di­
gestive, (2) problemes generaux, anesthesie, 
reanimation, (3) orthopedie et traumatologic, 
et (4) chirurgie urologique et gynecologique. 
Les forums sont divises en forum digestif, fo­
rum vasculaire et forum urologie et chirurgie 
generate. Quelques autres chapitres completent 
le volume: faces a faces techniques, chirurgie 
experimentale et communications particulieres.
Specifiquement, voici quelques sujets traites 
en chirurgie digestive: aigiie, tumeurs benignes 
gastro-duodenales, tumeurs du pancreas, her- 
nie hiatale, hemorroi'des et sutures automa- 
tiques.
Les septicemies pre- et per-operatoires, la 
prevention de l’infection operatoire ont fait 
l’objet de publications a ce congres.
En chirurgie vasculaire, on a traite entre 
autres sujets: des reinterventions precoces dans 
la chirurgie reconstructrice des arterites des 
membres inferieurs, de l’arteriographie per- 
operatoire, de la revascularisation de l’artere 
femorale profonde et des indications de la 
sympathectomie lombaire.
En chirurgie urologique, on a traite des tu­
meurs du rein, des kystes simples du rein et du 
cancer de la prostate.
Quelques travaux ont aussi ete presentes en 
chirurgie orthopedique et gynecologique, fa- 
ciles a interpreter.
II s’agit en conclusion, d’une etude impor- 
tante et bien documentee qui selon les auteurs 
“ne peut etre consideree que comme le point 
de depart d’une etude qui devrait permettre au 
moment de sa reappreciation, dans dix ans, 
une meilleure approche de cette maladie”.
R. Cote
Professeur associe,
Departement de chirurgie,
Universite Laval,
Quebec, PQ.
THE HIP. Proceedings of the Fourth Open 
Scientific Meeting of The Hip Society, 1976. 
270 pp. Illust. The C. V. Mosby Company, 
Saint Louis, 1976. $31.00.
This book consists of 20 papers presented by 
well-known orthopedic surgeons at the fourth 
annual scientific meeting on hip surgery held 
in New Orleans in 1976.
The book is well illustrated with numerous 
radiographs, drawings and charts; many vital 
statistics are included. The opening chapter is 
one of historical interest; it deals with the mile­
stones in the development of modern hip sur­
gery from the first American operation done 
in 1826 for an osteotomy of the hip, to the 
present. Included also is a retrospective review 
of 700 intertrochanteric fractures treated by 
various methods of internal fixation. The per­
plexing subject of idiopathic avascular necrosis 
is thoroughly reviewed and various methods of 
dealing with the problem are discussed.
The last half of the book is devoted to a 
discussion of the total hip prosthesis. Although 
this is a successful operation in 90% of cases, 
problems arise with the remaining 10%. Such 
difficulties are well discussed. In particular the 
management of complications associated with 
the use of methylmethacrylate is included. The 
final section deals with problems of total hip 
replacement that may arise in specific groups 
of patients. Particular attention is given to the 
subjects of hip surgery in the hemophiliac, to­
tal hip replacement for tumours of the hip and 
the management of patients with an infected 
hip both before and after surgery.
This is a useful reference book and is rec­
ommended for those who deal with surgical 
problems of the hip joint.
H. I. J. Kellam 
Orthopedic surgeon,
Ottawa Civic Hospital,
Ottawa, Ont.
PRACTICAL OPHTHALMIC PLASTIC 
AND RECONSTRUCTIVE SURGERY. 
Merrill J. Reeh, Charles K. Beyer and Ge­
rard M. Shannon. 205 pp. Illust. Lea & Fc- 
biger, Philadelphia, 1976. Price not stated.
For anyone interested in the anatomy and sur­
gical treatment of the eye and eyelids this is an 
excellent work; it is more atlas than text.
The first chapter could hardly be improved; 
the structures of the orbital cavity and the soft 
tissues of the orbital region are beautifully 
illustrated. The second chapter on basic prin-
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ciples is a description of plastic surgery tech­
nique. It is written clearly and simply; its les­
sons can be applied by all surgeons.
Among the chapters in this book are sec­
tions on eyelid reconstruction, surgery of the 
canthus, blepharoplasty and the lacrimal 
system; all are well illustrated. As a plastic sur­
geon, I was particularly interested in the section 
on blepharoplasty. The authors have provided 
a statement on the present standard plastic 
surgical procedures; there are no surprises. 
The section on ptosis of the upper eyelids is 
particularly well done.
Some of the descriptions of operative pro­
cedures do not match in clarity the diagrams 
illustrating them; a picture is indeed often more 
useful than many words. Frequently, to gain a 
full understanding of the subtleties of tech­
nique, the explanations must be re-read and the 
diagrams re-examined.
All doctors, regardless of their type of prac­
tice, can turn to this slim volume when they 
want to know something about plastic surgical 
problems of the eye. It is a useful book and is 
recommended especially for its illustrations.
D. C. Robertson 
Head,
Divison of plastic surgery,
Toronto General Hospital,
Toronto, Ont.
1976 YEAR BOOK OF SURGERY. Edited
by Seymour I. Schwartz and others. 520 pp.
Must. Year Book Medical Publishers, Inc.,
Chicago, 1976. Price not stated.
This volume continues in the style of previous 
editions. Papers are chosen and abstracted by 
the editors with a short editorial comment fol­
lowing. The papers are mostly from the Amer­
ican literature but other English language jour­
nals are included. Publication dates of the 
originals range from March 1974 to February 
1976. Most articles are of a clinical nature, 
but some experimental presentations are in­
cluded.
After a brief overview the text is divided into 
27 sections including general topics such as 
shock, infections and healing and more spe­
cific subjects such as skin, breast, head and 
neck, and the cardiothoracic, vascular, gastro­
intestinal and endocrine systems.
The book will be of interest to those wishing 
to have a quick review of the recent literature 
in general surgery.
J. E. Devitt 
Director,
Department of continuing medical education, 
University of Ottawa,
Ottawa, Ont.
